Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRP,Agouti-related protein,40058,0.302677008283177,0.00471014561917414,0.293445122869596,0.311908893696759,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL27,C-C motif chemokine 27,39868,0.273535258362247,0.00577958445472336,0.262207272830989,0.284863243893504,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN1,CCN family member 1,39758,0.397169117491108,0.00684074681432124,0.383761253735038,0.410576981247178,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.110436472887703,0.00271372966501599,0.105117562744271,0.115755383031134,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES1,Liver carboxylesterase 1,39854,0.321412380503479,0.00744064172899281,0.306828722714653,0.335996038292305,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F7,Coagulation factor VII,39899,0.123670548105343,0.00278743673890403,0.118207172097091,0.129133924113595,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FURIN,Furin,39913,0.134414284504585,0.00316991100357832,0.128201258937572,0.140627310071599,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCG,Pro-glucagon,39477,0.513037707368988,0.0114067121702973,0.490680551515205,0.535394863222771,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHR,Growth hormone receptor,37124,0.111255852598939,0.00267622726703832,0.106010447155544,0.116501258042334,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.30652843651259,0.00710847988270403,0.29259581594249,0.32046105708269,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF9,Protein turtle homolog A,37437,0.317408784268377,0.00767866310763762,0.302358604577407,0.332458963959347,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.085352725142469,0.00203282272068018,0.0813683926099359,0.0893370576750022,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLR,Low-density lipoprotein receptor,39882,0.443709383032489,0.00382120404389663,0.436219823106451,0.451198942958526,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPL,Lipoprotein lipase,39868,-0.197749952146385,0.00439790796997799,-0.206369851767542,-0.189130052525229,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFGE8,Lactadherin,39858,0.257904006570741,0.00381060025406757,0.250435230072768,0.265372783068713,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPY,Pro-neuropeptide Y,40030,0.382085491063758,0.00580884880485862,0.370700147406235,0.393470834721281,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.121096428392279,0.00285232578710928,0.115505869849545,0.126686986935014,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.159371850480639,0.00374048890515246,0.15204049222654,0.166703208734738,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH,Parathyroid hormone,37039,0.314072317835466,0.00739861694925566,0.299571028614925,0.328573607056007,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.200783925126127,0.00437966402104724,0.192199783644875,0.20936806660738,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.139618239907657,0.00303434366373508,0.133670926326736,0.145565553488578,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.162781565415184,0.00399459123040574,0.154952166603589,0.170610964226779,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBC,Inhibin beta C chain,39858,0.152701966168518,0.00391180989601558,0.145034818772328,0.160369113564709,1.11253692934484e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROC,Vitamin K-dependent protein C,39908,0.0940133379270404,0.00243141191954812,0.0892477705647261,0.0987789052893547,1.11257924658913e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APCS,Serum amyloid P-component,37333,0.122602997054126,0.00327599895351037,0.116182039105245,0.129023955003006,1.01129418018143e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR37,Prosaposin receptor GPR37,39585,0.226745567426395,0.0060905730368802,0.21480804427411,0.23868309057868,8.25210625940984e-291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADIPOQ,Adiponectin,37453,-0.231788569380574,0.00622026704566944,-0.243980292790086,-0.219596845971062,1.79791700002012e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.29713149775576,0.00800733023824267,0.281437130488804,0.312825865022716,5.25720415384462e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL23,C-C motif chemokine 23,39931,0.144505650724856,0.00389780913061091,0.136865944828858,0.152145356620853,9.35931539697098e-289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.290225895747952,0.00782673895956596,0.274885487387203,0.305566304108701,1.54363977326963e-288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPM,Carboxypeptidase M,39955,0.119760740430751,0.00326726727208222,0.11335689657747,0.126164584284032,1.38759594562624e-282
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.183369210954582,0.00501395427340656,0.173541860578705,0.193196561330459,2.63583551396829e-281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.300249301643236,0.0082252244327441,0.284127861755058,0.316370741531415,2.98571329765323e-280
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.493205860946413,0.0137230960254705,0.466308592736491,0.520103129156335,6.3887456069946e-272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS15,Enteropeptidase,39788,0.301271382556059,0.00845674399282437,0.284696164330123,0.317846600781994,1.60452600663423e-267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG2,Desmoglein-2,39858,-0.0891254554194405,0.00253942792691439,-0.0941027341561927,-0.0841481766826883,4.93314106013742e-260
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.261877955891599,0.00755357126602306,0.247072956210194,0.276682955573004,5.65249696306103e-254
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.219165765869021,0.00632572434106803,0.206767346160527,0.231564185577514,1.17460701036911e-253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP1,Neuropilin-1,39949,-0.0913115523224178,0.002636489571443,-0.0964790718824461,-0.0861440327623895,1.45358141587224e-253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA1,Glutathione S-transferase A1,39841,0.278808634777351,0.00808709435836464,0.262957929834956,0.294659339719746,2.69403874296479e-251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTR,Transthyretin,37309,0.0816295728353659,0.00238716227729319,0.0769507347718713,0.0863084108988606,8.12368989076394e-246
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0944193172539495,0.00277202045476258,0.0889861571626148,0.0998524773452841,1.68250891861017e-245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIP2,Cysteine-rich protein 2,39749,0.116503223626317,0.00342061992320134,0.109798808576843,0.123207638675792,1.81899260357502e-245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.109462471181213,0.00323297203589983,0.10312584599085,0.115799096371577,7.6318848690719e-243
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.34204610167484,0.0101505766864523,0.322150971369394,0.361941231980287,1.62263013381619e-240
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0903354949568275,0.00268302445828191,0.085076767018595,0.09559422289506,2.96549100491269e-240
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCHE,Cholinesterase,37208,0.088189737969479,0.00261880869843477,0.0830568729205468,0.0933226030184111,1.10115921204158e-238
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.245084661435973,0.00732788056111119,0.230722015536195,0.259447307335751,3.23880141084754e-237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLTP,Phospholipid transfer protein,39976,-0.114355578850017,0.00342962518949117,-0.12107764422142,-0.107633513478615,8.60703720732103e-236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.0988822236385285,0.0030021608204818,0.0929979884303841,0.104766458846673,2.99899032406563e-230
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAT,Tissue-type plasminogen activator,40002,0.155888097187558,0.00474105141533939,0.146595636413493,0.165180557961623,1.45368158142799e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.385582435066445,0.0117456830591638,-0.408603973862406,-0.362560896270484,7.31126070560495e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP5,Retinol-binding protein 5,39788,0.175336414942368,0.00534183559980761,0.164866417166745,0.185806412717991,1.05922727413945e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA3,Glutathione S-transferase A3,39477,0.239862662886962,0.0073063897645578,0.225542138948429,0.254183186825495,1.2319470908051e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFI,Complement factor I,37453,0.0624634722548583,0.00189850222315335,0.0587424078974777,0.0661845366122389,1.69337691782852e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFH,Complement factor H,36763,0.0734771188759792,0.00223479216231878,0.0690969262378344,0.077857311514124,9.54810919391587e-228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.354451320178703,0.0108389210126273,0.333207034993954,0.375695605363453,4.17454878081922e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY1,Aminoacylase-1,39868,0.192873302327799,0.00589977719251474,0.18130973903047,0.204436865625127,5.56230639439706e-227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.191434005097915,0.00594471344058854,-0.203085643441469,-0.179782366754362,1.44555063362643e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0924068882941642,0.0028629066466332,-0.0980181853215653,-0.0867955912667631,4.21719236500264e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.157115107546076,0.00488478829241991,0.147540922492933,0.166689292599219,7.66363784621664e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0955246391988567,0.00297275352888224,0.0896980422822475,0.101351236115466,1.23939476478863e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUSB,Beta-glucuronidase,39919,0.180451264503528,0.00561778742064163,0.16944040115907,0.191462127847986,1.82949953276896e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F9,Coagulation factor IX,39908,0.0558250096167332,0.00173879033480607,0.0524169805605133,0.0592330386729531,2.97520781294589e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.0783275092405449,0.00243437673430182,0.0735561308413134,0.0830988876397765,7.39935312638366e-219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0848587542728118,0.00265327309756452,0.0796583390015853,0.0900591695440382,1.27106065058158e-217
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0588756569778444,0.00184613326478534,0.0552572357788651,0.0624940781768236,2.0705717132778e-216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0917763115158991,0.00289147312175746,0.0861090241972545,0.0974435988345437,1.80511855818956e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA4,Kallistatin,37241,0.0707782474401148,0.00223097413186984,0.0664055381416499,0.0751509567385797,4.87807084928766e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.178659048984266,0.00567117512400553,0.167543545741216,0.189774552227317,3.03167123093791e-211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0849051327284537,0.00269771399083808,-0.0901926521504963,-0.0796176133064111,4.89671816808029e-211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPB1,Beta-ureidopropionase,37437,0.275310506017116,0.0087864849920404,0.258088995432717,0.292532016601515,3.84533403378491e-208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFP,Properdin,37453,0.0690408844844281,0.00220917629069689,0.0647108989546622,0.073370870014194,4.08672036059427e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN3,Contactin-3,39858,0.0975506490140252,0.00313130409264009,0.0914132929924506,0.1036880050356,6.57243620000833e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPIND1,Heparin cofactor 2,37424,0.0839478181332062,0.00268814635114327,0.0786790512849654,0.089216584981447,8.26818142360524e-207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYNU,Kynureninase,40058,0.135508965155309,0.00435951507439931,0.126964315609486,0.144053614701131,4.32967243363355e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.0946408503455694,0.00303714449405436,0.0886880471372229,0.100593653553916,7.03411670655154e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9,Complement component C9,37445,-0.157718226673806,0.00506269970975534,-0.167641118104926,-0.147795335242685,7.3630635657859e-206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFM,Afamin,37453,0.0562413112192026,0.0018117470941907,0.0526902869145888,0.0597923355238163,1.80505795447845e-204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.161554359110549,0.00523551505008528,0.151292749612382,0.171815968608716,4.78702532819729e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.154731556128196,0.00501850838599132,0.144895279691653,0.164567832564739,7.03019218024062e-203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0565607948552562,0.00184861681238065,0.0529375059029901,0.0601840838075223,1.10574903594241e-199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCA,Alpha-synuclein,37124,0.3392121709985,0.0110875052572687,0.317480660694254,0.360943681302747,1.07647638269158e-198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0879689816038464,0.00288629844117717,0.0823118366591391,0.0936261265485537,2.40378045286125e-198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.320872300528195,0.0105743176563237,0.3001466379218,0.341597963134589,1.43807832415916e-196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.245411214847873,0.00807401088877886,0.229586153505866,0.261236276189879,2.40105933618641e-196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.164449331749762,0.00542461419553598,0.153817087926511,0.175081575573012,2.16138071468714e-195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHBG,Sex hormone-binding globulin,37445,-0.149115390359004,0.00493095506273364,-0.158780062281962,-0.139450718436046,1.78885150880148e-194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0980607225502356,0.00326363409812914,-0.104457445382569,-0.0916639997179025,4.64459602864971e-193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBP,Protein AMBP,40003,0.0556801249375627,0.0018568831287099,0.0520406340052913,0.0593196158698341,2.70688683281617e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.104561406052704,0.00352242405879656,-0.111465357207945,-0.0976574548974626,1.51615996608302e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.205035886876864,0.00692148995666642,0.191469766561798,0.21860200719193,9.46116282609608e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR2,Cadherin-related family member 2,39788,0.207458758216228,0.00700404566090535,0.193730828720853,0.221186687711602,9.82451952267698e-188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR3,Anterior gradient protein 3,39464,0.16791783383651,0.00567055016571652,0.156803555511706,0.179032112161314,1.53573301924913e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.132088454456252,0.00446671270744842,0.123333697549653,0.140843211362851,4.08681500850068e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL16,C-C motif chemokine 16,40052,0.148121869941766,0.0050134518927692,0.138295504231938,0.157948235651594,6.71663809227311e-187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRP,Gastrin-releasing peptide,37043,0.147511092439304,0.00499194663021303,0.137726877044086,0.157295307834521,7.06379152575856e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELN,Elastin,37437,0.0949976206737916,0.00321810367754326,0.0886901374658068,0.101305103881776,1.10642948047772e-185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.207998495644085,0.00712444768528582,0.194034578180925,0.221962413107246,1.43113318228325e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.173722397301512,0.00600959544174593,0.16194359023569,0.185501204367334,4.81119470574452e-179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0679795894826941,0.00234896030598687,0.0633756272829598,0.0725835516824284,9.25354666797697e-179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.0597658293492412,0.00207556773193862,0.0556977165946415,0.0638339421038409,7.96978553459381e-178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F10,Coagulation factor X,37445,0.0732933084988666,0.00254304002127485,0.0683089500571679,0.0782776669405653,2.39367777949901e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0693447061209861,0.00241361359184142,0.064614023480977,0.0740753887609953,4.63326921519315e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOST,Sclerostin,39846,0.105162393939564,0.0036848611601479,0.0979400660656739,0.112384721813454,8.98370986413708e-175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEG1,Protein HEG homolog 1,37124,0.0740612258656417,0.00260061434391728,0.0689640217515639,0.0791584299797196,3.34101684748416e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.184889532614771,0.0065133708988355,0.172123325653054,0.197655739576489,7.1140079263116e-173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAB2,Stabilin-2,37437,0.0765100602420009,0.00269226823798484,0.0712332144955506,0.0817869059884512,1.28334858772587e-172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPC,C-type natriuretic peptide,39866,0.124415322530342,0.00440412133127918,0.115783244721035,0.133047400339649,2.23190059791674e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0766694426542155,0.00271284294197569,0.0713522704879432,0.0819866148204879,8.5598318027387e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO3,Beta-enolase,37043,0.162915004154122,0.00580248369012699,0.151542136121473,0.174287872186771,1.62206015085443e-168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.231536641728465,0.00827338451757286,0.215320808074022,0.247752475382908,1.78991680317949e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,P4HB,Protein disulfide-isomerase,39776,0.104521149200983,0.0037499900378,0.0971711687268945,0.111871129675071,5.74468102499056e-167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.185440198314847,0.00666780902072908,0.172371292634218,0.198509103995476,1.39860927684432e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.157312856305601,0.00567530405549238,0.146189260356836,0.168436452254366,2.98163596218281e-165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0692797526267917,0.00250532839535545,0.0643693089718951,0.0741901962816884,1.95048317492587e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0735612744515044,0.00266894463419669,0.0683301429684789,0.0787924059345299,1.96341892382781e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF21,Fibroblast growth factor 21,40011,0.316669968508774,0.0115003439684434,0.294129294330625,0.339210642686923,3.7586421462761e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0562007433604128,0.00204439074518757,0.0521937374998452,0.0602077492209805,1.24975521823277e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MME,Neprilysin,39788,0.208360920265355,0.0075814335723625,0.193501310463525,0.223220530067186,1.68756214348977e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL16,Pro-interleukin-16,40058,0.109088409687281,0.00397313322745095,0.101301068561477,0.116875750813085,2.94413004601494e-162
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.200136621087814,0.00728629973436269,0.185855473608463,0.214417768567165,1.36293272519017e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCLY,Selenocysteine lyase,39984,0.13007584540723,0.00474779684884967,0.120770163583485,0.139381527230975,1.45415400135146e-161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH1,Somatotropin,39846,-0.475092930260363,0.01742158852984,-0.50923924377885,-0.440946616741877,4.29293861729532e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.130816118252383,0.00479782694689707,0.121412377436464,0.140219859068301,4.89707136087269e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTYMK,Thymidylate kinase,37437,0.180465918843873,0.00660668801619846,0.167516810332124,0.193415027355622,5.60828916194427e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0671388602705861,0.00246348083022916,0.062310437843337,0.0719672826978353,6.4148718059362e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.326951938123263,0.0120017191405508,0.303428568607783,0.350475307638743,9.24170378897779e-160
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPY30,Protein dpy-30 homolog,39979,0.155610004028348,0.00571796964746333,0.14440278351932,0.166817224537377,1.73556470899279e-159
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.168829790900034,0.00621248136604151,0.156653327422592,0.181006254377475,2.08302912753168e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUMB,Protein numb homolog,37056,0.22056264930673,0.00814475628094419,0.20459892699608,0.236526371617381,3.19336867021346e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS1,Protein MTSS 1,37382,0.287112222567497,0.0106305007373358,0.266276441122319,0.307948004012676,1.61358963712141e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORT1,Sortilin,39846,0.0970403750635355,0.00360144564135258,0.0899815416064845,0.104099208520587,2.00223840791939e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0868212034293184,0.00322408507007174,0.0805019966919778,0.093140410166659,2.93391493174417e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11R,Junctional adhesion molecule A,39858,0.146688990688199,0.0054657640230347,0.135976093203051,0.157401888173347,3.13934299698161e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLA,Alpha-galactosidase A,37088,0.0978311714341169,0.00363793128485783,0.0907008261157955,0.104961516752438,3.88462010249715e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.152902152636768,0.00569905532107548,-0.164072301066076,-0.14173200420746,4.10604465529843e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL22,C-C motif chemokine 22,39686,0.130377989212773,0.0048638446386293,0.120844853721059,0.139911124704486,7.81169860472062e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKB,Creatine kinase B-type,37437,-0.150462626970661,0.00560332136578101,-0.161445136847592,-0.139480117093731,8.42137303264612e-155
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORD,Sorbitol dehydrogenase,39963,0.177094018908417,0.00661713609984245,0.164124432152726,0.190063605664108,2.04270196623353e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EEF1D,Elongation factor 1-delta,37437,0.23526191907092,0.00879119649956438,0.218031173931774,0.252492664210066,8.63941086126008e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH9,Myosin-9,37437,0.285588163591571,0.0107372199790663,0.264543212432601,0.306633114750541,5.43090170755898e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.360920307833219,0.0135813325476775,0.334300896039771,0.387539719626667,1.01238739439286e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRN,"Attractin, Isoform 2",37453,0.0416645638947132,0.00156912209381491,0.038589084590836,0.0447400431985904,1.68575495311476e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS8,Prostasin,39805,0.102679506087988,0.00387521197850417,0.09508409061012,0.110274921565856,1.9820814293732e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.2336679838395,0.00882009574391107,0.216380596181434,0.250955371497566,2.07856048291892e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.217556597592176,0.00824312533657639,0.201400071932486,0.233713123251866,3.06423355292682e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOMO1,Nodal modulator 1,39858,0.0604627540805159,0.00229373972763622,0.0559670242143489,0.0649584839466829,6.17783942094929e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0828835258589169,0.00314567458589614,0.0767180036705604,0.0890490480472733,7.56454570439175e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MVK,Mevalonate kinase,39587,0.201545708086233,0.00764980443995526,0.18655209138392,0.216539324788545,9.8000023999562e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.147246671078417,0.00558805740774087,0.136294078559245,0.158199263597589,2.84450697951017e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.124369119507109,0.00471924507471297,0.115119399160672,0.133618839853547,3.13148782354834e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLN,Promotilin,39866,0.226250399770041,0.00861185987000029,0.20937115442484,0.243129645115242,5.67691974038352e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.108939107433043,0.00414851453306565,0.100808018948235,0.117070195917852,7.09776771027089e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3F,Semaphorin-3F,39868,0.0648059206404901,0.00246765920706138,0.0599693085946498,0.0696425326863304,7.2716712137193e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHK,Ketohexokinase,37043,0.163995088974061,0.00624450115958909,0.151755866701266,0.176234311246855,3.2421905158926e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.135420042906764,0.00517425032491164,0.125278512269937,0.145561573543591,7.19000645588715e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR5,Cadherin-related family member 5,39868,0.0978384451716714,0.00375098535456368,0.0904865138767266,0.105190376466616,6.49222551306243e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.172065842671193,0.00658693516078467,0.159155449756055,0.184976235586331,1.07920611049613e-146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.200118096930997,0.00771507788963334,0.184996544267316,0.215239649594679,8.33987444602982e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.13102302542264,0.00505145344442889,0.121122176671559,0.14092387417372,8.52404939551851e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYAP1,Synapse-associated protein 1,37124,0.143887692364334,0.00554700293053117,0.133015566620493,0.154759818108175,9.36958937002589e-145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.109108990407987,0.00421563562071114,0.100846344591393,0.117371636224581,1.02565868166361e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.302014357895225,0.011650579058193,0.279179222941167,0.324849492849284,1.5027156760123e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0539449986341616,0.00208440634730157,0.0498595621934505,0.0580304350748727,4.0680473106949e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0563919563447174,0.00218485585997762,0.0521096388591613,0.0606742738302735,5.81684687926762e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.170017833649786,0.00660702091657389,0.157068072653301,0.182967594646271,4.14166554302494e-143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.282571628466512,0.0110180398173373,0.260976270424531,0.304166986508493,3.52109467318822e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0724715423250916,0.00282578532944852,0.0669330030793726,0.0780100815708107,1.06446569800748e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.117005628552635,0.00457559823080476,0.108037456020257,0.125973801085012,7.96095201252126e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.123176078479345,0.00482980110841843,0.113709668306845,0.132642488651845,1.2860434146636e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRN,Agrin,39931,0.0804380830020277,0.00315721455060886,0.0742499424828343,0.0866262235212211,2.11039815678596e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4R,Reticulon-4 receptor,40030,0.0816401706995244,0.00320770909611642,0.0753530608711362,0.0879272805279126,3.87202282335396e-140
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN2,Ficolin-2,39810,0.0994752537039349,0.00391942161819034,0.0917931873322819,0.107157320075588,2.40380706741443e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0957286568550046,0.00378509450473272,0.0883098716257285,0.103147442084281,2.13197723813224e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0329914099910472,0.00130231216884523,0.0304388781401106,0.0355439418419839,2.47928419744404e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLUL1,Clusterin-like protein 1,39840,-0.110556313432645,0.00437763635696898,-0.119136480692304,-0.101976146172986,5.03927537283579e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.140042228506558,0.00554354982272291,0.129176870854021,0.150907586159094,1.51404656801047e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0937187118094539,0.00372016712672284,-0.101010239377831,-0.0864271842410771,2.23592787903448e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.095996608881218,0.00381253560129136,0.0885240391026869,0.103469178659749,3.11736040977026e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLKB1,Plasma kallikrein,37187,0.0608767479166623,0.00241325604395214,0.0561467660705161,0.0656067297628085,3.35347337181599e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FN1,Fibronectin,37453,0.0648549937232689,0.00257195753179075,0.059813956960959,0.0698960304855788,3.69068022810082e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FYB1,FYN-binding protein 1,39836,0.223206526389849,0.00889083987888099,0.205780480227242,0.240632572552456,1.89983404534112e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK1,Dickkopf-related protein 1,40009,0.144906817529437,0.00578479319076165,0.133568622875544,0.15624501218333,6.84005909359721e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPY,Pancreatic prohormone,39826,0.241779906409551,0.00969387340547673,0.222779914534816,0.260779898284285,9.88552280232601e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.152842569751017,0.00613342992169497,-0.164864092397539,-0.140821047104495,1.6987801346699e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.204804372767517,0.00820664833692111,0.188719342027152,0.220889403507883,2.35872339018413e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCXR,L-xylulose reductase,39913,0.129379104114148,0.00521886515003233,0.119150128420085,0.139608079808212,3.56988978132604e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.131144148038933,0.00530515686626153,0.120746040581061,0.141542255496806,2.15876165062546e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.194057011922329,0.00787192668634459,0.178628035617093,0.209485988227564,1.02342939958704e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.213874402478876,0.00867570949556062,0.196870011867577,0.230878793090175,1.04022797293685e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0618894172773643,0.00250704073170171,0.0569756174432289,0.0668032171114996,1.20727965310639e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEP,Leptin,39868,0.161633779110524,0.00656809425635241,0.148760314368073,0.174507243852975,2.75673807144984e-131
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0661302303387409,0.00269649174136192,0.0608451065256715,0.0714153541518103,2.04057672433635e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.17200002501027,0.00702237495099056,0.158236170106329,0.185763879914212,4.12453348137468e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0472644864982246,0.00193082875735353,0.0434800621338117,0.0510489108626376,6.11463811746531e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP20,Centrosomal protein 20,39477,0.174893542728759,0.00716463586317039,0.160850856436945,0.188936229020573,3.43109528292795e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.258192613566066,0.0105953360984509,0.237425754813102,0.27895947231903,2.11782822244621e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGF,Hepatocyte growth factor,40058,0.0799271668341422,0.0032936746079627,0.0734715646025353,0.0863827690657491,8.31140182638024e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.127851804822207,0.00529055469139879,0.117482317627066,0.138221292017349,1.08257759279655e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL17,C-C motif chemokine 17,39836,0.211097128262046,0.00874661990983257,0.193953753238774,0.228240503285317,1.96222383585319e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THOP1,Thimet oligopeptidase,39798,0.0712005901095639,0.00295110916063722,0.065416416154715,0.0769847640644129,2.39276887012004e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EZR,Ezrin,40009,0.0561870143209229,0.00233099887698537,0.0516182565220315,0.0607557721198142,3.77967765483573e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUOM,Fucose mutarotase,37124,0.148040979188095,0.0061432176997088,0.136000272496666,0.160081685879524,1.28156816663125e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.069047789802385,0.00286693365416938,0.063428599840213,0.0746669797645569,1.58249031670019e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYY,Peptide YY,37021,0.21493044586834,0.00893522678683858,0.197417401366137,0.232443490370544,3.71220461100857e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.12015304512204,0.00500388304397984,0.110345434355839,0.12996065588824,3.81294653865661e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSD,Cathepsin D,38721,0.0910952966313863,0.00380455499180374,0.083638368847451,0.0985522244153217,2.40059076974939e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0804690797195313,0.00337830638588326,0.0738475992032001,0.0870905602358625,2.87033710600878e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSO,Cathepsin O,40058,0.0691575592227709,0.00290434853464337,0.0634650360948699,0.0748500823506719,3.27795458587314e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPL,N-acetylneuraminate lyase,37437,0.101350550374661,0.00426032713698195,0.0930003091861761,0.109700791563145,1.36373283104816e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0731528777329899,0.00308670374316977,0.0671029383963771,0.0792028170696027,1.37482922331996e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.09439046905491,0.00399130852492163,0.0865675043460636,0.102213433763756,3.42233693211972e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.208658127567203,0.00884848774627312,0.191315091584507,0.226001163549898,7.4506491357494e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXLNA,Alpha-taxilin,39749,0.203846349627574,0.00865471860583221,0.186883101160143,0.220809598095005,1.3447084407271e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0639434392927916,0.00272128949118301,0.0586097118900729,0.0692771666955103,4.63120231422448e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHBP1,EH domain-binding protein 1,37437,0.171047293991778,0.00727276061344426,0.156792683189427,0.185301904794128,6.42947109278609e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTD,Biotinidase,37453,0.0467340601171437,0.00198822603327703,0.0428371370919207,0.0506309831423667,8.67022466064597e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2AP,CD2-associated protein,39868,0.144271429475279,0.00615064820194372,0.132216158999469,0.156326699951088,1.17919341023673e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJAP1,Tight junction-associated protein 1,39913,0.188897283300234,0.00806015726534919,0.17309937506015,0.204695191540318,1.84902331436099e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.186451208954525,0.00794467359577054,0.170879648706815,0.202022769202235,2.05724046723275e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD63,CD63 antigen,39720,0.11706934721505,0.00499608851764976,0.107277013720457,0.126861680709644,2.12577485168213e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HJV,Hemojuvelin,37411,0.100588944541157,0.00429884942713283,0.0921631996639764,0.109014689418337,9.73237129482016e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUCB2,Nucleobindin-2,39995,0.0848954207084943,0.00363947633867444,0.0777620470846924,0.0920287943322962,2.16744680834772e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.218113629248334,0.00935437094336965,0.199779062199329,0.236448196297338,2.67713998632323e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.186242015763324,0.0079941774150064,0.170573428029911,0.201910603496736,4.1638409753709e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.160497189334402,0.00688711461325849,0.146998444692415,0.173995933976388,8.1720356356966e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.125089472704829,0.00540550699558834,0.114494678993476,0.135684266416182,3.20783044362773e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.23394632246406,0.010127615711886,0.214096195668764,0.253796449259357,3.76566462477929e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5E,5'-nucleotidase,39913,0.123887213638635,0.00536955979488085,0.113362876440669,0.134411550836602,6.72591217471846e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0877984968824369,0.00381203744683992,-0.0952700902782432,-0.0803269034866307,1.67725881298796e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.178172102159422,0.00773621332173328,0.163009124048824,0.193335080270019,1.89451896184954e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.21806696250726,0.0094724976963289,0.199500867022455,0.236633057992064,2.17684790077579e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.105082350335506,0.00456377684059786,0.0961373477279338,0.114027352943077,4.18863762225664e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.119195663290976,0.00518919874711074,0.109024833746639,0.129366492835313,6.87438987059178e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELP,P-selectin,39931,0.127847140830052,0.00557051797934656,0.116928925590532,0.138765356069571,1.00702167635295e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.146637630334963,0.00640287109771838,0.134088002983435,0.159187257686491,2.98267326945242e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN1,Perilipin-1,39489,0.0770444224625447,0.00336457237410745,0.0704498606092941,0.0836389843157953,3.59163795078526e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES3,Carboxylesterase 3,39788,0.152889175595158,0.00668014876414905,0.139796084017426,0.16598226717289,4.29579239079425e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0898540631663008,0.00392861621887908,0.0821539753772978,0.0975541509553038,5.92681361381134e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.216965584553851,0.00947778442700116,0.198389127076929,0.235542042030774,7.94476456156744e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.157658777317728,0.00689755672022803,0.144139566146081,0.171177988489375,9.0522849867261e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0866087648083311,0.00379703974080568,-0.0940509627003102,-0.0791665669163519,2.34758365918461e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE4,Ribonuclease 4,37051,0.0574640361821778,0.00251971703272381,0.0525253907980392,0.0624026815663165,6.05829406610329e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.250166708008978,0.0109825334980747,0.228640942352752,0.271692473665204,1.05364593968835e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0812974109544847,0.00357490613892605,0.0742905949221897,0.0883042269867798,1.06558995961507e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.148543298256757,0.00653719434347296,0.13573039734355,0.161356199169964,1.76463756770718e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0847341483437217,0.00373997392970521,0.0774037994414995,0.0920644972459439,6.61277747496768e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0863365440984887,0.00381117884204756,0.0788666335680755,0.0938064546289019,7.01969358290136e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BECN1,Beclin-1,37043,0.133199780435034,0.00587531027914688,0.121684172287906,0.144715388582162,1.16293746706897e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0955488354017516,0.00422225063331731,0.0872732241604497,0.103824446643054,1.2359540406949e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN1,Dynactin subunit 1,40030,0.142976488070402,0.006319951474856,0.130589383179684,0.15536359296112,1.37885944746837e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.134595193404736,0.00594856311092248,0.122936009707328,0.146254377102144,3.10520995001355e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.180923860896201,0.00801791620604687,0.165208745132349,0.196638976660053,1.14521230850931e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0604442193192549,0.0026794786370074,0.0551924411907204,0.0656959974477894,1.24955209266402e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.044689325446545,0.00199105968221826,0.0407868484693972,0.0485918024236928,7.19615755521538e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS2,Protein MTSS 2,37368,0.217549793203079,0.00968026446647213,0.198576474848794,0.236523111557365,7.68423453689933e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC1,Stanniocalcin-1,40009,0.0914387290015173,0.00407647379504156,0.0834488403632358,0.0994286176397987,9.29677153645012e-110
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.139071611290498,0.0062130633399613,0.126894007144174,0.151249215436822,2.94502874368334e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST3,Cystatin-C,39897,0.0577516837592967,0.0025815183596717,0.0526919077743402,0.0628114597442532,3.49489693669593e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.105524607105408,0.00471953021075851,0.0962743278923213,0.114774886318495,4.38305762969121e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.120776839263405,0.00540133808078296,0.110190216625071,0.13136346190174,4.39025405501671e-109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARF6,ADP-ribosylation factor 6,37382,0.230783085424239,0.0103265618351064,0.21054302422743,0.251023146621047,1.14652063149788e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.212798597381448,0.00954119326696959,0.194097858578187,0.231499336184708,1.54243872175385e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.23525071348032,0.0105340320482177,0.214604010665813,0.255897416294827,1.6179554022759e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.179960455155355,0.00807523015381695,0.164133004053874,0.195787906256836,2.48011777471157e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL5,C-C motif chemokine 5,39931,0.218259012436366,0.00981239911778747,0.199026710165503,0.23749131470723,5.5642027302778e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD6,T-cell differentiation antigen CD6,40040,0.113276932647676,0.00509739330409895,0.103286041771642,0.12326782352371,8.48507751733028e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.157148493046499,0.00706233999398463,0.143306306658289,0.170990679434709,1.03402462187444e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.245950668032984,0.011078621993355,0.224236568926009,0.26766476713996,1.44084888249097e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.229338350273204,0.0103401612667096,0.209071634190453,0.249605066355955,2.23962854532523e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB2,Carboxypeptidase B2,37424,0.0485101499253597,0.00219124740253034,0.0442153050164002,0.0528049948343191,1.04202628538949e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAB2,Disabled homolog 2,40030,0.23917263983838,0.0108491041138535,0.217908395775227,0.260436883901533,3.8521479218139e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNA4,Plexin-A4,39866,0.174004486769219,0.00789982215772351,0.158520835340081,0.189488138198357,6.00117075359934e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0620220540041798,0.00281672890745117,0.0565012653455755,0.0675428426627841,6.72290908179968e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXIN1,Axin-1,39866,0.204441506573015,0.00928435332763934,0.186244174050842,0.222638839095188,6.87924296536072e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAXX,Protein PAXX,37124,0.0982716692034392,0.0044623102581623,0.0895255410974411,0.107017797309437,1.35021716483599e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN2,CCN family member 2,39880,0.124868845797465,0.00568721203940969,0.113721910200222,0.136015781394708,2.6917273074532e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FETUB,Fetuin-B,39908,0.0717577989114724,0.00327201899453727,0.0653446416821793,0.0781709561407654,4.59466163360657e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.232437004896798,0.0106036324438234,0.211653885306904,0.253220124486691,1.09878620285236e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREG1,Protein CREG1,39660,0.079858952902316,0.00365998922464853,0.0726853740220049,0.0870325317826271,5.17961577071788e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A4,Protein S100-A4,39913,0.12056305782713,0.00553018191157217,0.109723901280448,0.131402214373811,7.26799102910359e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBIN,Erbin,39788,0.217474570002399,0.00998595134987877,0.197902105356637,0.237047034648161,1.21220691846585e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD5,Programmed cell death protein 5,40009,0.12175188920584,0.00564454816942269,0.110688574793771,0.132815203617908,9.37561718235739e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA5,Integrin alpha-5,39858,0.0520483214071435,0.00241401965174265,0.0473168428897279,0.0567797999245591,1.16700382583409e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL13,C-C motif chemokine 13,40024,0.144109652752265,0.00669674688776975,0.130984028852236,0.157235276652294,2.6959604486207e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH2,Cadherin-2,39868,0.0735043936162671,0.00341614620850303,0.0668087470476011,0.080200040184933,2.9369118381957e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZN,Kazrin,37382,0.217841204033179,0.0101251776302623,0.197995855877865,0.237686552188493,5.53504513720364e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.132213813119817,0.00615358844975127,0.120152779758305,0.14427484648133,5.63714697830641e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.269538625689086,0.0125517453568845,0.244937204789592,0.29414004658858,6.93344365455535e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0608822533333571,0.00284045836623631,0.0553149549355339,0.0664495517311802,1.79813711702737e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0560936100806101,0.00261804963927423,0.0509622327876326,0.0612249873735876,1.91667464372017e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.263380735743556,0.0122956164556773,0.239281327490429,0.287480143996684,2.1622230254113e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCTN3,Tectonic-3,37437,0.0614068313322773,0.00286672631239516,0.0557880477599828,0.0670256149045718,3.87469486330848e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.179057689585623,0.00836066722095778,0.162670781832546,0.195444597338701,4.26270845039091e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.102722083351934,0.0048031065927921,0.093307994430061,0.112136172273806,4.82588220743891e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCR,Breakpoint cluster region protein,39866,0.19080512116751,0.00895121739705191,0.173260735069288,0.208349507265731,1.93316835893902e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.175121012176209,0.00822017465230281,0.159009469857696,0.191232554494723,2.53420607612417e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.154529256769691,0.00725200427847303,0.140315328383884,0.168743185155498,4.40178604398289e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0866501378949865,0.00407441688413545,0.078664280802081,0.094635994987892,5.6717601975064e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0485857325132034,0.00228707818253037,0.0441030592754439,0.0530684057509629,8.71367126922842e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.076895076644424,0.00361738515483762,0.0698050017409423,0.0839851515479058,1.24191650599894e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.139765082028592,0.00658979988782167,0.126849074248462,0.152681089808723,1.7071338834747e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.127088965475897,0.00599471480968459,0.115339324448916,0.138838606502879,2.29902306418976e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0684725021289852,0.0032308509889577,0.0621400341906281,0.0748049700673423,2.43517374403275e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP5,Fatty acid-binding protein 5,39972,0.140809212957098,0.00664456096598514,0.127785873463767,0.153832552450429,2.49625565254417e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.122560456747772,0.00578733914955682,0.111217272014641,0.133903641480903,5.98704384025484e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINH1,Serpin H1,37169,0.264166393033377,0.0124807782894042,0.239704067586145,0.288628718480609,8.00552790688624e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.181335193926107,0.0085775821108339,0.164523132988873,0.198147254863342,1.26784100568567e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.178360727966997,0.00847299392116242,0.161753659881519,0.194967796052476,4.65926005271808e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.136933564052202,0.00650594338287645,0.124181915021765,0.14968521308264,4.83231118911504e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.153047057373333,0.00727737133126699,0.13878340956405,0.167310705182617,1.3276771738626e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.118546152345082,0.00565172934748037,0.107468762824021,0.129623541866144,2.22866157280776e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.193283983060896,0.00921740819110654,0.175217863006328,0.211350103115465,2.43242447730188e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.154433715701675,0.00738872974224742,0.13995180540687,0.16891562599648,9.54508140991643e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0894728726372927,0.0042854924973384,0.0810733073425094,0.097872437932076,1.60642849610466e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELE,E-selectin,40052,0.101206808610916,0.00485081292327325,0.0916992152813005,0.110714401940532,2.04643949336183e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R9B,Neurabin-2,40058,0.192394745858956,0.00922476954773139,0.174314197545403,0.21047529417251,2.38477180566904e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.136706800458768,0.00654694492962584,0.123874788396702,0.149538812520835,2.77360112573818e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.218606430038699,0.0104757275820131,0.198074003977953,0.239138856099445,3.2522633225166e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.170881351689667,0.0082238917209512,0.154762523916602,0.187000179462731,1.99019723926729e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.11519298800594,0.00555390773890594,0.104307328837684,0.126078647174196,2.51281319061297e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.201279891257533,0.00970489871536414,0.182258289775419,0.220301492739646,2.5285556597292e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPK2,SRSF protein kinase 2,39866,0.169931005631697,0.00819476495219896,0.153869266325387,0.185992744938007,2.80578667701462e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0456994293519312,0.00220381094212546,0.0413799599053653,0.0500188987984971,2.94243652037693e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANG,Angiogenin,39843,0.0681594397937515,0.00328944039647909,0.0617121366166525,0.0746067429708505,3.88240708637005e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.129397947448375,0.006241507922288,0.117164591920691,0.14163130297606,5.11397431734424e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGF,Placenta growth factor,40058,0.0518607391456464,0.0025059701514699,0.0469490376487654,0.0567724406425274,6.3035311214995e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BACH1,Transcription regulator protein BACH1,39866,0.149366635348495,0.00722524132980823,0.135205162342071,0.163528108354919,1.01546997239838e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.209267238326581,0.0101256073693157,0.189421047882722,0.229113428770439,1.14069926845674e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.172522811653719,0.00834842961139278,0.156159889615389,0.188885733692049,1.17040969953113e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.141738717051444,0.00686296648051794,0.128287302749629,0.155190131353259,1.60284662744672e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F13B,Coagulation factor XIII B chain,37380,0.0512522218560443,0.00248046772138262,0.0463905051221344,0.0561139385899543,2.08509407959448e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM1,Isthmin-1,39866,0.080167134325573,0.00388594091599917,0.0725506901302146,0.0877835785209314,2.40912650445455e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGLN1,Egl nine homolog 1,39866,0.107124401817902,0.00519965206644404,0.0969330837676719,0.117315719868133,4.2176110082872e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.275985255511734,0.0133980557950081,0.249725066153518,0.30224544486995,4.5696996061943e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMIP,C-Maf-inducing protein,37368,0.1663788220346,0.00807483846416635,0.150552138644834,0.182205505424366,6.65249528881759e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLM2,Protein GOLM2,40009,0.0442846796252314,0.00215808107554415,0.0400548407171648,0.0485145185332979,2.12961069868485e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0801792436311016,0.00390844275720573,0.0725186958269784,0.0878397914352249,4.02354041335164e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLA2,Src-like-adapter 2,37411,0.210387331098892,0.0102570319797254,0.19028354841863,0.230491113779154,4.23009525357582e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.152041193040456,0.00743094624090095,0.13747653840829,0.166605847672621,1.16072659326507e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.20534918238126,0.0100370860147124,0.185676493792424,0.225021870970097,1.31238524150208e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.127267306410921,0.00622835839300481,0.115059723960631,0.13947488886121,1.98632190212096e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXT,Oxytocin-neurophysin 1,40009,0.275517049443269,0.0135131701833741,0.249031235883856,0.302002863002683,2.95582644082105e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0733975008430088,0.00360102314848349,0.0663394954719812,0.0804555062140365,3.50825679930369e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.192765823204115,0.00945854117802327,0.174227082495189,0.21130456391304,3.76973005312645e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS9,Galectin-9,39859,0.0625494897151404,0.00306953702445364,0.0565331971472113,0.0685657822830695,3.79155366098422e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.140687019051526,0.00690731920600231,0.127148673407762,0.154225364695291,4.80976315710778e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXN,Paxillin,39489,0.102657227786963,0.00504156734946036,0.0927757557820204,0.112538699791905,5.47231050930554e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTBDN,Retbindin,39788,0.0580442405778337,0.00285460394955776,0.0524492168367005,0.063639264318967,9.19269607977375e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0725205279805754,0.00356786832108761,0.0655275060712437,0.0795135498899071,1.69187375579367e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.210054643711962,0.0103549201093964,0.189759000297545,0.230350287126379,2.33173525400551e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINK1,Misshapen-like kinase 1,37388,0.18369097532271,0.00904798134633278,0.165956931883897,0.201425018761522,2.72584006291443e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.144856257144453,0.00714890219887913,0.13084440883465,0.158868105454256,3.87193602661189e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.128030195692268,0.00632387598591003,0.115635398759884,0.140424992624651,5.5403332342044e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.157015904291792,0.00775004957402494,0.141825807126703,0.172206001456881,6.71812685102089e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.06481302965924,0.00320538091721891,0.058530483061491,0.0710955762569891,8.4186378754358e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.120985976387878,0.00598273985031746,0.109259806281256,0.1327121464945,8.73291272843769e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AAMDC,Mth938 domain-containing protein,37043,0.105165586656456,0.00521013111536782,0.0949537296703351,0.115377443642577,2.95372507902718e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.180984560378931,0.00898574363422459,0.163372502855851,0.198596617902011,4.06895785058064e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.185434432949636,0.00922151990234643,0.167360253941037,0.203508611958235,7.84279520109315e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.177608065868245,0.00883616829712497,0.16028917600588,0.19492695573061,1.43833162387902e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0991623831215185,0.00495761253124122,0.0894454625602857,0.108879303682751,1.06285442894675e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USO1,General vesicular transport factor p115,39788,0.174619498900437,0.00874203346982561,0.157485113299578,0.191753884501295,1.08095299806448e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.150821362869523,0.00754568280714771,0.136031824567513,0.165610901171532,1.28214767209157e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0530035319316292,0.00265508232344744,0.0477995705776722,0.0582074932855862,1.42162525868806e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.101241945146395,0.00507532739410521,0.0912943034539487,0.111189586838841,1.79260541200555e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.104276601406506,0.00522101520362867,0.0940434116073943,0.114509791205619,1.81788452508705e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPD52L2,Tumor protein D54,37124,0.211889513024095,0.0106336170731871,0.191047623560648,0.232731402487542,4.49278012994714e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC13,Mucin-13,39489,0.0983245498654478,0.00494217701706263,0.0886378829120051,0.108011216818891,5.35403455883597e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK2,Docking protein 2,39868,0.237921586885059,0.0119688211780489,0.214462697376083,0.261380476394035,6.97233145831764e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0504176633935263,0.00253322782482591,0.0454525368568675,0.0553827899301851,7.25893523418116e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.221474430144012,0.0111627747393794,0.199595391654829,0.243353468633196,2.23330767815407e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.220821698844773,0.011157694046404,0.198952618513821,0.242690779175725,5.85454602820569e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.04534337469261,0.00229671293380403,0.0408418173423541,0.0498449320428659,9.90438039765593e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGFR,Opioid growth factor receptor,39788,0.0628656430268122,0.00318506084192659,0.0566229237766361,0.0691083622769884,1.08037999968063e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP43,Centrosomal protein 43,39476,0.134691179027939,0.00682743725037498,0.121309402017204,0.148072956038674,1.36542785228636e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.129529068189546,0.00657072242656465,0.116650452233479,0.142407684145612,1.81525163087466e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO1,Forkhead box protein O1,39866,0.165231877328742,0.00838970237051881,0.148788060682526,0.181675693974959,2.4518637349564e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEXIM1,Protein HEXIM1,39866,0.156682837090876,0.00796588289083066,0.141069706624848,0.172295967556904,3.99723717517767e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PENK,Proenkephalin-A,37124,0.0558558682980719,0.00283836054408163,0.0502926816316719,0.0614190549644719,5.30719493148256e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.133030598618443,0.00676428416566988,0.11977260165373,0.146288595583156,6.369643083825e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0676778493091174,0.0034528616706126,0.0609102404347167,0.0744454581835181,1.51454926331785e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.107052852654581,0.005466259017069,0.0963389849811261,0.117766720328037,1.99085134584899e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0379665921315786,0.00193653651130484,0.0341709805694211,0.0417622036937361,2.05519438304727e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEC31A,Protein transport protein Sec31A,37043,0.147287958618955,0.00751436806967463,0.132559797202393,0.162016120035517,2.40346886352219e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0621364306023144,0.00317798115772328,0.0559075875331767,0.068365273671452,3.80959874236953e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.206316739289796,0.0105546521215966,0.185629621131467,0.227003857448125,6.21900498013978e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.102569264860529,0.00525790112942971,-0.112874751074211,-0.0922637786468464,9.14547649246438e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.215377892431355,0.0110507143195576,0.193718492365023,0.237037292497688,1.24301575987742e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.14579351718644,0.00748148341005491,0.131129809702732,0.160457224670147,1.32301424200491e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.049319025408605,0.00253481059083887,0.0443507966505609,0.0542872541666492,2.28430624782465e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BID,BH3-interacting domain death agonist,39866,0.125470410458384,0.00645519350763854,0.112818231183412,0.138122589733355,3.40275353808612e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QDPR,Dihydropteridine reductase,39790,0.0824797591466003,0.00424482060806263,0.0741599107547976,0.0907996075384031,3.88688023643319e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLK1,Protein delta homolog 1,40052,0.105460952635004,0.00544232451105957,0.0947939965933273,0.116127908676681,1.02310821555683e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0506369031203134,0.00261403182042766,0.0455134007522752,0.0557604054883516,1.20148842042733e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.137057087946364,0.0070703916302749,0.123199120351025,0.150915055541703,1.36085838752602e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.132393943793215,0.00682891701010142,0.119009266453416,0.145778621133013,1.39016620694866e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.144950178878317,0.00748390845024542,0.130281718315836,0.159618639440799,1.86576788334128e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN1,Pantetheinase,37445,0.136665474082123,0.00706325243393943,0.122821499311601,0.150509448852644,2.66244588137176e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.106530815768716,0.00552254192129603,0.0957066336029762,0.117354997934457,5.52729812973455e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNMBP,Dynamin-binding protein,39749,0.116655919079071,0.00605149462227945,0.104794989619403,0.128516848538739,7.17261496027695e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDUA,Alpha-L-iduronidase,40030,0.0862677133166185,0.00447873609657001,0.0774893905673412,0.0950460360658957,9.27998109329938e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.117771840924315,0.00610907925485143,0.105798045584807,0.129745636263824,1.01853890499045e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB3,Plexin-B3,39812,0.0895071826980729,0.00465183076197239,0.080389594404607,0.0986247709915388,1.4012042816351e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX2,Heme oxygenase 2,39489,0.0885510585099758,0.00461758995069366,0.0795005822066162,0.0976015348133354,4.91380986140017e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIAE,Sialate O-acetylesterase,39875,0.0883189362810698,0.0046068958719295,0.079289420372088,0.0973484521900516,5.21495952515016e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBPL,FK506-binding protein-like,37382,0.111449319735754,0.00580847623310923,0.10006470631886,0.122833933152648,5.60686298941724e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.191597188252005,0.00999013029855133,0.172016532866844,0.211177843637166,6.60032076450392e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP10,Stromelysin-2,39857,-0.109574243458327,0.00572960002866725,-0.120804259514515,-0.0983442274021391,1.25794374578525e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0572039252169632,0.00298810413910978,0.0513472411043081,0.0630606093296184,1.26325032119839e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COCH,Cochlin,37437,0.0853050862231139,0.00445935051799877,0.0765647592078363,0.0940454132383915,1.63893096335996e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.11133954347037,0.00582044565694357,0.099931469982761,0.12274761695798,1.66879153066562e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAG1,Dystroglycan,39931,0.0904951946973934,0.00473846437593846,0.081207804520554,0.0997825848742328,2.03752886206203e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.134740084113515,0.00704802307689229,0.120925958882806,0.148554209344224,2.05275314068252e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT2,Omega-amidase NIT2,37377,0.140507425666421,0.00735429496182701,0.12609300754124,0.154921843791602,2.59222331262053e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EREG,Proepiregulin,39713,0.148547101193353,0.00779320351643934,0.133272422301132,0.163821780085574,4.17642228049667e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTDH,Protein LYRIC,37056,0.1722053767797,0.00903034103032286,0.154505908360267,0.189904845199132,5.35684545554757e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.106845970079935,0.00561676998800036,0.0958371009034538,0.117854839256415,8.278947131651e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0976314763084724,0.00513341423680155,0.0875699844043413,0.107692968212603,9.03008514955954e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.207718880728673,0.0109341702179602,0.186287907101471,0.229149854355875,1.37528793119978e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.16852211406393,0.00887038146775631,0.151136166387128,0.185908061740732,1.90301187376383e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.1444086455485,0.00760076069016881,0.12951115459577,0.159306136501231,1.9570422595796e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.101457267701725,0.0053463525083414,0.0909784167853761,0.111936118618074,1.96932118384152e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0830895565524515,0.004382158910575,0.0745005250877245,0.0916785880171785,2.67981078638557e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0789296984189287,0.00416863438385382,0.0707591750265752,0.0871002218112822,4.28200251064986e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.167476596855714,0.00884055306552891,0.150149112847277,0.184804080864151,5.14346940640773e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.113387258633792,0.00599588119329364,0.101635331494936,0.125139185772647,6.73980171678188e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0931485696819921,0.00493447130399959,0.0834770059261529,0.102820133437831,1.31589173553684e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0827825922778113,0.00438303196119153,-0.0913733349217467,-0.0741918496338759,1.48324086883337e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSB,Arylsulfatase B,39788,0.101694014224361,0.00539071772904445,0.0911282074754343,0.112259820973289,1.59669322885288e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.109775791414598,0.00581943604822703,0.0983696967600731,0.121181886069123,1.62664341062385e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.0361124389655228,0.00191467644066116,0.032359673141827,0.0398652047892187,1.70411601600521e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.155727148142561,0.00825770218982914,0.139542051850496,0.171912244434626,1.79209668215802e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNST,Consortin,39868,0.198904507059617,0.0105510116015042,0.178224524320669,0.219584489798566,2.00941353716345e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0395146433146029,0.0020978244002251,0.0354029074901617,0.043626379139044,2.62757298438637e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0639366818204929,0.00339436021060163,-0.0705896278332721,-0.0572837358077137,2.67923752455994e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0993581088765399,0.0052757948674455,0.0890175509363467,0.109698666816733,2.88973389077499e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0626236102216121,0.00332718174253346,-0.0691448864369777,-0.0561023340062466,3.49304989998936e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.051618841134664,0.00274258175711685,0.046243380890715,0.0569943013786131,3.52679105606646e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMN,Protein amnionless,39587,0.0875266025272129,0.00465675917288433,0.0783993545483596,0.0966538505060661,5.85803345774733e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.156537284063956,0.00833369990582085,0.140203232248547,0.172871335879365,7.39105867189097e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL11,Eotaxin,40058,0.06992987448798,0.00372731273674844,0.0626243415239531,0.077235407452007,1.03867457713691e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.119008259049119,0.00634826886785869,0.106565652068116,0.131450866030122,1.37428158663495e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP2,Methionine aminopeptidase 2,40011,0.105698293372869,0.00563960888482182,0.094644659958618,0.116751926787119,1.49082066028094e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCG,Gamma-synuclein,39749,0.118428082644497,0.00634398232828951,0.10599387728105,0.130862288007944,6.01767382555522e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.15836175066158,0.00848993145862529,0.141721485002674,0.175002016320485,7.7600627880656e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.138363701496078,0.00741817097146003,0.123824086392016,0.15290331660014,8.19210352943294e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.067802512786088,0.00363913173095614,0.060669814593414,0.074935210978762,1.13180648775428e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.119685069960827,0.00641745638010567,0.10710685545582,0.132263284465834,1.14941255211849e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.189349127334574,0.0101666795085353,0.169422435497844,0.209275819171303,1.30153164056798e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2B3,SH2B adapter protein 3,39477,0.17888792601508,0.00963259613899455,0.160008037582651,0.197767814447509,3.63539521698017e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.15518801512317,0.00835000265829701,0.138822009912908,0.171554020333432,3.97070525126784e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSNL1,Visinin-like protein 1,37388,0.0685044018617745,0.00368670646713428,0.0612784571861913,0.0757303465373577,4.01124428311945e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.114402217270258,0.00615893013322821,0.102330714209131,0.126473720331386,4.50986450378351e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.131967212882607,0.00710465083544681,0.118042097245132,0.145892328520083,4.54481332576279e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.138892210437161,0.00747764221261442,0.124236031700436,0.153548389173885,4.54956752110178e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS1,Galectin-1,39868,0.0607132234040152,0.0032756116273451,0.0542930246144188,0.0671334221936116,6.71394416168993e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOA,Elongin-A,39788,0.0923501100327999,0.00498696871962258,0.0825756513423397,0.10212456872326,9.1698957281743e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0910815217079745,0.00492216581359746,0.0814340767133235,0.100728966702626,1.17170545237575e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR,GMP reductase 1,40058,0.0896259423470111,0.00484740966951881,0.0801250193947542,0.099126865299268,1.50272273286221e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH2,Neutral ceramidase,39749,0.0945138724264965,0.00511580787856962,0.0844868889845,0.104540855868493,2.02629773921443e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD36,Platelet glycoprotein 4,37056,0.0824781188158479,0.00446414696363848,0.0737283907671165,0.0912278468645794,2.8759410094647e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAMBP,STAM-binding protein,39713,0.11580883861369,0.00629105260300051,0.103478375511809,0.128139301715571,6.76670060477319e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.09270996276716,0.00504389367639203,0.0828239311614316,0.102595994372888,1.10165072696942e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0502301694808578,0.0027338256160577,0.0448718712733848,0.0555884676883309,1.26080545223279e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX15,Sorting nexin-15,37124,0.0966502715471651,0.00526032261653596,0.0863400392187546,0.106960503875576,1.79425698910345e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0911183114572301,0.00496977000480187,0.0813775622478185,0.100859060666642,2.63952107939562e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0525312229389231,0.00286566152362464,0.0469145263526188,0.0581479195252275,2.67486546658502e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0992260359937011,0.00541277748879926,0.0886169921156545,0.109835079871748,3.62585402115156e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.23183550343778,0.0126623336642976,0.207017329455757,0.256653677419803,3.96955028629956e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA2,Apolipoprotein A-II,37445,-0.0849736897365438,0.00464872564051624,-0.0940851919919556,-0.075862187481132,9.30683992229574e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0778647138825945,0.00426030870481643,0.0695145088211543,0.0862149189440347,1.02785780475819e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TALDO1,Transaldolase,37415,0.0797713530703194,0.00436858919349896,0.0712089182510614,0.0883337878895773,1.30633942544252e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.171852489341185,0.00941627081413711,0.153396598545476,0.190308380136893,1.55894691719967e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.113692300512945,0.00623547477271467,0.101470769958424,0.125913831067466,1.62905317263449e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.10159618088158,0.00557222770752952,0.0906746145748219,0.112517747188338,2.15406238695871e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.157572767659577,0.00864206655396976,0.140634317213797,0.174511218105358,2.23262596464771e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C19orf12,Protein C19orf12,39489,0.115527088904216,0.00634848650681621,0.103084055350856,0.127970122457576,3.07374012410051e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.102386157065828,0.0056228567437649,0.0913653578480487,0.113406956283607,3.45944100218317e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.13349696633472,0.00734487454962,0.119101012217465,0.147892920451975,4.37795989930151e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.153194794090374,0.00843726242093955,0.136657759745333,0.169731828435416,6.10172039966039e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYDGF,Myeloid-derived growth factor,37437,0.179736263670937,0.00989205669931976,0.160347832540271,0.199124694801604,6.53453115719103e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.182824084982653,0.0100781557515942,0.163070899709528,0.202577270255777,8.06826184303324e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.179909388846114,0.00991904188432601,0.160468066752835,0.199350710939393,8.58620083324016e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GLB2,Endophilin-B2,37388,0.117306240100061,0.00646322413888913,0.104638320787838,0.129974159412284,9.38388919190627e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0302281240375574,0.00166784349707179,0.0269591507832967,0.0334970972918181,1.46813690949343e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0470926671595425,0.00260298690358949,0.0419908128285071,0.0521945214905779,2.60623871325615e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C3,Complement C3,36816,0.0814538663385981,0.00450189466188007,0.0726301528013131,0.090277579875883,2.7878480015674e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0891687594490393,0.0049355617401589,0.0794950584383278,0.0988424604597507,4.10794487258503e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.172350460584335,0.00954141989307815,0.153649277593902,0.191051643574769,4.55735988193517e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES2,Cocaine esterase,39788,0.0950956381648408,0.00528569932180875,0.0847356674940957,0.105455608835586,1.17018749817858e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASHC3,WASH complex subunit 3,37388,0.13323875418364,0.00740527960875148,0.118724406150487,0.147753102216793,1.52144177772441e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM2,Paralemmin-2,37388,0.0664308320050848,0.00369620733100913,0.0591862656363069,0.0736753983738627,2.15260711475036e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC4,Syndecan-4,39868,0.0795858317698455,0.00443603018400005,0.0708912126092054,0.0882804509304856,2.82461000854734e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0603501713993378,0.0033649955229499,0.053754780174356,0.0669455626243196,3.23533789367252e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1A,Meprin A subunit alpha,37382,0.125502171458528,0.00699366767459897,0.111794582816314,0.139209760100742,3.50044308427252e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.140805760287235,0.00784937661848099,0.125420982115013,0.156190538459458,3.91890046859632e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THPO,Thrombopoietin,39585,0.0668025264194321,0.00372822051850143,0.0594952142031693,0.0741098386356949,4.33647502500573e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL7,C-C motif chemokine 7,39866,0.102053491909431,0.00569887335084272,0.0908837001417795,0.113223283677083,5.06462905401623e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.165836072474274,0.00926105478771614,0.14768440509035,0.183987739858197,5.14342565828401e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0485316577907378,0.00270858346856805,0.0432228341923444,0.0538404813891312,5.87214194429771e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0976821135532979,0.00546101348107723,0.0869785271303865,0.108385699976209,7.26317629073514e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MITD1,MIT domain-containing protein 1,39749,0.169723860105164,0.00949822665846457,0.151107335854574,0.188340384355755,1.01129286312527e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.119696802784443,0.00670173597602633,0.106561400271431,0.132832205297454,1.14362463220101e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUS,RNA-binding protein FUS,39455,0.0685361383862546,0.0038401939448323,0.0610093582543833,0.0760629185181259,1.53150052968125e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OCLN,Occludin,37411,0.0748842392759369,0.00419275851484621,0.0666664325868383,0.0831020459650354,1.54176214455177e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.16420424691546,0.0092090653984602,0.146154478734478,0.182254015096442,2.01286537898541e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0545045684017615,0.00305847587035253,0.0485099556958705,0.0604991811076525,3.23849615195029e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.155076648431643,0.00870935480262682,0.138006313018495,0.172146983844792,4.0207389439614e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.131663396996014,0.00740046577019321,0.117158484086435,0.146168309905593,5.16030970393195e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.184508909600672,0.0103769433417844,0.164170100650775,0.20484771855057,6.41090076490817e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS8,Galectin-8,40009,0.106243625732746,0.00598210198043029,0.094518705851103,0.11796854561439,6.63233847278627e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.213508504404495,0.0120268781083807,0.189935823312069,0.237081185496921,8.06139398493984e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0823089808226951,0.0046344257841486,0.0732255062857639,0.0913924553596264,8.87391115037153e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.135818068742813,0.00765559816955991,0.120813096330476,0.150823041155151,9.76843971643926e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRAP,BRCA1-associated protein,37249,0.191159328445016,0.0107710625722287,0.170048045803448,0.212270611086584,1.12970900707504e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.12510172839912,0.00704922095513333,0.111285255327059,0.138918201471182,1.16122942505193e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0656498621109837,0.00371125495264485,0.0583758024037998,0.0729239218181676,2.29876908416305e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.0841187045371903,0.00475701121175579,0.074794962562149,0.0934424465122316,2.65059357321502e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBKS,Ribokinase,39504,0.0856189287262121,0.00484322500986524,0.0761262077068763,0.095111649745548,2.91518086936389e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D23,TBC1 domain family member 23,39788,0.155351349322739,0.00879474430749307,0.138113650480053,0.172589048165426,3.61659961870605e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCC,Tubulin-specific chaperone C,39749,0.140326534146816,0.00794785009351752,0.124748747963522,0.15590432033011,4.18584211197314e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0803916003735626,0.00455431568645941,0.0714651416281021,0.0893180591190231,4.45458218979979e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.183633090843235,0.0104239937542906,0.163202063084825,0.204064118601644,1.07344732457672e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0736311324662955,0.00418085535697725,0.0654366559666201,0.0818256089659709,1.22950606859371e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINC1,Antithrombin-III,37424,0.0250319765887272,0.00142227063382749,0.0222443261464253,0.0278196270310291,1.42193967686037e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.18917660589505,0.0107649213468553,0.168077360055213,0.210275851734886,1.71950757322335e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL4,C-C motif chemokine 4,39882,0.107063561010739,0.00609638308518124,0.0951146501637843,0.119012471857695,2.11134098934472e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.102978689887842,0.00586690866207507,0.0914795489101745,0.114477830865509,2.4549109124298e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD1,COMM domain-containing protein 1,37043,0.10639850251578,0.00606397127427323,0.0945131188182048,0.118283886213356,3.78901738919476e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0505077053907415,0.00288558443038303,0.0448519599071907,0.0561634508742922,5.78775963584366e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM13A,Protein FAM13A,37382,0.116061605582131,0.00662521703836678,0.103076180186932,0.12904703097733,5.85380762508499e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSZ,Cathepsin Z,39865,0.0530267099997648,0.00303106346080715,0.0470858256165828,0.0589675943829468,6.76410027082105e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRKL,Crk-like protein,39881,0.182458997301297,0.0104701314548273,0.161937539649835,0.202980454952758,2.16667244960506e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0454542345821631,0.00260964404935218,0.0403393322454329,0.0505691369188934,2.52007214356223e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.251327239348486,0.0144230725526471,0.223058017145298,0.279596461551675,2.87262175008534e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.132251654759711,0.00759202210280299,0.117371291438217,0.147132018081205,3.14682201880902e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.139292916156431,0.00801794067427637,0.12357775243485,0.155008079878013,7.01776929881162e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.0847203723996616,0.0048818798791366,0.0751518878365539,0.0942888569627693,1.01015207854684e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.198141646181958,0.0114315113224467,0.175735883989963,0.220547408373953,1.08547666762225e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.104236334986355,0.00602258050651634,0.0924320771935835,0.116040592779128,1.66135274973258e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDHD2,Phospholipase DDHD2,37411,0.112964078061059,0.00652331699489258,0.10017837675107,0.125749779371049,1.81667897563464e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0632862084473142,0.00365965311749536,0.0561132883370233,0.0704591285576051,2.13183486117173e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1S,Complement C1s subcomponent,37453,0.0353809470813926,0.00204601286574465,0.0313707618645331,0.0393911322982521,2.73310228949276e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.154045427788564,0.00891172046427334,0.136578455678588,0.17151239989854,3.22582429467873e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.130097560990962,0.00754692073603294,-0.144889525633587,-0.115305596348338,5.36319914961596e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0898014138258781,0.0052078726797876,0.0795939833734944,0.100008844278262,6.35030518411295e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.141311474184165,0.00819622112594152,0.12524688077732,0.157376067591011,6.61835891420119e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.132788461711314,0.00770527912046319,0.117686114635206,0.147890808787421,7.81780102264621e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0405717542069935,0.00235775928989974,0.03595054599879,0.045192962415197,9.07266746963397e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.125832996000359,0.00731362403018618,0.111498292901194,0.140167699099524,9.54143788356884e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBNL,Drebrin-like protein,39931,0.156376120324165,0.00910419475720601,0.138531898600042,0.174220342048289,1.53712755265407e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGA,Protein O-GlcNAcase,37382,0.119692764595995,0.00696279676004374,0.10604568294631,0.133339846245681,1.55733701496308e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.156805949937823,0.00913347575487069,0.138904337458277,0.17470756241737,1.81223795104516e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0951456379772396,0.00554369483055599,0.0842799961093499,0.106011279845129,1.94172867213142e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0552404604634665,0.00321534991288362,0.0489383746342146,0.0615425462927184,1.97059027059947e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18,Interleukin-18,39795,0.0764769863526977,0.00445661243911707,0.0677420259720283,0.0852119467333672,2.0354496477431e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0675310983302765,0.0039362090610544,0.0598161285706098,0.0752460680899431,2.13072445808227e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.200952740850203,0.0117065904018632,0.178007823662551,0.223897658037855,2.34836264849447e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0978992113925425,0.00570371230954979,0.0867199352658249,0.10907848751926,2.49812016295722e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPHN1,Oligophrenin-1,37388,0.181105455185578,0.0105598408791357,0.160408167062472,0.201802743308684,3.05129911589931e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.121801838040794,0.00710969205756282,0.10786684160797,0.135736834473617,3.26425356364714e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.120222394576504,0.00702841887606093,0.106446693579424,0.133998095573583,5.05713779772444e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC5,Glypican-5,39749,0.0935178049538498,0.00546945340410303,0.0827976762818078,0.104237933625892,5.83137993352484e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IST1,IST1 homolog,37287,0.167122625312801,0.00976708845743875,0.147979131936221,0.186266118689381,6.01046300689345e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.104447020095953,0.00610970879253147,0.092471990862591,0.116422049329314,8.05201530013467e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.122371874453736,0.00716687012793088,0.108324809002991,0.13641893990448,8.58423935614008e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAX,Protein max,39489,0.176081412370193,0.0103229543388231,0.155848421866099,0.196314402874286,1.18669547069721e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0913566957997231,0.00535991675981818,0.0808512589504794,0.101862132648967,1.87934280608217e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.107911658438451,0.00633788907718352,0.0954893958471708,0.12033392102973,1.93659650294044e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0442993302577527,0.00260321362536064,0.0391970315520459,0.0494016289634596,2.25640520732008e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0543307797688354,0.003197114789876,-0.0605971247569924,-0.0480644347806785,3.32508510112357e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG2,Secretogranin-2,39949,0.0517180321657906,0.00304471740471539,0.0457503860525485,0.0576856782790328,3.76718273402423e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEFTY2,Left-right determination factor 2,40011,0.0886378741596781,0.00522064119142029,0.0784054174244944,0.0988703308948619,4.27189872989837e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.112593500975031,0.00662931993064429,0.0996000339109683,0.125586968039094,4.93875232341894e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.137391477996498,0.00809606635482708,0.121523187941037,0.153259768051959,6.4453490046614e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.151982736925189,0.00896637717909976,0.134408637654153,0.169556836196224,9.05653913548166e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLB1,Beta-galactosidase,39749,0.0695445029573993,0.00412503809334172,0.0614594282944495,0.077629577620349,3.18599600160699e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0747922796629527,0.00443852636842053,0.0660927679808485,0.0834917913450569,3.74474870574231e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD22,B-cell receptor CD22,40058,0.0661209015961431,0.00392513208145145,0.0584276427164983,0.073814160475788,3.89954007622174e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASC3,Protein CASC3,37039,0.0691719835369343,0.00410230323809699,0.0611314691902642,0.0772124978836044,3.94219011091501e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0797924933287457,0.00473443942526895,0.0705129920552185,0.0890719946022728,4.34739166252314e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.057351587756113,0.00340765005094001,0.0506725936562706,0.0640305818559554,5.09883761963627e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.057983669018072,0.00344659723845139,0.0512283384307073,0.0647389996054367,5.69658246569408e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTPBP2,GTP-binding protein 2,37039,0.133245947143009,0.00791406436323655,0.117734380991065,0.148757513294952,5.97671813859868e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.129368697789883,0.0076943294773135,0.114287812014349,0.144449583565418,6.79229632960733e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0654133408571948,0.00389061022788258,0.057787744810545,0.0730389369038447,6.92286957800126e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.132858376179832,0.0079048613310561,0.117364847970962,0.148351904388702,7.47570087813485e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.137263687147937,0.00816897956266001,0.121252487205123,0.15327488709075,8.00578705762982e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.13987717225336,0.008334870219674,0.123540826622799,0.156213517883921,1.16621386940346e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0545015667646667,0.0032492289553724,0.0481330780121368,0.0608700555171967,1.30161477125595e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0991009413570368,0.00590437017507368,0.0875283758138924,0.110673506900181,1.36065556523164e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.112515347998389,0.00670882046201976,0.0993660598928301,0.125664636103948,1.75784078984077e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0380834010801647,0.00227436695906785,0.0336256418403917,0.0425411603199377,2.07848431978104e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0557056870775574,0.00332795593311443,0.0491828934486531,0.0622284807064617,2.31216929021406e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS2,Trypsin-2,39931,0.0840657000814546,0.00502268328650473,0.0742212408399053,0.0939101593230039,2.36696333819398e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA11,Annexin A11,39829,0.109351458600982,0.00654361269089515,0.0965259777268272,0.122176939475136,3.66452765808643e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RWDD1,RWD domain-containing protein 1,40009,0.104376475801743,0.00624997131374786,0.0921265320267971,0.116626419576689,4.32461224027238e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT1,Deaminated glutathione amidase,37043,0.0770899968856206,0.00461462427175213,0.0680453333129864,0.0861346604582548,5.17489048663957e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST13,Hsc70-interacting protein,37124,0.0902939310506513,0.00540771866952559,0.0796948024583811,0.100893059642921,5.88322904481456e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.151383023634994,0.00907674186989601,-0.16917343769999,-0.133592609569998,6.29682702423948e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0470623434187249,0.0028229108774668,0.04152943809889,0.0525952487385598,6.9170446602325e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0778658527442236,0.00466688424928137,0.0687187596156321,0.0870129458728151,7.00318994323354e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YJU2,Splicing factor YJU2,37368,0.0529501369009019,0.00317895256911861,0.0467193898654294,0.0591808839363744,1.1184946591437e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.150941108419056,0.00906870952526798,0.13316643774953,0.168715779088581,1.13327251282436e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.128412070284771,0.00772803509206722,0.113265121504319,0.143559019065223,1.78308862900219e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY4,Protein canopy homolog 4,39788,0.122850496251852,0.0073980996431932,0.108350220951194,0.137350771552511,2.0805494473176e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0908871255453727,0.00547976695336447,0.0801467823167783,0.101627468773967,2.82850244459852e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.101766515081883,0.0061389055417805,0.089734260219993,0.113798769943773,4.06097990264981e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT1,Angiopoietin-1,39794,0.136646870398294,0.00825658203662149,0.120463969606516,0.152829771190072,5.1657567415224e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0629458444695082,0.00380521839052198,0.0554876164240852,0.0704040725149313,7.43499909941672e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0708018763455982,0.00428162307675272,0.0624098951151629,0.0791938575760335,8.12994011614194e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.110094385095983,0.00665940229712655,0.0970419565936146,0.123146813598351,8.72055995598646e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNMT,Histamine N-methyltransferase,39669,0.0747653608674975,0.0045263603099302,0.0658936946600343,0.0836370270749607,8.82753464207442e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPBP,Platelet basic protein,37371,0.137446505802837,0.00831535839197786,0.12114840335456,0.153744608251114,8.91934270314582e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0479914822595974,0.00291340083320332,0.0422812166265189,0.0537017478926759,1.83513185663518e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2,Prothrombin,37453,0.0236762632173626,0.00143658675995567,0.0208605531678495,0.0264919732668757,1.93898996166161e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMNL1,Formin-like protein 1,39489,0.0983174950871496,0.00596967139169533,0.0866169391594268,0.110018051014872,1.96202731748035e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICA1,Islet cell autoantigen 1,39587,0.129188608190131,0.00785828720221681,0.113786365273786,0.144590851106476,3.15521606985202e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL18,C-C motif chemokine 18,39715,0.113630887535416,0.00691338582625954,0.100080651315947,0.127181123754885,3.30529641905791e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRY2,Protein sprouty homolog 2,39587,0.149003788692845,0.00907499450182112,0.131216799469275,0.166790777916414,4.40849972333339e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.138829023764425,0.00845559644208582,0.122256054737937,0.155401992790913,5.51317716730038e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.125382069383404,0.0076392890525908,0.110409062840326,0.140355075926482,5.86368739531421e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESYT2,Extended synaptotagmin-2,37388,0.132266050564293,0.00806101813987872,0.11646645501013,0.148065646118455,6.33875692109691e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.142285749281071,0.00867840228964144,0.125276080793374,0.159295417768768,6.38650287217417e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPART,Spartin,37124,0.125280630613023,0.00763836082604359,0.110309443393977,0.140251817832068,7.23802868353679e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TWF2,Twinfilin-2,37437,0.13561912827476,0.00827799908783655,0.1193942500626,0.151844006486919,9.44779417627057e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0523139183700545,0.0031986032042104,0.0460446560898021,0.0585831806503069,1.21530547607467e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK10,Kallikrein-10,39856,0.062980887366753,0.00385643827698596,0.0554222683438606,0.0705395063896455,1.78794907394354e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.116226379091027,0.00711362925224175,0.102283665756633,0.130169092425421,2.01219193923522e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.099352154336965,0.00609730320050352,0.0874014400639781,0.111302868609952,3.32403084947235e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARC,SPARC,39913,0.11247812627604,0.00690424295944971,0.0989458100755185,0.126010442476561,3.40291080571905e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.127030899357688,0.00779746942147089,0.111747859291605,0.142313939423771,3.43345726442958e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0939766734257548,0.0057741373601245,0.0826593641999108,0.105293982651599,4.51718081611875e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD69,Early activation antigen CD69,39785,0.14007352138577,0.00860852219871023,0.123200817876298,0.156946224895242,4.7088253390881e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.138244987375032,0.00849941573236601,0.121586132539595,0.154903842210469,5.3374711622683e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMA,Granzyme A,40058,0.0538194142141475,0.00331039357009393,0.0473310428167634,0.0603077856115316,5.76958222230238e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0948880452019776,0.00583661808847588,0.0834482737485648,0.10632781665539,5.98889281540856e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0420875653609139,0.00258845958955945,0.0370141845653774,0.0471609461564504,6.85939086543562e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSS,Cathepsin S,36543,0.0388640323592796,0.00239072561220444,0.0341782101593589,0.0435498545592003,7.93316174853328e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PF4,Platelet factor 4,37385,0.153542425776866,0.00944953534852073,0.135021336493765,0.172063515059966,8.22224806542298e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.112871206991042,0.00695904700517632,0.0992314748608965,0.126510939121188,1.08100769395606e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF19,Fibroblast growth factor 19,39931,0.121407817190902,0.00749380704048862,0.106719955391544,0.13609567899026,1.44187678570893e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.152865929909138,0.00944683219229562,0.134350138812239,0.171381721006038,1.97394162636851e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MENT,Protein MENT,37124,-0.0352256522299631,0.00217523629074735,-0.0394891153598279,-0.0309621891000983,2.01976890162757e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2,Microtubule-associated protein 2,37388,0.0727909984355084,0.00450812360802397,0.0639550761637814,0.0816269207072354,4.18525583932328e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0504809010451835,0.0031292245668289,0.0443476208941988,0.0566141811961681,4.34501051482144e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RFC4,Replication factor C subunit 4,37368,0.0337717226720572,0.00209315821306269,0.0296691325744543,0.0378743127696601,5.09753726666109e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.134888502595654,0.00836753293865131,0.118488138035898,0.151288867155411,6.35438295613469e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGF,Pro-epidermal growth factor,39808,0.163500932895561,0.0101552249018195,0.143596692087995,0.183405173703127,7.26959568346355e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.112646661720204,0.00699739691977989,0.0989317637574351,0.126361559682972,7.43573513070333e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLG,Plasminogen,37162,0.0356869775133636,0.0022155197784125,0.0313445587476751,0.0400293962790521,7.92715398634615e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDT,D-dopachrome decarboxylase,37437,0.0633246663179758,0.00393177067789284,0.0556183957893058,0.0710309368466458,7.9580971506139e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0654062366795525,0.00406402163570984,0.0574407542735612,0.0733717190855438,9.89359073248901e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN3,Ataxin-3,37388,0.0966029918398598,0.00600326601409308,0.0848365904522373,0.108369393227482,1.00039805521096e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0859839668132617,0.005352900557366,0.0754922817208244,0.0964756519056991,1.31265148150851e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0771078661069047,0.00480414343466225,0.0676917449749667,0.0865239872388427,1.99085668586662e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.035279568653608,0.00219988922792993,0.0309677857668653,0.0395913515403507,2.43733871588002e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILPL2,RILP-like protein 2,37437,0.154970453304556,0.00966863458090248,0.136019929525987,0.173920977083125,2.72332201215398e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR2,GMP reductase 2,37124,0.105148679986849,0.00656274120957677,0.0922857072160789,0.11801165275762,3.08403286893118e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPSE,Heparanase,37306,0.147598726350116,0.0092156866461206,0.129535980523719,0.165661472176512,3.33663412782513e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0885641815134938,0.00553732952853739,0.0777110156375605,0.0994173473894271,3.99652051905217e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0443454072011578,0.00277656507722978,0.0389033396497874,0.0497874747525281,5.6149801273095e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX8,Syntaxin-8,39866,0.076297245466339,0.00477929634126681,0.0669298246374561,0.085664666295222,6.24962507970234e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0873947026065561,0.00547516071159809,0.0766633876118239,0.0981260176012884,6.5739947377002e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.121695743352235,0.00763013803315687,0.106740672807247,0.136650813897222,7.88718833058002e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0776312364542752,0.00487450512365838,0.0680772064119047,0.0871852664966456,1.3930803724536e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.163352108798763,0.0102686199938495,0.143225613610818,0.183478603986708,1.51493325403255e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD2,Polycystin-2,37021,0.0928777665563161,0.00583413362294987,0.0814428646553343,0.104312668457298,1.55730237044627e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBXN1,UBX domain-containing protein 1,37124,0.108140560025647,0.00679699219324072,0.0948184553268956,0.121462664724399,1.79509611845636e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4D,Semaphorin-4D,40009,0.0466425495895574,0.00293415896326282,0.0408915980215622,0.0523935011575525,1.79923344193759e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN2,Centrin-2,39489,0.105482268502498,0.00663988541546372,0.0924680930881891,0.118496443916807,2.18265339188026e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0894007675809035,0.00562891497794334,0.0783680942241346,0.100433440937672,2.27694414081177e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.0454130663527686,0.00285993760229471,0.0398075886522709,0.0510185440532662,2.36292168102166e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK1,Docking protein 1,37388,0.213438200551158,0.0134417546617568,0.187092361414114,0.239784039688201,2.86458887655473e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.151316476813746,0.00952998778257436,0.1326377007599,0.169995252867591,2.99040618738786e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN3,Centrin-3,37382,0.122845254441954,0.00773785036852041,0.107679067719654,0.138011441164254,2.99706504107101e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB1,Carboxypeptidase B,40052,0.0892225059548548,0.00562651761283935,0.0781945314336897,0.10025048047602,3.30428420048218e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0774503539352872,0.00488603567756316,0.0678737240072634,0.087026983863311,3.70497977885745e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0583293346952274,0.00368022208184924,0.0511160994148028,0.0655425699756519,3.88172430245783e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.130643835965909,0.0082570336778122,0.114460049957398,0.146827621974421,5.81397351055165e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD226,CD226 antigen,37056,0.0649567926837664,0.00410747448387226,0.0569061426953768,0.0730074426721561,8.06685722918904e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTNB,Dystrobrevin beta,37348,0.0679806498158777,0.00430779364383011,0.0595373742739707,0.0764239253577848,1.32402021000606e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOD,Apolipoprotein D,36780,-0.0671106108189705,0.00425331506214092,-0.0754471083407667,-0.0587741132971743,1.44495180387755e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.131801937167473,0.00836385801920204,0.115408775449837,0.148195098885109,1.60710420773575e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPACT,Protein IMPACT,37388,0.0854815146783785,0.00542434226514582,0.0748498038386927,0.0961132255180643,1.85714136417454e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.118584997360344,0.00754096963744169,0.103804696870958,0.13336529784973,3.21286546741457e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM17,Splicing factor 45,37411,0.117873891570581,0.00750260023595501,0.103168795108109,0.132578988033053,3.89124851210365e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APP,Amyloid-beta precursor protein,39829,0.102451638903839,0.00652675788028693,0.0896591934584762,0.115244084349201,4.08269392286826e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.122735452398179,0.00782512039361331,0.107398216426697,0.138072688369661,6.03469916255041e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRAS,Ras-related protein R-Ras,37039,0.202346442277312,0.0129021085873636,0.17705830944608,0.227634575108545,6.17829076703798e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.068902558770861,0.00439746675717263,0.0602835239268026,0.0775215936149193,7.54087022438341e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL3,C-C motif chemokine 3,39866,0.0963318788437006,0.00615318677467471,0.0842716327653382,0.108392124922063,7.75932734730134e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPP,Lipoma-preferred partner,37021,0.102922702499753,0.00657516832799509,0.0900353725768822,0.115810032422623,9.82910974807786e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.196784203378849,0.0125898313770243,0.172108133879881,0.221460272877816,1.14571757073067e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.094077589688118,0.00602532568090782,0.0822679513535387,0.105887228022697,1.47949197788818e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.081903237876194,0.00524111623441352,0.0716306500567435,0.0921758256956445,1.49033627599241e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0897007622869231,0.00574155781954891,0.0784473089606072,0.100954215613239,1.56035367248103e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.117634621834562,0.00753951421553219,0.102857173972119,0.132412069697005,1.80630340473573e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOT,Angiomotin,37124,0.0631047714470855,0.00404717741210402,0.0551723037193616,0.0710372391748093,2.49143467310668e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53,Cellular tumor antigen p53,39477,0.0674263097078546,0.00433090220189178,0.0589377413921468,0.0759148780235625,3.03902037364107e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDC,Nuclear migration protein nudC,40058,0.0980441782477225,0.00630686568547256,0.0856827215041963,0.110405634991249,4.18952665653069e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0701371946232233,0.00451069157571149,0.0612962391348287,0.0789781501116178,4.73436083932467e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX4,Syntaxin-4,39788,0.0900621804808224,0.00580211897054566,0.0786900272985529,0.101434333663092,6.08749716847305e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE2,Glia-derived nexin,37437,0.0981645426725964,0.00632641477510942,0.0857647697133819,0.110564315631811,7.75874092039951e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0452163705797716,0.00291536543859191,0.0395022543201314,0.0509304868394117,8.74313192492046e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0698930701502673,0.00451045468114554,0.0610525789752221,0.0787335613253126,1.10081128693984e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM3,Junctional adhesion molecule C,37124,0.0768023408311156,0.00495719046520437,0.067086247519315,0.0865184341429162,1.13920915819248e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0387332349122236,0.00250246611100351,-0.0436380684897905,-0.0338284013346567,1.18953995145249e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLG4,Disks large homolog 4,37388,0.108801655893487,0.0070249933984095,0.0950326688326044,0.12257064295437,1.2102587669066e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0784760353588704,0.00506716660574698,0.0685443888116064,0.0884076819061345,1.25461171738941e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0542524327680366,0.00350891013096182,0.0473749689113514,0.0611298966247218,1.54553245041294e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP10,Caspase-10,39489,0.108348490810359,0.00700732908311001,0.0946141258074631,0.122082855813254,1.55588107972821e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEXN,Nexilin,37445,0.10425387737141,0.00674226867288202,0.091039030772561,0.117468723970258,1.76683207679819e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.126832380729536,0.00820899729995518,0.110742746021624,0.142922015437448,2.14232939479531e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA1,Carboxypeptidase A1,40052,0.0892136254368036,0.00579676947795323,0.0778519572600153,0.100575293613592,4.52123709325491e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXJ3,Forkhead box protein J3,37056,0.0676948816062333,0.00439841830947857,0.0590739817196553,0.0763157814928113,5.44813780192218e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSL,Cathepsin L1,39868,0.0360108204916954,0.00234163994540073,0.03142120619871,0.0406004347846809,5.46199501271847e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.129760974477366,0.00843444546356484,0.113229461368778,0.146292487585953,5.94341045939432e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0747035582842657,0.00485598436395105,0.0651858289309216,0.0842212876376097,6.19626185621355e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.19060276918595,0.0124016047682886,0.166295623840105,0.214909914531796,7.51283794714843e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRADD,Death domain-containing protein CRADD,39713,0.114823919839153,0.00748271762591302,0.100157793292363,0.129490046385942,9.13027976881176e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0539387953688042,0.00351298223859566,0.0470533501811567,0.0608242405564517,9.26616250872204e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK13,Kallikrein-13,39490,0.0633751359276873,0.00413405133484874,0.0552723953113838,0.0714778765439908,1.16388355823535e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0420766078465105,0.00274722661529159,0.036692043680539,0.047461172012482,1.40511635423061e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSTN,Growth/differentiation factor 8,39585,0.0778718149708541,0.00508447106319883,0.0679062516869844,0.0878373782547238,1.44053010497851e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.10163295682694,0.00664347645586438,0.0886117429734456,0.114654170680434,1.8299587487168e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL8,C-C motif chemokine 8,40003,0.0905046090520992,0.00591639159713977,0.0789084815217053,0.102100736582493,1.86018950882168e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.104036436361572,0.006798697273311,0.090710989705882,0.117361883017261,2.06426107167767e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0976820702311201,0.00638443969211595,0.0851685684345729,0.110195572027667,2.13815538804557e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6AP2,Renin receptor,39477,0.060986947112707,0.00399633753976398,0.0531541255347696,0.0688197686906444,3.32531741678774e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADD1,Alpha-adducin,37124,0.103050784346659,0.00675996465970102,0.0898012536136445,0.116300315079673,4.9577885614899e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0860283245676467,0.0056527661564782,0.0749489029009494,0.097107746234344,6.13086345912493e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0696703707593421,0.00457707055146734,0.0606993124784661,0.078641429040218,6.81294392918797e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0913240849951855,0.00600617143178719,0.0795519889888826,0.103096181001488,7.56991383512886e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.146677061601898,0.0096497889408474,0.127763475277838,0.165590647925959,8.29901195668485e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0475302055767569,0.00312839205562192,0.041398557147738,0.0536618540057759,8.95098180425595e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0883971354911514,0.00581911495754142,0.0769916701743702,0.0998026008079326,9.28191267607999e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATOX1,Copper transport protein ATOX1,39913,0.108386997549396,0.00713494176331338,0.0944025116933022,0.122371483405491,9.28861330049148e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KITLG,Kit ligand,39868,-0.0551985933799208,0.00363362220482145,-0.0623204929013708,-0.0480766938584707,9.30279026398443e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFB,Complement factor B,37220,0.0491327607124756,0.00323458186410106,0.0427929802588375,0.0554725411661137,1.11519311174682e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0410581070412224,0.00270570216261475,0.0357549308024975,0.0463612832799473,1.20099219523932e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGLAP,Osteocalcin,37437,0.128625095526018,0.00847602813787628,0.11201208037578,0.145238110676255,1.36794799782731e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.092636455073054,0.00610817383599729,0.0806644343544993,0.104608475791609,1.56962468770712e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.118664624347125,0.00782568371700088,0.103326284261803,0.134002964432446,1.677405898401e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.065819627175481,0.00435456449243977,0.0572846807702991,0.074354573580663,2.92613130395353e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0481720772393034,0.00319125661186427,0.0419172142800495,0.0544269401985574,3.9427026059529e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGLL,Monoglyceride lipase,39908,0.129241416033784,0.00856293693167425,0.112458059647703,0.146024772419866,4.03192096005779e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.100182804057907,0.0066378546638719,0.087172608916718,0.113192999199096,4.83774034598359e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP7,Caspase-7,37388,0.124669437554918,0.00827039155845851,0.108459470100339,0.140879405009497,6.20343379734805e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0424856219528321,0.00282006943009339,0.0369582858698491,0.0480129580358152,6.22662537716967e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0606735527682569,0.00402849059012719,0.0527777112116076,0.0685693943249062,6.49465640398371e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP7,Matrilysin,39563,0.07301704008732,0.0048485495150615,0.0635138830377994,0.0825201971368405,6.77103418166719e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMT,Catechol O-methyltransferase,39403,0.125556595622995,0.00834365249102378,0.109203036740588,0.141910154505401,8.09282074312775e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0833549871822261,0.00554123984677618,0.0724941570825448,0.0942158172819075,8.61196259871056e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0499352279165598,0.00332046000094955,0.0434271263146987,0.0564433295184209,9.04342769335445e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIFBP,KIF-binding protein,39788,0.122277611794346,0.00813080894751288,0.106341226257221,0.138213997331471,9.12158636010224e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2,Complement C2,39908,0.0347608806526391,0.00231594063691049,0.0302216370042945,0.0393001243009836,1.40439286270109e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0849756495788066,0.00566517001898516,0.0738719163415957,0.0960793828160175,1.65839598995324e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTF1,Cardiotrophin-1,39585,0.124634979944593,0.00832228851214193,0.108323294460795,0.140946665428392,2.34170346883405e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.14398654943201,0.00960893921384559,0.125153028572873,0.162820070291147,2.34431619580432e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.114051362861422,0.00761737222296522,0.0991213133044099,0.128981412418434,2.43383560010972e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0565714777377511,0.00378256035182092,0.0491576594481821,0.0639852960273201,3.6639623725865e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED8,Protein TMED8,37382,0.151506816473919,0.0101514364225646,0.131610001085692,0.171403631862146,5.68975388995061e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.124922245606111,0.00838013761995421,0.108497175871001,0.141347315341222,7.37411785345696e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM3,Dynamin-3,37411,0.0800988207882956,0.00538106132991754,0.0695519405816572,0.090645700994934,1.01382915309693e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0688860994373049,0.00463118913216536,0.0598089687382608,0.077963230136349,1.03128348762239e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.136659427285377,0.00918263578167949,0.118661461153286,0.154657393417469,1.05872026532948e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0927506324284205,0.00624167719675406,0.0805169451227826,0.104984319734058,1.275597320377e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0699597636127963,0.00470991183799452,0.060728336410327,0.0791911908152655,1.61281413009831e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCB,Tubulin-folding cofactor B,39749,0.147406215450247,0.0099355619385875,0.127932514050615,0.166879916849878,1.83082774581919e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0893085042626262,0.00602420181677599,0.0775010687017452,0.101115939823507,2.46081091570563e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0541509384079476,0.00366460376507996,0.0469683150283909,0.0613335617875043,4.41511347744507e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0986669953863696,0.00667882821551087,0.0855764920839683,0.111757498688771,4.59616239720375e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.109676325697136,0.00741975903629759,0.0951335979859923,0.124219053408279,4.6274903142248e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D5,TBC1 domain family member 5,39866,0.112818717565058,0.00764394853338391,0.0978365784396254,0.12780085669049,5.63180386522271e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0902703673063835,0.00611476705180146,0.0782854238848527,0.102255310727914,6.11512217301675e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.08441150180983,0.00572134447059492,0.073197666647464,0.0956253369721961,6.97551330616304e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM106A,Transmembrane protein 106A,37368,0.103064315920672,0.00698855839887504,0.0893667414588769,0.116761890382467,7.64343317279328e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.139052966512922,0.00944116629728145,0.12054828057025,0.157557652455593,8.85148573002196e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.110821001577018,0.0075270367619999,0.0960680095234987,0.125573993630538,9.53382964690485e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0796008037374691,0.00540635780832128,0.0690043424331594,0.0901972650417788,9.65649895649917e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YWHAQ,14-3-3 protein theta,37124,0.107196828991922,0.00728038348727571,0.0929272773568619,0.121466380626983,1.09380298924704e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIN2,Bridging integrator 2,39858,0.129426055715297,0.00880055004725981,0.112176977622668,0.146675133807926,1.21501806155e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0571494964024225,0.00388668626662792,0.0495315913198318,0.0647674014850133,1.27929202909735e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12A_IL12B,Interleukin-12,39788,0.106036678320354,0.00721556039302107,0.0918941799500324,0.120179176690675,1.4314128325197e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.04615439813025,0.00314046123900253,0.039999094101805,0.052309702158695,1.63575065352817e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.162803471851824,0.0110849907903422,0.141076889902753,0.184530053800895,1.87902814979754e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHD3,EH domain-containing protein 3,37043,0.169418337965997,0.0115383325546055,0.146803206158971,0.192033469773024,1.9947854336134e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.0956348480445726,0.00653537374300853,0.0828255155082759,0.108444180580869,3.51961351236655e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0344326608683585,0.00235300264798025,0.0298207756783172,0.0390445460583998,3.99130289606103e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.106810909510436,0.0073033449412503,0.0924963534255856,0.121125465595287,4.04957076116845e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164,Sialomucin core protein 24,39858,0.0375938658568263,0.0025716706415777,0.032553391399334,0.0426343403143186,4.37391134367057e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB1,Heat shock protein beta-1,39617,0.0999305255854577,0.00683589186068532,0.0865321775385145,0.113328873632401,4.41860118941048e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0451796435459738,0.0030924111236617,0.0391185177435969,0.0512407693483508,4.97091709739459e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0970863489633827,0.00664669735555009,0.0840588221465045,0.110113875780261,5.8893466061875e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH9,Protocadherin-9,37382,0.047567093032641,0.00326096287459178,0.0411756057984411,0.0539585802668409,7.86126081118698e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0611241736420838,0.00419615216602963,0.0528997153966657,0.0693486318875019,9.16941168118744e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0958978196774296,0.00658176347526527,0.0829975632659097,0.10879807608895,1.01187707930592e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TADA3,Transcriptional adapter 3,37368,0.056630314586484,0.00388716578036769,0.0490114696569633,0.0642491595160047,1.02420563296216e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.104247001134901,0.00715625484931108,0.0902207416302515,0.118273260639551,1.03840022462664e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.111682492000509,0.00767547562326069,0.0966385597789185,0.1267264242221,1.16767308130782e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.170504956654293,0.0117129990577631,0.147547478501077,0.193462434807509,1.22954054242676e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0935859147243644,0.00643393799041029,0.0809753962631602,0.106196433185569,1.24487108784707e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.104737017122705,0.00719814486625787,0.0906286531848399,0.118845381060571,1.34326909633127e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.12300200471325,0.00845974621678576,0.10642090212835,0.13958310729815,1.37010141748527e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0677039440147311,0.00465548160386858,0.0585792000711487,0.0768286879583136,1.47577724716492e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.125265243048847,0.00861660142405645,0.108376704257697,0.142153781839998,1.59074390333778e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB6,Serpin B6,39970,0.0857935076776147,0.00590510570506644,0.0742195004956845,0.0973675148595449,1.59247500254917e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.072723296104645,0.00500662437196511,0.0629103123355934,0.0825362798736966,1.90487246209459e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0941713891668501,0.00648682429074674,0.0814572135569865,0.106885564776714,1.90722541907031e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.104832710486121,0.00721861980267179,0.0906842156728842,0.118981205299358,2.02537175943326e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WDR46,WD repeat-containing protein 46,37368,0.0513543538778318,0.00353940091305077,0.0444171280882523,0.0582915796674113,2.39970398454527e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F12,Coagulation factor XII,37453,0.0589757586605283,0.00406499215790615,0.0510083740310323,0.0669431432900244,2.42644578174501e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.156247552480798,0.0107824307178002,0.135113988273909,0.177381116687686,2.75970938328339e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0756691820623197,0.00522712730300335,0.0654240125484332,0.0859143515762063,3.91401779316511e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL32,Interleukin-32,39866,-0.0607685944992758,0.00420120650239532,-0.0690029592439706,-0.052534229754581,4.02233782600335e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0705096287602804,0.00487583601049483,0.0609529901797106,0.0800662673408503,4.2308944597533e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0545183570042162,0.00376904138451372,0.0471310358905693,0.0619056781178631,4.53918537355731e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0524077890343729,0.00362728551577089,0.045298309423462,0.0595172686452839,5.14639568375724e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.140960592221039,0.00976095624205782,0.121829117986606,0.160092066455473,6.5079017402806e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD83,CD83 antigen,39866,0.0464502749099246,0.00321933539374227,0.0401403775381898,0.0527601722816595,6.74021033072852e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOF,Apolipoprotein F,37445,-0.0366020982430873,0.00253879239501159,-0.0415781313373101,-0.0316260651488646,8.93822002166118e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0918999456803407,0.00637431311228007,0.0794062919802718,0.10439359938041,8.95800928939469e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACYBP,Calcyclin-binding protein,37088,0.146638326668668,0.0101805117050163,0.126684523726836,0.1665921296105,1.10363463247517e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP1,Guanylate-binding protein 1,37376,0.0898148152638805,0.00623600921887967,0.0775922371948763,0.102037393332885,1.10383513789313e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL2,C-C motif chemokine 2,39720,0.0729390517902398,0.00506812147553892,0.0630055336981835,0.0828725698822961,1.1474823634142e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.125841608962563,0.00873975481698468,0.108711689521273,0.142971528403853,1.16203706123413e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7,Interleukin-7,39866,0.0920766300150182,0.00639900884896305,0.0795345726710507,0.104618687358986,1.18244206462244e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0962433042590681,0.0066922501346223,0.0831264939952084,0.109360114522928,1.32564429269401e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0873596798207813,0.00607259909000929,0.0754573856043631,0.0992619740371996,1.42891884553631e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.07765746032141,0.0053992345511733,0.0670749606011103,0.0882399600417097,1.45917274295939e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3C,Protein FAM3C,39846,0.040793158450632,0.00284035384891166,0.0352260649067652,0.0463602519944989,1.74426548217156e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0424938878417317,0.00295984859863154,0.0366925845884138,0.0482951910950495,1.86730457973927e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID1,Nidogen-1,39892,0.0528477411477609,0.00368405993783932,0.0456269836695959,0.060068498625926,2.2185940106328e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0627618320678676,0.00437243514720372,0.0541918591793483,0.0713318049563869,2.24717159396967e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0864576798590436,0.00603215392899079,0.0746346581582217,0.0982807015598656,2.96814952761904e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0591097831545046,0.00412454318375418,0.0510256785143464,0.0671938877946628,3.04704892510298e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0741885904991585,0.00517946764949138,0.0640368339061554,0.0843403470921616,3.05942250433466e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMVK,Phosphomevalonate kinase,39480,0.156141268656697,0.0109036218711983,0.134770169789148,0.177512367524245,3.21335931897206e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.143847650632331,0.0100536157643204,0.124142563734263,0.163552737530399,4.22883152755158e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMMT,MICOS complex subunit MIC60,37368,0.0615844732139814,0.00430650363876579,0.0531437260820004,0.0700252203459624,4.7203472543841e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.146599467524507,0.0102648281068933,0.126480404434996,0.166718530614018,6.22913659052808e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.132673469093441,0.00929384788833227,0.11445752723231,0.150889410954572,6.71626087107665e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.125242071288466,0.00878544348468192,0.108022602058489,0.142461540518442,7.9066937703499e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0932957566659181,0.00654466334930397,0.0804682165012823,0.106123296830554,9.10900324544144e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0939156394745878,0.0065883299049381,0.0810025128609091,0.106828766088266,9.159746644466e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2R,Proteinase-activated receptor 1,39908,0.081601962349104,0.00573113798766233,0.0703689318932859,0.0928349928049222,1.005583997052e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.156826703706674,0.0110190367832646,0.135229391611475,0.178424015801872,1.09365132904939e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3,Galectin-3,39901,0.0411786039470207,0.00289427153558346,0.0355058317372771,0.0468513761567643,1.17045394370269e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0624690515489696,0.00439699494329041,0.0538509414601204,0.0710871616378188,1.58796533260798e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LARP1,La-related protein 1,37368,0.0893167539022711,0.00629219602629684,0.0769840496907293,0.101649458113813,2.09033760036426e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0894548697601588,0.00630310189528407,0.077100790045402,0.101808949474916,2.19946841309467e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIAPIN1,Anamorsin,39913,0.0877839912016254,0.00619422342959545,0.0756433132796184,0.0999246691236325,2.56515421486715e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARK7,Parkinson disease protein 7,39858,0.0729809330596388,0.0051497785853665,0.0628873670323205,0.0830744990869572,2.5796475166407e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THTPA,Thiamine-triphosphatase,37345,0.122801993314698,0.0086692836792262,0.105810197303414,0.139793789325981,3.17425356846097e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRL,Appetite-regulating hormone,39868,0.106532864781228,0.00753000068838231,0.0917740634319991,0.121291666130458,3.60668262018146e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CERT,Ceramide transfer protein,39489,0.085597499744696,0.00605002695982482,0.0737394469034394,0.0974555525859526,3.6361162869622e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0396302687145459,0.00280149075708799,0.0341393468306534,0.0451211905984384,4.12508293616604e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0716260700018976,0.00506633331558545,0.0616960567033501,0.081556083300445,4.1590613423628e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0837519203763444,0.00592838967926217,0.0721322766049906,0.0953715641476983,4.88560484577238e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.139615705675322,0.00988598553333971,0.120239174029976,0.158992237320667,5.13684271612254e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON2,Spondin-2,39775,-0.0464721941863625,0.00329212397218098,-0.0529247571718372,-0.0400196312008877,5.63988306196306e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0815427679141935,0.00578003856766049,0.0702138923215789,0.092871643506808,6.43036861643946e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0369612080710219,0.00262035284132395,0.031825316502027,0.0420970996400168,6.48517864983139e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.065354005427813,0.00463369363013751,0.0562719659127435,0.0744360449428825,7.59081337986576e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.126213941568962,0.00894895046120029,0.108673998665009,0.143753884472914,7.61858885799903e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0583200980636833,0.00413553509440656,0.0502144492786464,0.0664257468487201,7.75908779033798e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0574013692628573,0.00407382674347804,0.0494166688456403,0.0653860696800742,8.11172304630106e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0878576559185346,0.00623746412961158,0.0756322262244959,0.100083085612573,8.63596728479214e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0392471725360745,0.00278872137083581,0.0337812786492363,0.0447130664229126,1.02223154622633e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEPR,Leptin receptor,39868,-0.0426803342351857,0.00303330166210644,-0.0486256054929143,-0.0367350629774571,1.0633697883721e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.106799295004622,0.0075919737281062,0.0919190264975335,0.12167956351171,1.24267254681957e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0468312273155522,0.00333141623841984,0.0403016514882493,0.053360803142855,1.2919994760135e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11,Coagulation factor XI,37249,0.0430342985375985,0.00306781112557834,0.037021388731465,0.0490472083437321,2.17525698059771e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MESD,LRP chaperone MESD,39858,0.168040000557584,0.0119870419247732,0.144545398385028,0.191534602730139,2.20004464986828e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0660338023686147,0.00472794284222671,0.0567670343978503,0.075300570339379,5.01901685493166e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.154525068877884,0.0110710495526397,0.13282581175471,0.176224326001057,5.19707138513806e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.129930583628971,0.00931218553972042,0.111678699971119,0.148182467286823,5.50237007831331e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.062495178242302,0.00448400537446147,0.0537065277083575,0.0712838287762465,6.74507972606932e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAP3,Cytosol aminopeptidase,39587,0.066543904548393,0.00477624020791801,0.0571824737408737,0.0759053353559123,7.34964282791984e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL1,Growth-regulated alpha protein,39839,0.129742277520814,0.00931297306405804,0.11148885031526,0.147995704726368,7.37510537396912e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBN,Nibrin,39587,0.0704228480118025,0.00505865498346196,0.0605078842442171,0.080337811779388,8.5591827755011e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0550062449305934,0.00394961959817491,0.0472649905181706,0.0627474993430162,8.70635238693466e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0831994057621913,0.00597733916648943,0.0714838209958721,0.0949149905285106,8.72324545270714e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.088815491630352,0.00639038280370504,0.0762903413350901,0.101340641925614,1.2936326689607e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0529197391517832,0.00381026404524536,-0.0603878566804641,-0.0454516216231023,1.32743060054408e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMSB10,Thymosin beta-10,39858,0.105279016812889,0.00758627059538688,0.0904099264459303,0.120148107179847,1.5487093525727e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0929256495617732,0.00670179099029777,0.0797901392207895,0.106061159902757,1.84727368590492e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.1115068409044,0.00804852291207089,0.0957317359967406,0.127281945812058,2.13253033936541e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0413197720267242,0.00298363765494752,0.0354718422230271,0.0471677018304213,2.56525564388737e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.13416915161417,0.00969188314573073,0.115173060648537,0.153165242579802,2.74211517752605e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0542857412891599,0.0039215679551381,0.0465994680970892,0.0619720144812306,2.76436395762914e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.119936928633725,0.00866793383571133,0.102947778315731,0.136926078951719,3.01263965191983e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.042404157956896,0.0030683167727356,0.0363902570823342,0.0484180588314577,3.39553621251011e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0464039294765947,0.00335846340160802,0.039821341209443,0.0529865177437465,3.61169040337355e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRB1,Chymotrypsinogen B,39858,0.0724630247059592,0.0052471830213047,0.062178545984202,0.0827475034277164,3.9277719998778e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.125497009211195,0.00908662645215797,0.107687221364965,0.143306797057424,4.35351551691882e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.135625501143325,0.00982507535121144,0.11636835345495,0.154882648831699,4.71874397670099e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.146348325969489,0.0106068826303677,0.125558836013968,0.167137815925009,5.16469629566544e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.063731116101606,0.00461941691509723,0.0546770589480154,0.0727851732551965,5.23421428348051e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP2,Caspase-2,39866,0.0923919725876771,0.00670929169856054,0.0792417608584984,0.105542184316856,6.7127238839313e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF6,SLAM family member 6,39477,0.0510351798131864,0.00370757602990992,0.043768330794563,0.0583020288318099,7.3527378657735e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.125136792276444,0.00909312818103018,0.107314261041625,0.142959323511264,7.59831892305778e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA2,Carboxypeptidase A2,39933,0.087068477214922,0.00632714994094367,0.0746672633306724,0.0994696910991716,7.64295487531455e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.138514909564551,0.0100598407638789,0.118797621667349,0.158232197461754,7.73705168192449e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0488071759048126,0.00354787219919626,0.041853346394388,0.0557610054152373,8.11613479813223e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.060546767584313,0.00439879621199496,0.0519251270088029,0.0691684081598232,8.2440135986719e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLMH,Bleomycin hydrolase,40052,0.0431993300054303,0.00314068532657114,0.0370435867653509,0.0493550732455098,8.30135106878743e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0725449711278254,0.00527669446604145,0.0622026499743841,0.0828872922812666,1.0114774909694e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RP2,Protein XRP2,39788,0.0562572105234689,0.00409469889677991,0.0482316006857803,0.0642828203611575,1.03822968710204e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0508606031614412,0.00370046264302733,0.0436076963811076,0.0581135099417747,1.06619055151216e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBI,Acyl-CoA-binding protein,39793,0.107704583040653,0.00785138046066923,0.0923158773377409,0.123093288743564,1.38455194072353e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.134007731237451,0.00977126729660313,0.114856047336109,0.153159415138793,1.59891122332067e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UMOD,Uromodulin,40012,-0.0708358393510107,0.00517420492274698,-0.0809772809995948,-0.0606943977024267,2.00467919007828e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.126888781246257,0.00930917987380139,0.108642788693606,0.145134773798908,4.54159811218227e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA3,Annexin A3,39985,0.0934053522633055,0.00685486907401012,0.0799698088782457,0.106840895648365,4.78678630154403e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICALL2,MICAL-like protein 2,37039,0.0910513570223961,0.00667834588068643,0.0779617990962507,0.104140914948541,4.85850976802167e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO3,Forkhead box protein O3,39477,0.130652260421247,0.00959353123278387,0.11184893920499,0.149455581637503,5.37936976305519e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB1,Beta-crystallin B1,37437,0.0889134591964823,0.0065349340830806,0.0761049883936443,0.10172192999932,6.95321180742682e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOC1,Apolipoprotein C-I,37424,0.0499157705536608,0.00367443048536424,0.0427138868023469,0.0571176543049747,9.26487622827024e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.061221587109686,0.00450643919651296,0.0523889662845206,0.0700542079348514,9.34095752779365e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0525664275272174,0.00387275583496968,0.0449758260906769,0.060157028963758,9.93269949876183e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0816254785430913,0.00601382360526844,0.0698383842767651,0.0934125728094174,1.10376609839084e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA4,Ephrin-A4,39720,0.0368225727972799,0.00271695752586242,0.0314973360465895,0.0421478095479702,1.29896705035328e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB2,Calretinin,39489,0.0387194783428471,0.00286552597348598,0.0331030474348146,0.0443359092508796,2.26304724417032e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.109543146537131,0.00810402474966732,0.0936592580277826,0.125427035046479,2.2941797609258e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0861740630207176,0.00639215790754725,0.073645433521925,0.0987026925195102,3.71927834198126e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0443720462217242,0.00329327631477595,0.0379172246447633,0.050826867798685,3.76726234589133e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGT1,Protein SGT1 homolog,39477,0.107318145455118,0.00796547465136274,0.0917058151384475,0.122930475771789,3.83266665760247e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP3,Caspase-3,40052,0.117664225645612,0.00873486911555885,0.100543882179116,0.134784569112107,3.87843478026383e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.102886850926363,0.00764255475843558,0.0879074435998292,0.117866258252897,4.33845631740231e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMFG,Glia maturation factor gamma,37437,0.0952693200538144,0.00707324244346118,0.0814057648646305,0.109132875242998,4.3710963287354e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0656802957839794,0.00488124113588332,-0.0752475284103107,-0.0561130631576481,4.76746206254811e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0801056837098298,0.00595598049920425,0.0684319619313894,0.0917794054882701,5.74070511828975e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0857362722658507,0.00637464935664243,0.0732419595268315,0.0982305850048698,5.77249921051956e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0752850094719848,0.00560329060427823,0.0643025598875995,0.0862674590563702,6.92320842873362e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POSTN,Periostin,37437,-0.0489284768384438,0.00365021138638168,-0.0560828911557519,-0.0417740625211357,1.03553158317044e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0699288950676794,0.00522727688037363,0.0596834323821471,0.0801743577532117,1.34296580925577e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0862283509755828,0.00644900694372295,0.0735882973658859,0.0988684045852798,1.49689463708508e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL26,C-C motif chemokine 26,39866,0.112267265447494,0.00840351235020573,0.0957963812410906,0.128738149653897,1.71647184550327e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0657973542223779,0.00492576186867404,0.0561428609597767,0.075451847484979,1.74778606757223e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADM,Pro-adrenomedullin,40030,0.034505235536119,0.00258437605777508,0.0294398584628798,0.0395706126093581,1.9015697139299e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA1,Apolipoprotein A-I,37453,-0.0358127522191079,0.00268090269692747,-0.0410673215050857,-0.03055818293313,1.90160774649886e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.14736531516069,0.0110377036960215,0.125731415916488,0.168999214404892,1.93814618160719e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0499963329367971,0.00374644888557549,0.0426532931210691,0.057339372752525,2.08794316480257e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XCL1,Lymphotactin,40030,0.0718068704412551,0.00538473249921068,0.0612527947428022,0.082360946139708,2.35781933057443e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C4BPB,C4b-binding protein beta chain,39913,0.0518939718416609,0.00389280265966551,0.0442640786287165,0.0595238650546053,2.51248178962299e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSA,Arylsulfatase A,39858,0.0587835602882924,0.0044175695175495,0.0501251240338953,0.0674419965426894,3.45781633370648e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0753727355428031,0.00566564935668215,0.0642680628037061,0.0864774082819001,3.62455147789854e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFASC,Neurofascin,40058,0.0361192177586355,0.00271909874565178,0.030789784217158,0.041448651300113,4.67372475025257e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.115228651543835,0.00867339146591518,0.0982288042706417,0.132228498817029,5.01861819379361e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPT,Dermatopontin,40052,0.0349287059682754,0.0026317830991916,0.0297704110938599,0.0400870008426909,5.45193509237038e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTF2,Transcription termination factor 2,37039,0.0641320245327981,0.00483163204228274,0.054662025729924,0.0736020233356723,5.96176701872749e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPPK1,Epiplakin,37043,0.0972484128540714,0.00733198463072838,0.0828777229778438,0.111619102730299,6.77993698783119e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0992767155565645,0.00751244553185597,0.0845523223141268,0.114001108799002,1.17491255097458e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFA,Protransforming growth factor alpha,39866,0.0595137067660794,0.00450714667444834,0.0506796992841607,0.0683477142479982,1.33493167987944e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0590072021554973,0.00446674653297503,0.0502523789508663,0.0677620253601284,1.34494875887031e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRD2,Protein ZNRD2,37382,0.0880997187384456,0.00667217770769898,0.0750222504313556,0.101177187045536,1.46092386673254e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0390243041732278,0.00295822214708442,0.0332261887649423,0.0448224195815132,1.70994075400799e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.101264622739825,0.00767900560237312,0.0862137717591735,0.116315473720476,1.81935097790657e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0626328524737811,0.00475466320794136,0.053313712586216,0.0719519923613462,2.03767346211295e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0520781368573266,0.00395398346386667,0.0443283292681479,0.0598279444465052,2.07499520573169e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.026035543570706,0.00197896370439347,-0.0299143124313172,-0.0221567747100948,2.50515115511023e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0957476924335161,0.00727733699605551,0.0814841119212473,0.110011272945785,2.6990919613839e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0465893873179773,0.00354430495131364,0.0396425496134026,0.053536225022552,2.89349764755919e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.155539641657435,0.0118484268579812,0.132316725015792,0.178762558299078,3.64601428157443e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.163933446719391,0.0124841420407416,0.139464528319537,0.188402365119245,3.77561662279767e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0521727068835068,0.00397360802977105,0.0443844351451555,0.059960978621858,3.85515027300863e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREH,Trehalase,37437,0.0969093117200306,0.0074033664546553,0.0823987134689062,0.111419909971155,6.46932706681869e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMTN,Smoothelin,37342,0.123854293586964,0.00946405041485467,0.105304754773849,0.142403832400079,6.75926344786102e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASS1,Argininosuccinate synthase,37021,0.102694617866426,0.00785045410198439,0.0873077278265364,0.118081507906315,7.35214767722329e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0974876911165632,0.00745607973342748,0.0828737748390453,0.112101607394081,7.87582456384425e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0737524249325998,0.00564044228293729,0.0626971580580427,0.0848076918071569,7.90687321869067e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ING1,Inhibitor of growth protein 1,39453,0.0577949598819781,0.00442409559929434,0.0491237325073611,0.066466187256595,8.4873363632589e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0399715783175259,0.0030594465178892,0.0339750631424631,0.0459680934925887,8.96026415572432e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.0870007604409209,0.00666665885636522,0.0739341090824451,0.100067411799397,9.98703805691601e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.103034398310287,0.00789401812346335,0.0875621227882984,0.118506673832275,1.07157005819604e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDHB,Succinate dehydrogenase,37382,0.089845652285804,0.00689380062635382,0.0763338030581505,0.103357501513457,1.35959586387367e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCA,Tubulin-specific chaperone A,37124,0.110662031449384,0.00849160494703066,0.0940184857532034,0.127305577145564,1.3895268835111e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB9,Serpin B9,39749,0.0427254857907759,0.00328305816528221,0.0362906917868227,0.049160279794729,1.60455335944969e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0613597672661306,0.00471252864325916,0.0521232111253426,0.0705963234069185,1.6142350554095e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCA,Calcitonin,39713,0.0778947456974572,0.00598580021081729,0.0661625772842553,0.0896269141106591,1.62027210420177e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP5,Platelet glycoprotein V,37124,0.0462422678004981,0.00355363095670955,0.0392771511253473,0.0532073844756488,1.78237634243339e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF23,Fibroblast growth factor 23,40008,0.0745764292578851,0.00573484909769044,0.0633361250264119,0.0858167334893584,1.8097280855442e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRGN,Neurogranin,37445,0.117181021445582,0.0090067079658145,0.0995278738325861,0.134834169058579,1.81216114840965e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0465712787546839,0.00358029523447946,0.0395539000951042,0.0535886574142636,1.90928635142178e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.0986038366378325,0.00758607021783075,0.0837351390108843,0.113472534264781,2.16129642397655e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0667206127435256,0.00513944044613652,0.0566473094690981,0.0767939160179532,2.40220747591412e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.106725272633311,0.00822102150939325,0.0906120704749006,0.122838474791722,2.41423512176288e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.097893968877597,0.00754195728101773,0.0831117326068022,0.112676205148392,2.69320198851901e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0554759810750732,0.00427832408619937,0.0470904658661224,0.063861496284024,3.23456145316701e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0709992474661689,0.00547722342771569,0.0602638895478461,0.0817346053844916,3.3862700581405e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GET3,ATPase GET3,37437,0.0711767731119605,0.00550108514889132,0.0603946462201335,0.0819589000037875,4.57036431459592e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0381404641123201,0.00294989430863627,0.032358671267393,0.0439222569572472,4.76253848672234e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.0461267154129766,0.00357189438266693,0.0391258024229495,0.0531276284030038,5.85274259071349e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGR1,Prostaglandin reductase 1,37437,0.101034498879753,0.00782252911088806,0.085702341822412,0.116366655937093,6.12897507040502e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL14,C-C motif chemokine 14,39843,0.0492957739539584,0.00381869604956044,0.0418111296968199,0.0567804182110968,6.19187828867503e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTD,Deoxycytidylate deaminase,37124,0.121395520737712,0.00940652456482127,0.102958732590663,0.139832308884762,7.08619268692455e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1R,Complement C1r subcomponent,37453,0.0244800666673129,0.00189909095543453,0.0207578483946612,0.0282022849399646,8.48594197763886e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.111630714477725,0.00866667641113213,0.0946440287119057,0.128617400243544,9.76165834542463e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAL,Integrin alpha-L,37056,0.0539223055494649,0.00420149742768453,0.0456873705912032,0.0621572405077266,1.7701303569716e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NADK,NAD kinase,39868,0.0672794498496194,0.00524523527909996,0.0569987887025835,0.0775601109966553,1.77575452814222e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP6,Platelet glycoprotein VI,39836,0.11177707801393,0.00871800382495153,0.0946897905170247,0.128864365510835,1.90333469429e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0735270817619617,0.00573570491000627,0.0622851001383494,0.0847690633855739,1.98183141430277e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNF,Tumor necrosis factor,39555,0.0478309742410826,0.00373401838973727,0.0405122981971975,0.0551496502849676,2.23193171262788e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSNAX,Translin-associated protein X,37021,0.0493746301464704,0.00385276059682414,0.041823219376695,0.0569260409162457,2.24885863618258e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDK,Midkine,39843,0.0636291970465715,0.00496881397346901,0.0538903216585722,0.0733680724345707,2.3249483880476e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0525987744131593,0.00410744633467616,0.044548179597194,0.0606493692291245,2.34208542908908e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0559796607259147,0.00437977833304084,-0.0645640262586747,-0.0473952951931546,3.15584486661107e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSTB,Cystatin-B,39619,0.0532495746989026,0.00416898087316281,0.0450783721875035,0.0614207772103017,3.55630490697847e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3B,Protein FAM3B,39788,0.0449861330430122,0.00352293398005296,0.0380811824421084,0.051891083643916,3.69199726128666e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLNK,B-cell linker protein,37056,0.0489224912514006,0.00384489512198098,0.0413864968123179,0.0564584856904833,7.16123634212778e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGMN,Legumain,39931,0.044846976997082,0.0035279007728317,0.0379322914823319,0.0517616625118322,7.62288482824659e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0615241903582662,0.00484473065375932,0.052028518276898,0.0710198624396345,9.67305798496558e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.056470791820272,0.00445104594737457,0.0477467417634178,0.0651948418771261,1.14163140758024e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN2,Nectin-2,39846,0.0350701056985491,0.00277127062450248,0.0296384152745243,0.040501796122574,1.57371406450395e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0478913766181663,0.00378831553119404,0.0404662781770259,0.0553164750593066,1.99190470058542e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0587194724988987,0.00464465708721367,0.0496159446079599,0.0678230003898375,2.00928235023243e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAP,Prosaposin,37347,0.0346978735030083,0.00274981514687524,0.0293082358151328,0.0400875111908838,2.68543678271572e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0884906744334573,0.00701571953732457,0.0747398641403011,0.102241484726613,2.85246414076524e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.085992478505953,0.00682252177427637,0.0726203358283713,0.0993646211835347,3.24007703720132e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL25,C-C motif chemokine 25,40058,0.0616746507902398,0.00489633777709972,0.0520778287471243,0.0712714728333553,3.28038395060322e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.067557928328044,0.00537846695176848,0.0570161331025778,0.0780997235535103,5.17710588968851e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.151260453572294,0.0120442805975924,0.127653663601013,0.174867243543575,5.26505901068382e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPH,Hephaestin,37437,0.0324991703226564,0.00258705930580384,0.0274285340832808,0.0375698065620319,5.40129977311031e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0653050135745332,0.00520790038432401,0.0550975288212582,0.0755124983278083,6.73093620045621e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACYP1,Acylphosphatase-1,37073,0.0809403300983814,0.00645375961660133,0.0682909612498428,0.09358969894692,7.07593018156467e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD46,Membrane cofactor protein,39777,0.034897915408096,0.00278415550677425,0.0294409706148184,0.0403548602013735,7.14287883898592e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.107754611360383,0.00859336236153409,0.0909116211317758,0.124597601588989,7.28901613237462e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0891193052204395,0.00711129717331231,0.0751811627607474,0.103057447680132,7.39437710359971e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0728486919001098,0.00582644709728911,0.0614288555894231,0.0842685282107964,1.06412874539396e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0290025009524762,0.00232150305230531,0.0244523549699577,0.0335526469349946,1.19511150058229e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0619797893550108,0.00497155253157554,0.0522355463931227,0.0717240323168989,1.66932634664305e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0861267332863164,0.00691230410278902,0.0725786172448499,0.0996748493277829,1.95654818837066e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0241987723186877,0.00194328141227902,-0.0280076038867545,-0.0203899407506208,1.98070502480333e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.065926352034125,0.00529719847800855,0.0555438430172282,0.0763088610510217,2.16091654936148e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL24,C-C motif chemokine 24,39908,0.100776510113292,0.0080994265822301,0.0849016340121205,0.116651386214463,2.23896682863161e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.121167631144678,0.00973438815229036,0.102088230366189,0.140247031923167,2.25765615844207e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN4,CCN family member 4,40030,0.0489416011529981,0.00393619445480888,0.0412266600215727,0.0566565422844235,2.48665687437923e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.133395284190137,0.0107385707907538,0.11234768544026,0.154442882940014,3.15968510028454e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0332640168460156,0.00268098930240074,0.0280092778133102,0.0385187558787211,3.44505977701299e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.105414584804824,0.00849220625010391,0.0887698605546208,0.122059309055028,3.48743153411598e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0451242870446806,0.00363582192339889,0.0379980760748188,0.0522504980145424,3.56949129018271e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.0365363268184585,0.00294532238500369,0.0307634949438513,0.0423091586930658,3.59296360767047e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0825273763179576,0.0066529713916207,0.069487552390381,0.0955672002455341,3.61272383290183e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.064810487223366,0.00522677014334269,0.0545660177424143,0.0750549567043176,4.11529374733623e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB6,Heat shock protein beta-6,40030,0.0456405234195521,0.00368297689777702,0.0384218886999091,0.052859158139195,4.15284844806307e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0530199035401657,0.00427975080648144,0.0446315919594621,0.0614082151208693,4.72302430102247e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0820332509986735,0.00662420452729977,0.069049810125166,0.0950166918721811,5.00437471379359e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0403143154389635,0.00325721853217931,0.033930167115892,0.0466984637620349,5.04077147463343e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0795857812822761,0.00643147633929001,0.0669800876572677,0.0921914749072845,5.23133115024347e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0753207984220178,0.00608639040703157,-0.0872501236197997,-0.063391473224236,5.48899838781433e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0668218132394455,0.00539925656354825,0.0562392703748909,0.077404356104,5.50490594783415e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB10,Ras-related protein Rab-10,37437,0.0650928021610393,0.00526198191899389,0.0547793175998113,0.0754062867222673,5.83084227890557e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0582905192782988,0.00471508534454669,0.0490489520029872,0.0675320865536103,6.43255250089814e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0334936981217418,0.00271118090635546,0.0281797835452851,0.0388076126981985,7.14163852116479e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMD,Dystrophin,37043,0.062899258429585,0.00509565983244457,0.0529117651579937,0.0728867517011764,8.20161634620084e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.10690144288703,0.00866872588640293,0.08991074014968,0.12389214562438,8.76656217511219e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.114973147835969,0.00932337895756258,0.0966993250791467,0.133246970592792,8.82265151517949e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL19,C-C motif chemokine 19,40009,0.140128857136745,0.0113687142853985,0.117846177137364,0.162411537136126,9.42357328000946e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABHD14B,Protein ABHD14B,39687,0.0695044010385554,0.0056501741143382,0.0584300597744526,0.0805787423026583,1.28305092864656e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0891319443270658,0.00726800210501152,0.0748866602012432,0.103377228452888,2.17747254468334e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBN1,Drebrin,37056,0.0631655941861852,0.00515426212328546,0.0530632404245457,0.0732679479478247,2.42682274136426e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA2,Annexin A2,36879,0.0839985188484447,0.00685404392510397,0.0705645927552409,0.0974324449416485,2.43199697655108e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGRN,Neugrin,37388,0.025655038786737,0.002096517729778,0.0215458640363721,0.0297642135371019,2.99249325915601e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0998780844857731,0.00817493159787499,0.0838552185539382,0.115900950417608,3.55442729550791e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLF4,Krueppel-like factor 4,36991,0.0473477571802419,0.00387750934088131,0.0397478388721146,0.0549476754883693,4.16306760644086e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN4,Cerebellin-4,40030,0.0371842277610955,0.00304704003253988,0.0312120292973173,0.0431564262248736,4.2111890816961e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0772435069324826,0.00633278547644881,0.0648312473986429,0.0896557664663223,4.58392531471743e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0837420492338942,0.00686774428527151,0.0702812704347621,0.0972028280330264,4.77286911369342e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FADD,FAS-associated death domain protein,39868,0.0921352293158871,0.00755877445578672,0.0773200313825451,0.106950427249229,5.02368795002171e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.060708756349596,0.00498182600885668,0.0509443773722369,0.0704731353269551,5.21876883606756e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0508738384106411,0.00417608222849153,0.0426887172427977,0.0590589595784845,5.48999759427918e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL15,C-C motif chemokine 15,40052,0.0518567280628946,0.00426057508043321,0.0435060009052455,0.0602074552205437,6.2180527576637e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF2,Fibroblast growth factor 2,39866,0.0796189921922167,0.00655325226906879,0.0667746177448418,0.0924633666395915,8.12808769495153e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0368038970266306,0.00302973668229744,-0.0427421809239336,-0.0308656131293277,8.29320442147945e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX,Glutaredoxin-1,39771,0.0669648323771735,0.00551327878261152,0.056158805963255,0.0777708587910921,8.49121928334782e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.084773516575869,0.00699199264792809,0.0710692109859299,0.098477822165808,1.17355960796397e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0277433245742207,0.00228990539145424,0.0232551100069704,0.032231539141471,1.22933545510109e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARCO,Macrophage receptor MARCO,39868,0.0312262944557206,0.00257763508048548,0.026174129697969,0.0362784592134721,1.24473533317833e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.047040174170101,0.00388582323736743,0.0394239606248609,0.0546563877153412,1.38755173978939e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40LG,CD40 ligand,40058,0.0923765791161688,0.00764515145105566,0.0773920822720997,0.107361075960238,1.80885434276702e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.080410612812763,0.0066632340149197,0.0673506741435204,0.0934705514820056,2.34354120964597e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC79,Protein unc-79 homolog,36962,0.0669039081217767,0.00555167556997555,0.0560226240046246,0.0777851922389288,2.86863602008346e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPLAH,5-oxoprolinase,37043,0.0821829693189027,0.00682553105186481,0.0688049284572477,0.0955610101805577,3.24941107618363e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID2,Nidogen-2,39858,0.0859180972509488,0.0071453090969741,0.0719132914208796,0.099922903081018,3.67598771953472e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN9,Septin-9,39788,0.033394080608783,0.00278120668531378,0.027942915505568,0.038845245711998,4.53295431116396e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.103453127572698,0.00861303269840217,0.0865715834838296,0.120334671661566,4.56951519232064e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FST,Follistatin,39908,0.0606752663106812,0.00505507222951142,0.0507673247408388,0.0705832078805236,4.75516316160599e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0665153173047558,0.00554659613437326,0.0556439888813842,0.0773866457281274,5.45540908179938e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENAH,Protein enabled homolog,39587,0.0565845113830915,0.00471903406815381,0.04733520460951,0.065833818156673,5.53604279627575e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.142446000416239,0.0118808362502706,0.119159561365709,0.16573243946677,5.57980675652828e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.06483229876003,0.00540953260718928,0.054229614849939,0.075434982670121,5.95268970180897e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0706582665756731,0.00589636345721975,0.0591013941995224,0.0822151389518238,6.44267425841067e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.106086527282744,0.00886965973868441,0.0887019941949221,0.123471060370565,8.44230893375538e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0736838246785186,0.00616975147037467,0.0615911117965843,0.085776537560453,1.03492940593732e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0375199425869705,0.00314665442084064,0.0313524999221228,0.0436873852518181,1.21912692890293e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0702730852389381,0.0058931827761439,0.058722446997696,0.0818237234801801,1.29817974784383e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.103900603782097,0.00871900146473815,0.08681136091121,0.120989846652984,1.34030660910564e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC3B,Tetranectin,37138,0.0248139795309755,0.00208185226568158,0.0207335490902396,0.0288944099717114,1.37852848483004e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH7,Protocadherin-7,37382,0.039326993265141,0.00330349289607565,0.0328521471888328,0.0458018393414493,1.62651214064882e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0624182714194474,0.00525008702269058,0.0521281008549738,0.0727084419839209,1.86384210958784e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0224897265425993,0.00189138987575546,0.0187826023861186,0.0261968506990801,1.91958687515909e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLTA,Clathrin light chain A,39585,0.0544009951052668,0.00457711200268003,0.0454298555800139,0.0633721346305196,1.93988816904843e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVR,Poliovirus receptor,40009,0.0434385778560929,0.00365769705654781,0.0362694916252592,0.0506076640869266,2.1533113874928e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.052340653273633,0.00440801792837926,0.0437009381340097,0.0609803684132564,2.21366707846726e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COLEC12,Collectin-12,39862,0.028961453824668,0.00244106374711218,0.0241769688803281,0.0337459387690079,2.47937550090892e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0515738423242126,0.00434759171011845,0.0430525625723805,0.0600951220760448,2.54778198611931e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN2,Matrilin-2,39885,0.0346657669057363,0.00292448374043723,0.0289337787744793,0.0403977550369932,2.81092701957284e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0510196469223631,0.00430326957553094,0.0425852385543225,0.0594540552904038,2.89455698937679e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF2,Growth/differentiation factor 2,39868,0.0410995997655979,0.00346966091283198,0.0342990643764472,0.0479001351547486,3.09876379263058e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.042143125460967,0.0035665728068797,0.0351526427594828,0.0491336081624512,4.36347610824926e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0564856419759413,0.00478692606613169,0.0471032668863232,0.0658680170655594,5.60393302334396e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA6,Integrin alpha-6,39866,0.0614818776854468,0.00521717232688557,0.0512562199247511,0.0717075354461426,6.35605553403502e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH1,Acid ceramidase,37340,0.0547989544047501,0.00465072523335976,0.045683532947365,0.0639143758621352,6.85642680946326e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0801155864017315,0.00680244718881799,0.0667827899116482,0.0934483828918147,6.88145686030492e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX9,Sorting nexin-9,39868,0.0802789389244698,0.00681869815136702,0.0669142905477905,0.0936435873011492,7.24794651155917e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA13,Carbonic anhydrase 13,39657,0.122134238394019,0.010377673247145,0.101793998829615,0.142474477958423,7.66425688279594e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FEN1,Flap endonuclease 1,39477,0.0721933428064337,0.00613632218307909,0.0601661513275987,0.0842205342852687,8.06326859200809e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLO1,Lactoylglutathione lyase,39585,0.0669209416637011,0.00569059002108299,0.0557673852223784,0.0780744981050238,8.53186285885243e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGN,Biglycan,39448,-0.137894071868458,0.0117374362538008,-0.160899446925907,-0.114888696811008,9.81396188272349e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.03050876205631,0.00260022794992777,0.0254123152744515,0.0356052088381684,1.16134316599919e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0536559816846578,0.00457320538931691,0.0446924991215966,0.0626194642477189,1.17031313633244e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRBP,Acrosin-binding protein,37368,0.0443328786077135,0.00377723902745609,0.0369294901138996,0.0517362671015274,1.17535751760466e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.034572596951154,0.00295373458000114,-0.0403619167279563,-0.0287832771743518,1.61925627626294e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0550600661824893,0.0047105991902831,0.0458272917695344,0.0642928405954442,2.06527882286289e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0524620555646228,0.00449053733229208,0.0436606023933303,0.0612635087359153,2.08590537959702e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0324820414821211,0.00278602244930214,0.0270214374814889,0.0379426454827533,2.93705645206543e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0316517131042486,0.0027173084120331,0.0263257886166637,0.0369776375918334,3.33428277367714e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.024766341593981,0.00213211963161074,0.0205873871160239,0.028945296071938,4.56892307964736e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN1,Ficolin-1,37430,0.0642677974966443,0.00553220153766398,0.0534246824828229,0.0751109125104657,4.73540240502551e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0806352246192312,0.00694490440757024,0.0670232119803935,0.0942472372580689,5.14461868454372e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCOF1,Treacle protein,37437,0.0347556679247817,0.00299505661775842,0.0288853569539752,0.0406259788955882,5.48435339425173e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0689936265830433,0.00595800771684809,-0.0806713217080655,-0.057315931458021,7.3411458465687e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASET2,Ribonuclease T2,39974,0.0289866797615397,0.00250518758880097,0.0240765120874898,0.0338968474355896,7.68366497558248e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0536265738187521,0.00463967471532475,0.0445328113767156,0.0627203362607886,8.94609679044275e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2,Brorin,39684,0.0437720451945778,0.00378732546180115,0.0363488872894475,0.051195203099708,8.99046064501235e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.053596387187727,0.00464153822165845,0.0444989722732765,0.0626938021021776,1.01241420208403e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.103656117504317,0.00897566342997025,0.0860638171815754,0.121248417827059,1.04493066260613e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0434964793642387,0.00377064865882086,0.0361060079929498,0.0508869507355276,1.16235185405608e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100P,Protein S100-P,39585,0.0597123668147491,0.0051809789315475,0.049557648108916,0.0698670855205822,1.30555117015523e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF22,Kinesin-like protein KIF22,37021,0.137472135212807,0.0119249005626825,0.114099330109949,0.160844940315664,1.33460151554444e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0986863080688657,0.00856151468297447,0.0819057392902357,0.115466876847496,1.34431050991194e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0492000298025713,0.00427867438891405,0.0408138280002998,0.0575862316048429,1.77232765513979e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLB,Beta-klotho,39489,-0.0831571171672586,0.00724333921280651,-0.0973540620243593,-0.0689601723101578,2.18866608365188e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP1,Interstitial collagenase,39314,0.103563359092357,0.00902295402957041,0.0858783691943989,0.121248348990315,2.26536452635268e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS27,Serine protease 27,39818,0.0452952415613018,0.00395108091560318,0.0375511229667196,0.053039360155884,2.62868508834139e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRN1,Secernin-1,39866,0.0633939571733547,0.00553299356896262,0.052549289778188,0.0742386245685214,2.83179758377586e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0466850471989498,0.00407612664981091,0.0386958389653204,0.0546742554325791,2.96654080812192e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0555384599902064,0.00484939752626784,0.0460336408387214,0.0650432791416913,3.01162182490502e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO1A,Coronin-1A,39520,0.100589617667208,0.00879353536999556,0.0833542883420166,0.117824946992399,3.51614428501662e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APLP1,Amyloid-like protein 1,39868,-0.0576018035852536,0.00503617696541455,-0.0674727104374662,-0.0477308967330411,3.55309488864228e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.0356673447868931,0.00312504537685425,0.0295422558482588,0.0417924337255275,4.9135586393635e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0510655210413689,0.00447656133001868,0.0422914608345323,0.0598395812482055,5.01594239775173e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTC,Probetacellulin,39477,0.0829049354429493,0.00728478573045763,0.0686267554112524,0.0971831154746463,6.85435937699234e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA,Adenosine deaminase,40058,0.0388511521242553,0.00341838807368471,0.0321511114998332,0.0455511927486773,8.07039376736654e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA9,Serpin A9,39715,0.0811161824629724,0.00713756879626153,0.0671265476222998,0.095105817303645,8.17705568033666e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.133941698896912,0.0118010505573982,0.110811639804411,0.157071757989412,9.63464616177823e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAST,Gastrin,37388,0.129598878069148,0.0114235171861203,0.107208784384352,0.151988971753944,1.07048443234702e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0309720634210052,0.0027337049752253,0.0256140016695636,0.0363301251724468,1.21112216446583e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0808201803408814,0.00715309530754624,0.0668001135380907,0.094840247143672,1.72358589944161e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.026960960637853,0.00238781471478538,0.0222808437968736,0.0316410774788323,1.87808553563937e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0665578029520184,0.00589429203570213,0.0550049905620422,0.0781106153419946,1.94749244538334e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0391676568928353,0.00346874607522562,0.032368914585393,0.0459663992002775,1.95449483843141e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0408048711475665,0.00361468017592002,0.0337200980027633,0.0478896442923697,2.03833072313203e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFP,Alpha-fetoprotein,39699,0.0749013333019508,0.00664435989843978,0.0618783879010089,0.0879242787028928,2.30992733594042e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_E,,39866,0.0303531752815749,0.00269345924472772,0.0250739951619086,0.0356323554012412,2.40192643583422e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0249813544495274,0.00221618469341547,0.0206376324504331,0.0293250764486217,2.43101121863654e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0208310367252929,0.00184981152014704,0.0172054061458047,0.0244566673047811,2.75204328959145e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSE,Cathepsin E,37124,0.0584825726068552,0.00519602574563735,0.048298362145406,0.0686667830683044,2.96109359903089e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOM,Apolipoprotein M,39908,0.0294328466135079,0.00261676844292545,0.0243039804653741,0.0345617127616418,3.05528589135567e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0338992986539635,0.00301781487155534,-0.039814215802212,-0.027984381505715,3.72675142025764e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.117851088410444,0.0104929138512352,0.0972849772620232,0.138417199558865,3.84334475690265e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0738125404649327,0.00657668399226956,0.0609222398400843,0.086702841089781,4.23461312952704e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0414440338054383,0.00369993427821705,0.0341921626201329,0.0486959049907437,5.15264219544787e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN6,Dynactin subunit 6,39489,0.0782639236034289,0.00698846554042308,0.0645665311441996,0.0919613160626581,5.31655763648949e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD302,CD302 antigen,39788,0.0319177576946703,0.00285382504160285,0.0263242606131287,0.0375112547762119,6.2453685065507e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.10598576060533,0.00949843045297222,0.0873688369175046,0.124602684293156,8.35662784455936e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXN,"Frataxin, mitochondrial",40030,0.0805084582718366,0.00721956733734776,0.066358106290635,0.0946588102530382,8.97347921299446e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.096958974981121,0.00869852546191614,0.0799098650757653,0.114008084886477,9.49821761694038e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0444489035357694,0.00398967015082782,0.0366291500401468,0.0522686570313919,1.0148268120306e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.120864910838955,0.0108671033056883,-0.142164433318104,-0.0995653883598062,1.24939726531649e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN2,Dynactin subunit 2,39788,0.103445885307447,0.00931800698052841,0.0851825916256116,0.121709178989283,1.56596164333534e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0423501995474701,0.00381562235159686,0.0348715797383402,0.0498288193565999,1.61203855983461e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD84,SLAM family member 5,39866,0.0338491235554301,0.00306483399834592,0.0278420489186721,0.0398561981921881,2.95267791866116e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0826175435074973,0.00747813792045042,0.0679603931834145,0.0972746938315801,2.97791254214903e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1B,Meprin A subunit beta,39868,0.125064064016252,0.0113329489935123,0.102851483988968,0.147276644043537,3.25826617204524e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0343589694019621,0.00311725044706541,0.0282491585257139,0.0404687802782103,3.77715138492924e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPL,Periplakin,37056,0.0348344253560075,0.00315926889052593,0.0286422583305767,0.0410265923814383,3.79491816072188e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0764780917270058,0.00694128501236449,0.0628731731027714,0.0900830103512402,3.96253152080713e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX16,Syntaxin-16,39477,0.0629170421542775,0.00573631181197613,0.0516738710028043,0.0741602133057507,6.86889955933286e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0637479153634728,0.00581501058807374,-0.0751453361160973,-0.0523504946108482,7.24277427931438e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0546976621043274,0.00499340498487992,0.0449105883339627,0.064484735874692,7.97903081972955e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARFIP1,Arfaptin-1,37411,0.0746187438747987,0.00681584394341844,0.0612596897456985,0.0879777980038988,8.8957034703794e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX7,Syntaxin-7,37056,0.0531833527987362,0.00486047146504005,0.0436568287272577,0.0627098768702147,9.54853660059166e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1F,Protein phosphatase 1F,37437,0.0573105619686028,0.00524105244154768,0.0470380991831694,0.0675830247540363,1.02383964576004e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOE,Apolipoprotein E,37453,0.0779893411708997,0.00713214619865748,0.064010334621531,0.0919683477202683,1.02384402211766e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0637614005239793,0.00583650869172534,0.0523218434881976,0.0752009575597609,1.14703276415539e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.11707151441107,0.0107208141183809,-0.138084310083097,-0.0960587187390437,1.22613432146549e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0391627763019634,0.00358780587912781,0.0321306767788729,0.0461948758250539,1.27343153041358e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA14,Carbonic anhydrase 14,40030,-0.0376588957250802,0.00345290921107578,-0.0444265977787887,-0.0308911936713717,1.34004300186442e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO2,Gamma-enolase,40009,0.0709835711571344,0.00651224271649556,0.0582195754328031,0.0837475668814657,1.43748589036347e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0597656494066811,0.0054947507582651,0.0489959379204815,0.0705353608928807,1.93825359049211e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0411279981597834,0.0037843213436079,0.033710728326312,0.0485452679932549,2.12515855646497e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0679478748076673,0.0062550723800745,0.0556879329427213,0.0802078166726133,2.26278924739696e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0298966674447913,0.00275545323416337,0.0244959791058311,0.0352973557837515,2.60178016349663e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0592512516574264,0.00547133566149718,0.0485274337608919,0.0699750695539609,3.25708953742929e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0293724573258703,0.00271512538983231,0.024050811561799,0.0346941030899416,3.51135994533321e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIT2,Slit homolog 2 protein,39489,0.0549383878044722,0.00507920753997056,0.0449831410261299,0.0648936345828146,3.59535439353208e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0712185185109402,0.00658444444746558,0.0583130073939077,0.0841240296279727,3.74229701245045e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO2,Roundabout homolog 2,40009,0.0240795630481012,0.00223708840551596,0.0196948697732899,0.0284642563229125,6.29710884618064e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK4,Dickkopf-related protein 4,39718,0.0479334668886145,0.00445824099823048,0.0391953145320828,0.0566716192451462,7.20447224553797e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0571461465197729,0.00531760012169465,0.0467236502812514,0.0675686427582944,7.57581424037134e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA4,Laminin subunit alpha-4,39931,0.035553246353405,0.00330830381190772,0.0290689708820659,0.0420375218247442,7.5802635215905e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0463954255548678,0.00431961400612605,0.0379289821028607,0.0548618690068749,8.09472871672258e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0813081610724862,0.00757053356019535,0.0664699152945033,0.0961464068504691,8.18626629316122e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0712655840263407,0.00663628282285708,0.0582584696935408,0.0842726983591406,8.28930290486595e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0427142766946038,0.00398129781880419,0.0349109329697476,0.05051762041946,9.62425704128904e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0334938703447572,0.00312733444010879,0.027364294842144,0.0396234458473705,1.1242164212582e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0613483384714681,0.00573957828005161,0.0500987650425669,0.0725979119003692,1.46770030731012e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0335808175539153,0.00314989957625017,0.027407014384465,0.0397546207233656,1.97257021042625e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0389820606336569,0.00365855016388926,0.031811302312434,0.0461528189548799,2.03486224552565e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.04394548883261,0.00412403711865961,0.0358623760800372,0.0520286015851828,2.08273147143831e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0311480937462617,0.00292552221990545,0.025414070195247,0.0368821172972764,2.20167292003143e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0768407388043838,0.0072197242426245,0.0626900792888398,0.0909913983199278,2.30317547745789e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0938086454141147,0.00881498935486835,0.0765312662785727,0.111086024549657,2.42800137259445e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0264609278392126,0.00249284883189227,0.0215749441287038,0.0313469115497215,3.22409620234062e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0402647423456991,0.00379750369463086,0.0328216351042226,0.0477078495871756,3.51929914533578e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR3,Small proline-rich protein 3,37388,0.0683085874812093,0.00644801478546772,0.0556704785016925,0.080946696460726,4.03244720002316e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0360519561801302,0.0034074748212637,0.0293733055304534,0.0427306068298071,4.49299174893829e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0594819127033783,0.00562467832509647,0.0484575431861892,0.0705062822205674,4.758337263892e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0544689610874315,0.00515754296930044,0.0443601768676026,0.0645777453072603,5.69817212941335e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SWAP70,Switch-associated protein 70,37382,0.0372971576642888,0.00353437278083284,0.0303697870138565,0.0442245283147212,6.22562280095427e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.0936893973818651,0.00889740407770554,0.0762504853895623,0.111128309374168,7.90807034285719e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0640812195231371,0.00609141638063431,0.0521420434170938,0.0760203956291804,8.85039700193454e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0362773256753991,0.00344996719630362,-0.0430392613801541,-0.029515389970644,9.29100313941875e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL8,Interleukin-8,39750,0.068339684683679,0.00650423725433415,0.0555913796651841,0.0810879897021739,9.74592163205379e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0258702506270464,0.00246217851807824,0.021044380731613,0.0306961205224797,1.0060619313134e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0239703747561329,0.00228406426715609,0.019493608792507,0.0284471407197588,1.1100362105632e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0681715209714485,0.00651709302818059,0.0553980186362146,0.0809450233066825,1.59466916133493e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPR,Nucleoprotein TPR,37021,0.0484677864744521,0.00463296993909691,0.0393871653938222,0.0575484075550821,1.63421649842993e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0343981890717184,0.00329468482910657,0.0279406068066695,0.0408557713367673,2.03011272326964e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0567312430254799,0.00543906343466448,0.0460706786935375,0.0673918073574223,2.25415212340169e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0690508425404323,0.00662103096683664,0.0560736218454325,0.0820280632354321,2.27987467713801e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0425960612049169,0.00408576127380069,0.0345879691082676,0.0506041533015663,2.37663964565755e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTN,Pleiotrophin,39585,0.0516711779733076,0.00495813722799533,0.0419532290064368,0.0613891269401785,2.39247950570381e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0629884013569796,0.00604369125262587,0.0511427665018329,0.0748340362121263,2.46384305876065e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PER3,Period circadian protein homolog 3,37056,0.120478687475868,0.0115716654431018,0.0977982232073881,0.143159151744347,2.75233108679511e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRIB,Protein scribble homolog,37043,0.0925546749224196,0.00889235463400903,0.0751256598397619,0.109983690005077,2.84575134923352e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.035859366522142,0.00344714114076791,0.0291029698862369,0.0426157631580471,3.0135081031304e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA4,Annexin A4,39783,0.0739266144406616,0.0071372302119999,0.0599376432251418,0.0879155856561814,4.62894820104458e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL20,C-C motif chemokine 20,40058,0.0858304524439944,0.0082874537637287,0.0695870430670861,0.102073861820903,4.67308177188864e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.100815027976787,0.0097377098403825,0.0817291166896371,0.119900939263937,4.8598996101563e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TF,Serotransferrin,37453,0.0222026932084632,0.0021488809841051,0.0179908864796172,0.0264144999373092,6.23089265661994e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOB,Elongin-B,37021,0.039755375468423,0.00386506654653516,0.032179845037214,0.0473309058996319,1.01276363726814e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0619058309047576,0.00603458681588974,0.0500780407456137,0.0737336210639015,1.2932803518554e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0409807252674015,0.00400116374554067,0.0331384443261418,0.0488230062086612,1.52796722884076e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM1,Dynamin-1,37382,0.115465014338681,0.0112899548801953,0.0933367027734985,0.137593325903864,1.83815443350821e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0473506776004818,0.00463034724523065,0.0382751969998297,0.0564261582011339,1.85766025193488e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0358576157536931,0.00351403459235358,0.02897010795268,0.0427451235547061,2.32853636733615e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.059960998527143,0.00588362527471725,0.0484290929886972,0.0714929040655888,2.58413802626617e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0521758285136096,0.00512221617098356,0.0421362848184819,0.0622153722087374,2.71432389641811e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0485299161312767,0.00476875868399429,0.0391831491106479,0.0578766831519055,3.085117307872e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBS,Cystathionine beta-synthase,37043,0.0510482464214775,0.00502472582611019,0.0411997838023016,0.0608967090406535,3.6930146218896e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBD,Thrombomodulin,39868,0.0271762828856877,0.00267691392102853,0.0219295316004718,0.0324230341709036,3.83803390865383e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPG,Macrophage-capping protein,39739,0.0578401909451709,0.00571556068189596,0.0466376920086548,0.0690426898816869,5.33830264514291e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENR,Density-regulated protein,37056,0.0576108598994367,0.00569574102991046,0.0464472074808122,0.0687745123180612,5.81239169821736e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0262067472916439,0.00259388210133416,0.0211227383730289,0.0312907562102588,6.31273378214054e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0330844288174083,0.00327800290299673,0.0266595431275348,0.0395093145072819,6.99024602750164e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMB,RGM domain family member B,40009,0.0253215516580469,0.0025088652513413,0.0204041757654179,0.0302389275506758,6.99586878210074e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM,Paralemmin-1,37299,0.0282852747737158,0.00280176136446205,0.0227938224993702,0.0337767270480614,7.03365754038531e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.117610199004477,0.0116789792355965,0.0947193997027083,0.140500998306246,9.07036385395322e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0719865418330295,0.00716767577014939,0.0579378973235367,0.0860351863425222,1.16105846843016e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0732729460785477,0.00729925550273804,0.0589664052931812,0.0875794868639143,1.21148705897939e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0408464907966087,0.00406823056104623,0.0328727588969581,0.0488202226962593,1.22784013625176e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSB,Cathepsin B,39847,-0.0506666451136233,0.00505306163093941,-0.0605706459102645,-0.040762644316982,1.36294393698061e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOL1,Apolipoprotein L1,37445,0.0605465970999401,0.00604172844849163,0.0487048093408965,0.0723883848589837,1.48189742592425e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0616869219343478,0.00616600324283977,0.0496015555783818,0.0737722882903137,1.70944731237202e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.0293155444173325,0.00293170280557604,0.0235694069184034,0.0350616819162615,1.79423492447229e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0333653103744167,0.00333666204743617,0.0268254527614418,0.0399051679873916,1.80009101702307e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0294789886460194,0.00294748986855065,0.0237019085036601,0.0352560687883787,1.81175577032328e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0957281863976475,0.00959031577574767,0.0769311674771821,0.114525205318113,2.14499620331874e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA1,BolA-like protein 1,36991,0.0539979051495601,0.00541122817373988,0.04339189792903,0.0646039123700903,2.28447352335887e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0408479600276252,0.0041013508588788,0.0328093123442227,0.0488866077110276,2.68317651028603e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSG,Basigin,40040,0.0190435907389443,0.00191374995391746,0.0152926408292661,0.0227945406486225,2.91412052258176e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA2,Integrin alpha-2,37124,0.032917795047171,0.00331193523072087,0.0264264019949581,0.0394091880993839,3.38973312335579e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP12,Macrophage metalloelastase,39900,0.0490799133940623,0.00494624880943506,0.0393852657275696,0.0587745610605551,3.86875063992378e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0513809222247918,0.00517927641192265,0.0412295404574234,0.0615323039921602,4.0816909101524e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0472273524316379,0.00476231866672553,0.0378932078448559,0.0565614970184199,4.21524468128119e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0331794901123997,0.00334672691793197,0.026619905353253,0.0397390748715463,4.22087202677176e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0894932674090169,0.00902594871889662,0.0718024079199795,0.107184126898054,4.31051148730005e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0287653925836308,0.00290314852403075,0.0230752214765305,0.034455563690731,4.61026629554337e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0671726715493113,0.00678246779701763,0.0538790346671567,0.0804663084314658,4.79568620619621e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VGF,Neurosecretory protein VGF,37411,0.0285137963179003,0.00287925917485491,0.0228704483351847,0.0341571443006159,4.82903034201028e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0820135291847671,0.00828245639137934,0.0657799146576636,0.0982471437118706,4.88360959530825e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0848476621462788,0.00858943570364656,0.0680123681671315,0.101682956125426,6.02322456495494e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.0325748774222472,0.00330397871630997,0.0260990791382797,0.0390506757062148,7.45696864945072e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB8,Serpin B8,40058,0.0533216662405357,0.00541910452372458,0.0427002213740355,0.0639431111070359,8.80798521328616e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0705563043678371,0.00717304669255793,0.0564971328504235,0.0846154758852506,9.11905288771612e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIT,Vitrin,37437,0.0356007179566493,0.00362199997934208,0.0285015979971388,0.0426998379161597,1.00540025168198e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0235720594353823,0.00239989482615819,0.0188682655761122,0.0282758532946523,1.04827762907882e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIT,Citron Rho-interacting kinase,37039,0.0438192467287879,0.00446141375187624,0.0350748757751105,0.0525636176824653,1.08491114828166e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.059716927858452,0.00608048065314146,0.0477991857782947,0.0716346699386093,1.08717989398444e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB2,Plexin-B2,39984,0.0227753471586229,0.00232425070955489,0.0182198157678954,0.0273308785493505,1.31485329177508e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE6,Ribonuclease K6,37386,0.0266210215352306,0.00272082903082231,0.0212881966348189,0.0319538464356423,1.56416098599218e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0305692492041875,0.003128903061283,0.0244365992040728,0.0367018992043022,1.74850595243769e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPL14,60S ribosomal protein L14,37043,0.038789162685778,0.00398872215014199,0.0309712672714998,0.0466070581000563,2.81080514631162e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA2,Carbonic anhydrase 2,39821,0.0649783374606726,0.00668651574467745,0.0518727666011048,0.0780839083202404,2.91796141051548e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0801856025266239,0.0082526016245927,0.0640105033424222,0.0963607017108255,3.04301838566319e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0562178477711661,0.0058028666649538,0.0448442291078566,0.0675914664344755,4.00111005970919e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX6,Syntaxin-6,39477,0.0650400102864549,0.00671945672790495,0.0518698750997612,0.0782101454731486,4.25738316583624e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0447122885872961,0.00462214899013279,0.0356528765666358,0.0537717006079563,4.50736535823315e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0630823605008215,0.00652008316416201,0.050302997499064,0.0758617235025791,4.53496150100976e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.020867674007161,0.00215892648036185,0.0166361781056518,0.0250991699086703,4.96569559232261e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSHB,Follitropin subunit beta,37043,0.0622880595304512,0.00645062058595157,0.0496448431819861,0.0749312758789163,5.47488858991068e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.046020793381162,0.0047702532257872,0.0366710970586191,0.0553704897037049,5.80270503240116e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,39666,0.0343649519310635,0.00356365968017708,0.0273801789579164,0.0413497249042106,6.03882956054351e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0346547843391711,0.00359511055947231,0.0276083676426053,0.0417012010357368,6.43537539289098e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA,Lymphotoxin-alpha,39866,0.0374559436668345,0.00388812749139554,0.0298352137836992,0.0450766735499697,6.62520922158839e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.031805187104125,0.00331382863450887,0.0253100829804876,0.0383002912277624,9.35861813929818e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POMC,Pro-opiomelanocortin,37043,0.0671367842914288,0.00699820649085189,0.0534202995693591,0.0808532690134985,1.00326037903614e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0444600604275005,0.00463843103317996,0.0353687356024678,0.0535513852525332,1.05456013301635e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR3,Toll-like receptor 3,40058,0.0574183906945764,0.00599859872767344,0.0456611371883365,0.0691756442008163,1.19677442104428e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.072322889106405,0.00755547893422706,0.0575141503953199,0.08713162781749,1.23076009991338e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0442557405752665,0.00462530654990372,0.0351901397374552,0.0533213414130778,1.24299551710247e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ULBP2,UL16-binding protein 2,39749,0.0343729918907145,0.00359424570030927,0.0273282703181084,0.0414177134633207,1.30361023687541e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP8,Caspase-8,39984,0.058042666835434,0.00607207453627768,0.0461414007443298,0.0699439329265383,1.35710768717864e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMB1,Laminin subunit beta-1,37043,0.0286307041918125,0.00299802751733024,0.0227545702578452,0.0345068381257798,1.52491200030292e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0470560753737986,0.00495666771458264,0.0373410066532166,0.0567711440943806,2.61336590492921e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0876886062548431,0.00924220230817259,0.0695738897308249,0.105803322778861,2.67982792393818e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0775363747358145,0.00817605243991424,0.0615113119535826,0.0935614375180464,2.8010352363485e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDA,Cytidine deaminase,37422,0.0433507126758274,0.00457027903535012,0.0343929657665412,0.0523084595851136,2.81176523034815e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.020809061883724,0.00219649754310975,0.0165039266992289,0.0251141970682191,3.13973480899148e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0248516840571415,0.00262436512446195,-0.0299954397010869,-0.019707928413196,3.1914687702084e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.04900065289432,0.00518383444943737,0.0388403373734228,0.0591609684152173,3.85637052465438e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK3,NT-3 growth factor receptor,40009,-0.0198016947510957,0.00209942242954216,-0.0239165627129983,-0.015686826789193,4.55944037127047e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0343307889323145,0.0036399845751564,0.027196419165008,0.041465158699621,4.58173223379759e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.0247964403748587,0.00263148938578205,-0.0299541595709915,-0.0196387211787259,4.97151148225044e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0376361317991549,0.00400074249009851,0.0297946765185618,0.0454775870797479,5.90099777745367e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0376671049882495,0.00400814741057407,0.0298111360635243,0.0455230739129747,6.48620020876378e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0304099354027823,0.00323828978798699,0.0240628874183278,0.0367569833872368,6.74285472284073e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0450892176489136,0.00481032944453201,0.0356609719376308,0.0545174633601963,7.94007696718508e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.105478396864373,0.0112544586183217,0.0834196579724622,0.127537135756283,8.21854446085803e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0565142078304718,0.00603272606574835,0.044690064741605,0.0683383509193386,8.54461579014947e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0234424442007852,0.0025027959382389,-0.0283479242397335,-0.018536964161837,8.66016075479533e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM2,Junctional adhesion molecule B,40009,0.023072531138046,0.00246927096776684,0.018232760041223,0.027912302234869,1.04751143903206e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A12,Protein S100-A12,39615,0.0686810105969263,0.0073519547621505,0.0542711792631113,0.0830908419307413,1.07051352486296e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0386513962623719,0.00415189746740017,0.0305136772262675,0.0467891152984762,1.48182499651589e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD248,Endosialin,37437,-0.0362817707878756,0.0039079961958172,-0.0439414433316773,-0.0286220982440739,1.87673258262345e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0478910032247468,0.00515872673675489,0.0377798988207072,0.0580021076287864,1.89316915452385e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C5,Complement C5,37453,0.0139016103182011,0.00149850037836921,0.0109645495765974,0.0168386710598047,2.00242754740653e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0238318744711673,0.00257189865213866,0.0187909531129756,0.0288727958293591,2.21355974799155e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0732409031960476,0.00793453932729794,0.0576892061145437,0.0887926002775516,3.09525532810513e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0431262636066071,0.00468438093311009,0.0339448769777114,0.0523076502355029,3.79294142809943e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0597570721346915,0.00649141827892756,0.0470338923079935,0.0724802519613895,3.81120102131446e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0480916529811624,0.00522309313755095,0.0378543904315625,0.0583289155307622,3.81968823794231e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.049335412329488,0.00536916385902877,0.0388118511657916,0.0598589734931844,4.45858502252634e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD59,CD59 glycoprotein,39173,0.0191044502128712,0.00208084870789939,0.0150259867453884,0.023182913680354,4.80363492224391e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMM2,Phosphomannomutase 2,37021,0.0542746218752003,0.00592906820918651,0.0426536481851947,0.0658955955652058,6.28612382380374e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0220122873050202,0.00241145167566342,-0.0267387325893205,-0.0172858420207199,7.95666225568866e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0871346256283994,0.00954902791170155,0.0684185309214644,0.105850720335334,8.17734224153317e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRG,Histidine-rich glycoprotein,37380,0.0284277275441285,0.00311691147020568,0.0223185810625254,0.0345368740257316,8.52164579805446e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSF,Cathepsin F,39913,0.0362568033830156,0.00398142816342254,0.0284532041827074,0.0440604025833238,9.49245116103093e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0262286471094284,0.00288165452337169,0.0205806042436199,0.0318766899752369,9.91610103398206e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAEP,Glycodelin,39749,-0.129721476842994,0.0142571815898718,-0.157665552759143,-0.101777400926845,1.02076657970156e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA11,Integrin alpha-11,39866,-0.0304580247370152,0.00334958295224884,-0.0370232073234229,-0.0238928421506075,1.07357303861712e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0378737196367303,0.00417119000595573,0.029698187225057,0.0460492520484035,1.23609566210701e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0577975362690593,0.00637446000616995,0.0453035946569662,0.0702914778811524,1.39345456706945e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK6,Kallikrein-6,39889,0.0263145691426653,0.00291183522774436,0.0206073720962864,0.0320217661890442,1.78896855128884e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0441287490961478,0.00488172396269595,0.0345605701292637,0.0536969280630318,1.79099137894606e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0658379569988577,0.00729265935672443,0.0515443446596778,0.0801315693380376,1.98618446550544e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN3,CCN family member 3,40042,0.0287627052741433,0.00318756349745451,0.0225150808191324,0.0350103297291541,2.02415253689657e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRN,Progranulin,39787,0.0219314274059699,0.00243268928763839,0.0171633564021987,0.0266994984097412,2.1825456978278e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0449139777321462,0.00499688370367589,-0.054707869791351,-0.0351200856729415,2.83599486841483e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGT,Angiotensinogen,37445,0.0198524605819059,0.0022091541930293,0.0155225183635685,0.0241824028002434,2.88609368360523e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0475909429087921,0.00529851233200991,0.0372058587380527,0.0579760270795315,3.00636353454613e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.0605629243925737,0.00675719022519754,0.0473188315511865,0.0738070172339609,3.51101065981087e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0309542666366533,0.00347069203572462,0.0241517102466331,0.0377568230266736,5.22945995717607e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0224070232396177,0.00251376096451229,0.0174800517491736,0.0273339947300618,5.55819315017742e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0326737147029835,0.00366973540077024,0.0254810333174738,0.0398663960884932,6.10806351772902e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0512341896825763,0.00575927255506351,0.0399460154746518,0.0625223638905007,6.53929240262919e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0443198897060777,0.00498289724878873,0.0345534110984518,0.0540863683137036,6.63153419622267e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0455640531098452,0.00512864230839149,-0.0556161920342926,-0.0355119141853979,7.10955660854995e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRSF1,G-rich sequence factor 1,36874,0.0706823235337293,0.00796437152962079,0.0550721553356726,0.0862924917317861,7.9114558931189e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA6,Carbonic anhydrase 6,39817,-0.0555654334857013,0.00626385374808796,-0.0678425868319537,-0.0432882801394489,8.01867336665074e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0319533625607946,0.00360321399253,0.0248910631354358,0.0390156619861534,8.3951257457917e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0293912924744974,0.00331661009300844,0.0228907366922009,0.035891848256794,8.86736756829349e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0302133900343386,0.00341066248237929,0.0235284915688752,0.036898288499802,8.94980624602067e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL1,Chordin-like protein 1,39908,0.0267390623913498,0.00301867695617069,0.0208224555572552,0.0326556692254443,8.99528704557896e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXN,Thioredoxin,37289,0.0376884567872269,0.00425580209271808,0.0293470846854995,0.0460298288889544,9.34084925246655e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.0273522012541834,0.00308941493780329,0.0212969479760889,0.0334074545322778,9.55170508031889e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPO,Myeloperoxidase,39858,0.0395109801956217,0.00446497201096263,0.0307596350541349,0.0482623253371084,9.73068408801102e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0620102280178985,0.00701124841424421,0.0482681811259799,0.0757522749098171,1.03492401702436e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMS,Spermine synthase,36991,0.0558713001593015,0.00632196513171976,0.0434802485011308,0.0682623518174722,1.10067733665503e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO1,Roundabout homolog 1,39885,0.0205110623507623,0.00232422611780278,0.0159555791598688,0.0250665455416557,1.20684270275931e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEK,Angiopoietin-1 receptor,39913,0.0188057103348655,0.0021329303750091,0.0146251667998477,0.0229862538698834,1.29622801541517e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0203308077671595,0.00230990409707735,0.0158033957368879,0.0248582197974311,1.48428480958412e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPK2,Death-associated protein kinase 2,37056,0.046163097275184,0.00525041939272506,0.0358722752654429,0.0564539192849251,1.64544338887413e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0560239280147933,0.0063760269598912,0.0435269151734065,0.06852094085618,1.69860543924885e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0490304122747589,0.0055836606456157,0.0380864374093522,0.0599743871401657,1.7838667581251e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.036909269601544,0.0042075574904289,0.0286624569203034,0.0451560822827847,1.96623380523043e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0236938864362712,0.00270586651750292,0.0183903880619655,0.0289973848105769,2.21272567831274e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGA,Fibrinogen alpha chain,37149,0.0266098061513024,0.00303827834111608,0.0206547806027149,0.0325648316998899,2.22182985948386e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7,Complement component C7,37149,-0.0276539075199445,0.00315942742472624,-0.033846385272408,-0.0214614297674811,2.32940716886696e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.021428356520447,0.00245927132124634,0.0166081847308042,0.0262485283100899,3.23522544069039e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300A,CMRF35-like molecule 8,37124,0.0248020690736259,0.00285022261807547,0.019215632742198,0.0303885054050538,3.64820598912794e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300E,CMRF35-like molecule 2,39991,0.0329018556110913,0.00378776859570033,0.0254778291635187,0.040325882058664,4.09657546419627e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFC1,Cryptic protein,39477,0.0397208857165804,0.00460145850810721,0.0307020270406903,0.0487397443924706,6.58926669666369e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHPS,Deoxyhypusine synthase,37368,0.0347484614756168,0.00404014803766211,0.0268297713217991,0.0426671516294346,8.78135404035763e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.0334294611827667,0.00389967000112869,0.0257861079805545,0.0410728143849789,1.10538980088343e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0405696075247697,0.00473852087196842,0.0312821066157116,0.0498571084338278,1.21321002228749e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0516333380661881,0.00603769817903471,0.03979944963528,0.0634672264970961,1.34120155219138e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB2,Lamin-B2,37388,0.0230517427915062,0.00269568055031055,0.0177682089128975,0.0283352766701148,1.34590795161332e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0215469811403465,0.00252063556169697,-0.0264874268412726,-0.0166065354394204,1.38211419279748e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0402087064697504,0.00470748388653532,0.0309820380521411,0.0494353748873596,1.44342367136273e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0760448299790952,0.00894125589933632,-0.0935696915417944,-0.058519968416396,1.98015733933917e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0414075872567455,0.00489526616665768,0.0318128655700965,0.0510023089433946,2.97780378167032e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALCAM,CD166 antigen,40052,0.0161646999121904,0.00191182426298835,0.0124175243567333,0.0199118754676476,3.02287198701748e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP3,Stromelysin-1,39858,-0.0396814866981078,0.00469740847181826,-0.0488884073028716,-0.030474566093344,3.22819155106796e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0709364276914924,0.00840750780487387,0.0544577123939397,0.0874151429890452,3.52334047268864e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1,Programmed cell death protein 1,39998,0.0340047477059336,0.00403202434599981,0.026101979987774,0.0419075154240932,3.63020954480102e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0224043545874846,0.00266080894572384,-0.0276195401211033,-0.0171891690538658,4.07489971187284e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.018990992027018,0.00226152351451337,-0.0234235781154642,-0.0145584059385718,4.93911620404724e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.03635644372412,0.00433382557826167,0.0278621455907271,0.0448507418575128,5.30783457792995e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0185233158641824,0.00221121952040654,0.0141893256041856,0.0228573061241792,5.8787436895027e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0306654925955921,0.00366377444238927,0.0234844946885091,0.0378464905026751,6.24950161624056e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0493249905489448,0.00589484826910985,0.0377710879414895,0.0608788931564001,6.36988110251884e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0771332201220975,0.00922325440780102,0.0590556414828075,0.0952107987613875,6.61793669862957e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.0499218729508267,0.00597027560147303,0.0382201327719396,0.0616236131297138,6.6835163428694e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0294666998860026,0.00352388309902198,0.0225598890119195,0.0363735107600857,6.76486943587142e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0270528943817976,0.00323910239202258,-0.0334015350701619,-0.0207042536934333,7.35894267061191e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0230568373778769,0.00276335781459784,0.0176406560612652,0.0284730186944887,7.77202491573697e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK7,Kallikrein-7,36818,0.0320957046786139,0.00384812887022488,0.0245533720929732,0.0396380372642547,8.13369680367096e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0350096340743337,0.00421411411361574,0.0267499704116468,0.0432692977370205,1.0531085844534e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LF,CMRF35-like molecule 1,40030,0.048841311814449,0.00588140898806762,0.0373137501978365,0.0603688734310616,1.08226218392761e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A13,Protein S100-A13,37056,0.0284566899944865,0.00342821893403531,0.0217373808837773,0.0351759991051957,1.13477712326333e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRK1,Protein BRICK1,39489,0.036358271476236,0.004388363381687,0.0277570792481295,0.0449594637043426,1.2743853472791e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0440698231550108,0.00532452182174079,0.0336337603843988,0.0545058859256227,1.38293878939459e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP9,Caspase-9,37056,0.0516502532743704,0.0062470016566476,0.0394061300273411,0.0638943765213997,1.491634632012e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0299762014262783,0.0036346569528935,0.022852273798607,0.0371001290539496,1.74676520563712e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0457936876281202,0.00555331604421325,0.0349091881814622,0.0566781870747782,1.78536448530569e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0471207500573618,0.00571820469937056,0.0359130688465955,0.0583284312681281,1.85009773313503e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0428522915792093,0.00520649870340583,0.0326475541205339,0.0530570290378847,2.00864502168091e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0269388795747566,0.00327433533047796,-0.0333565768224934,-0.0205211823270198,2.06376735603548e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0339006728157495,0.00412540522201824,0.0258148785805938,0.0419864670509053,2.23478709461209e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0424296450612986,0.00516687502188304,-0.0525567201041893,-0.0323025700184078,2.34265199590335e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPOCK1,Testican-1,39749,0.0205298642275164,0.00250022617614403,0.015629420922274,0.0254303075327587,2.35668344702018e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN3,Calsyntenin-3,37388,0.0244602250703012,0.00298149362346192,0.0186164975683158,0.0303039525722866,2.53339325204149e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA9,Carbonic anhydrase 9,40030,-0.0349487587654291,0.00426380128024442,-0.0433058092747082,-0.02659170825615,2.65606080620327e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGCR6,Protein DGCR6,36991,0.0350011375407104,0.00427230321134278,0.0266274232464786,0.0433748518349423,2.79233781153943e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0380011564604449,0.00464440543623605,0.0288981218054222,0.0471041911154675,3.00174696522816e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPB,Natriuretic peptides B,39585,-0.102092576835569,0.0124781948811062,-0.126549838802537,-0.0776353148686009,3.01160106808552e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18BP,Interleukin-18-binding protein,39931,0.0237993341435975,0.00290917733231003,0.0180973465722698,0.0295013217149252,3.02933346279052e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0276907489180257,0.00338548102146312,0.021055206115958,0.0343262917200934,3.06939771816718e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0289231460555975,0.00354104036972055,0.0219827069309452,0.0358635851802497,3.36546294187117e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0231060956192242,0.00283001766493366,-0.0286529302424942,-0.0175592609959542,3.45911211002469e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI2,Serpin I2,37382,0.046076633024803,0.00564573848267898,0.0350109855987522,0.0571422804508538,3.60516172198909e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0806103418746952,0.00988035425640319,0.061244847532145,0.0999758362172455,3.64583991262351e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0333280038525326,0.00408952041874462,0.0253125438317932,0.0413434638732721,3.97829363817713e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XG,Glycoprotein Xg,39985,0.0241104032520937,0.00296211405816007,0.0183046596980999,0.0299161468060874,4.25324969412692e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.0204165826934078,0.00251449360398794,0.0154881752295915,0.0253449901572242,5.08100082155824e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0522228071045423,0.00643610641927714,0.0396080385227591,0.0648375756863255,5.24595078484493e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0302921267209069,0.00373433011526431,0.0229728396949889,0.037611413746825,5.41404529667822e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0385356329099931,0.00475374063739529,0.0292183012606984,0.0478529645592879,5.59608309073865e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.052334165282126,0.0064669150892221,0.0396590117072507,0.0650093188570013,6.35005055595577e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0403385485596869,0.00498815596355965,0.03056176287111,0.0501153342482638,6.63989043067129e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP2,Retinol-binding protein 2,39788,-0.0608095181361611,0.00752125048127085,-0.0755511690794519,-0.0460678671928702,6.65843492663113e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH1,Cadherin-1,39315,0.0319636653196572,0.0039710352641782,0.0241804362018679,0.0397468944374464,8.93592991761352e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN8,Septin-8,37357,0.0252753908395226,0.0031426693806697,0.01911575885341,0.0314350228256352,9.52026899588056e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0371865354484876,0.0046313199990433,0.0281091482503627,0.0462639226466124,1.04930064349717e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0259171690766667,0.00322786926326642,0.0195905453206646,0.0322437928326689,1.06388000340412e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.033800684137495,0.0042140710839329,-0.0420602634620034,-0.0255411048129865,1.12214922891976e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0750340532745185,0.00936709480307299,-0.0933935590885416,-0.0566745474604955,1.2216441226746e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX5,Sorting nexin-5,37043,0.0240828211999313,0.00300634614683113,0.0181903827521423,0.0299752596477203,1.23626417901342e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE3,Eosinophil cationic protein,39791,0.0843795560754746,0.0105970584042643,0.0636093216031164,0.105149790547833,1.79834473849758e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.022838109240894,0.00287384259936739,0.0172053777461339,0.0284708407356541,2.04006872673874e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0330182777636225,0.00415640490460266,0.0248717241506013,0.0411648313766437,2.11179255715563e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0227609590031104,0.00286619771898363,0.0171432114739025,0.0283787065323183,2.16032513665219e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX1,Heme oxygenase 1,39691,-0.0372899760491728,0.00469846452493951,-0.0464989665180542,-0.0280809855802913,2.2158135653783e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,39545,0.0588476557174909,0.00741594549841379,0.0443124025405998,0.0733829088943819,2.24117407154987e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSM,Oncostatin-M,39785,0.0558533413291753,0.00704352515120454,0.0420480320328144,0.0696586506255362,2.34083095876882e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP6,Gastrotropin,39564,0.0421942878673227,0.00532952202769703,0.0317484246930365,0.0526401510416089,2.59302388339046e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.032616002248065,0.00412594303390173,0.0245291539016176,0.0407028505945124,2.85529496396566e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAM,Integrin alpha-M,39858,-0.0245492974543774,0.00310840173817822,-0.0306417648612067,-0.0184568300475481,3.0238413961789e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0573884729414562,0.00726821745070416,0.043142766738076,0.0716341791448363,3.07491168787433e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0312094165580673,0.00396398557672439,0.0234400048276875,0.0389788282884471,3.72562203217392e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0534673853947674,0.00681340340345927,0.0401131147239872,0.0668216560655475,4.56628420955104e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0503668678519996,0.00642171938915967,0.0377802978492467,0.0629534378547526,4.66630773959872e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0195587212897213,0.00249819057486353,0.0146622677629888,0.0244551748164539,5.28295371112822e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH5,Cadherin-5,40052,-0.0234907646573257,0.00300462230712372,-0.0293798243792882,-0.0176017049353632,5.68599836971534e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0413571366769591,0.00529821807825081,0.0309726292435875,0.0517416441103307,6.27538400684714e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0220930718180107,0.00283161716417237,-0.0276430414597886,-0.0165431021762329,6.45232222551579e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0184746253679137,0.00237093431612961,0.0138275941082996,0.0231216566275277,6.99449578335676e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0291880966984607,0.00374849422768403,0.0218410480122,0.0365351453847214,7.38978392426986e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0919491830912106,0.0118130314817059,0.0687956413870671,0.115102724795354,7.56716765233879e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0369956799490873,0.00475814856374404,0.0276697087641489,0.0463216511340256,8.07578770959074e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300C,CMRF35-like molecule 6,40009,0.0254790427231503,0.00327781113375568,0.0190545329009892,0.0319035525453114,8.11239855608148e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CX3CL1,Fractalkine,39749,-0.0253978234380934,0.00326844634296624,-0.0318039782703072,-0.0189916686058796,8.286452010215e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.031523658537615,0.00406628007206844,0.0235537495963608,0.0394935674788691,9.67135127702485e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0385774213039424,0.00498164694101893,0.0288133932995453,0.0483414493083395,1.03421325605645e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.033726112713602,0.00435957006630457,0.025181355383645,0.042270870043559,1.09946478364927e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0413426154211722,0.00534963442175762,-0.0518278988878171,-0.0308573319545272,1.15597591423082e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0277604015910896,0.00359182590634872,0.0207204228146461,0.034800380367533,1.16234214642881e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0344097256197293,0.00445521052134727,-0.0431419382415699,-0.0256775129978886,1.19852811054385e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0323130169775287,0.00418712384798458,0.024106254235479,0.0405197797195785,1.25838054265047e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0591648621074774,0.00767189094256431,-0.0742017683549034,-0.0441279558600513,1.31220832965262e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAX,Apoptosis regulator BAX,39456,0.0693283044326899,0.00902781072543545,0.0516337954108365,0.0870228134545434,1.69272583978578e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS1,Nephrin,37056,0.0259392085489869,0.00337952627108036,0.0193153370576694,0.0325630800403044,1.76468498834596e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0612342221223253,0.00798207325791136,0.0455893585368191,0.0768790857078316,1.80043173975971e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMD,Osteomodulin,39931,-0.032844071499186,0.00428527244518989,-0.0412432054917582,-0.0244449375066138,1.89885943385283e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0302443296613567,0.00395235566312725,0.0224977125616272,0.0379909467610861,2.08746199583893e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX2,Sorting nexin-2,37368,0.0608385580863388,0.00795288344811906,0.0452509065280254,0.0764262096446521,2.14760799193448e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAT,Catalase,37252,0.039753038933605,0.00520788146544919,0.0295455912613246,0.0499604866058855,2.44374775402967e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.038544012999583,0.00505329383713217,0.028639557078804,0.0484484689203621,2.5310370175578e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0432476249396415,0.00567910342217129,0.0321165822321858,0.0543786676470973,2.77899027557209e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.020125307293335,0.00264842962939994,0.0149343852197111,0.0253162293669589,3.14937025971082e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0276667081752982,0.00364864357512329,0.0205153667680566,0.0348180495825399,3.60310252915883e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0772716930517342,0.0101944825776366,0.0572905071995665,0.0972528789039019,3.68701920829923e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0269298017661352,0.00355936206171064,0.0199534521251823,0.033906151407088,4.06074124703777e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPB2,Coatomer subunit beta',37021,0.0318177953696847,0.00421605460446698,0.0235543283449294,0.0400812623944399,4.75302820701821e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0579467280408809,0.0076826698116115,0.0428886952101224,0.0730047608716395,4.91097651577105e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHCY,Adenosylhomocysteinase,39868,0.050380248142617,0.00668146691015391,0.0372845729987154,0.0634759232865187,4.93989804452158e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0208464116286524,0.00276613836819007,-0.0262680428303049,-0.0154247804269999,5.09360375888182e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0343365667085192,0.00455987207539384,0.0253992174407473,0.0432739159762911,5.33542188610347e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1B,Interleukin-1 beta,39478,0.0414092355349147,0.00549963846496406,0.0306299441435851,0.0521885269262442,5.37357407580424e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0251047180835344,0.00333645524756116,0.0185652657983146,0.0316441703687543,5.63211020807317e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0415783409931417,0.00553631185070503,0.0307271697657598,0.0524295122205236,6.28775712125886e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PZP,Pregnancy zone protein,37453,0.0407452150277534,0.0054258947730961,0.030110461272485,0.0513799687830217,6.30957590011766e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0468084325342553,0.00624339181642786,0.0345713845740567,0.0590454804944539,6.85701752602395e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0266862461854134,0.00356814066320624,0.0196926904855292,0.0336798018852977,7.94882955006024e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GC,Vitamin D-binding protein,37453,0.0190327560003902,0.00254889934711645,0.0140369132800419,0.0240285987207384,8.700218993644e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS4,Thrombospondin-4,39892,0.0328609972817455,0.00440343790178082,0.024230258994255,0.0414917355692359,8.91935291217467e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL21,C-C motif chemokine 21,39931,0.0287446451558368,0.00385732548196139,0.0211842872111925,0.0363050031004811,9.66354277343736e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.028279634861897,0.00379715813226816,0.0208372049226514,0.0357220648011426,9.99452367532175e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0286180396324704,0.00385488848937037,0.0210624581933045,0.0361736210716363,1.196030957226e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0114635918123887,0.0015442810813333,0.00843680089297544,0.014490382731802,1.19951207983866e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR1,Complement receptor type 1,37420,0.0259691497744563,0.00351481267871558,0.0190801169241737,0.0328581826247388,1.57185782107589e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.041058266621388,0.00555762122019057,0.0301653290298144,0.0519512042129615,1.58338457446544e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0298137153245944,0.00404282632922438,0.0218897757193146,0.0377376549298742,1.73227998832019e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0716812518768475,0.00972496232578914,0.0526203257183008,0.0907421780353942,1.79658472200451e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0439184379273535,0.00596460263443205,0.0322278167638667,0.0556090590908403,1.9022277990412e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0280723727767547,0.00382121608884032,0.0205827892426277,0.0355619563108817,2.13397628764244e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVALB,Parvalbumin alpha,39971,0.0825731692530689,0.0112528872245482,0.0605175102929544,0.104628828213183,2.27217072904122e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17D,Interleukin-17D,39587,0.0244433551746447,0.0033404749170497,0.0178960243372273,0.0309906860120622,2.65168278975158e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0263896029722964,0.00360821508233434,0.0193175014109211,0.0334617045336717,2.74799653545437e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB6,Integrin beta-6,39587,0.0213852135333857,0.00292513008454023,0.0156519585676869,0.0271184684990846,2.78211185275207e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM3,Myomesin-3,37124,-0.0675210530400368,0.00923673031778899,-0.0856250444629032,-0.0494170616171704,2.82309955072443e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA4,Carbonic anhydrase 4,40052,-0.0168555796332759,0.00230831950714007,-0.0213798858672705,-0.0123312733992814,2.9647868272029e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0259080412427766,0.0035489308692981,0.0189521367389524,0.0328639457466009,3.00998846386512e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0237893713235123,0.00326016478621076,-0.0301792943044854,-0.0173994483425392,3.10688667659849e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYGD,Gamma-crystallin D,37388,0.0692636334881986,0.00950062289084799,0.0506424126221365,0.0878848543542606,3.26112949315289e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0170897679433309,0.0023456579492468,-0.0216872575238546,-0.0124922783628071,3.34866102873135e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0635407936235781,0.00872204518388496,0.0464455850631635,0.0806360021839926,3.36466272972901e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0431826917202304,0.00592900973634037,0.0315618326370033,0.0548035508034575,3.41327388963375e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0236840678276999,0.00325367170364242,0.0173068712885607,0.030061264366839,3.54284027817357e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0228483308720267,0.00314266957971722,0.016688698495781,0.0290079632482725,3.75304177793218e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0383420412209912,0.00527794585301639,0.0279972673490791,0.0486868150929033,3.94713162446373e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA1,Ephrin-A1,39826,0.018852744848097,0.00259775500524118,0.0137611450378243,0.0239443446583697,4.12990995505234e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0607074996331534,0.00836862310896777,0.0443049983395766,0.0771100009267303,4.26531766287207e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFR,Epidermal growth factor receptor,40052,0.011446351998913,0.00158066666226936,0.0083482453408651,0.014544458656961,4.63794219927703e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN5,CCN family member 5,39858,0.0274710699413756,0.00379406344973374,0.0200347055798974,0.0349074343028537,4.67226208329656e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0338057791934563,0.00467162422678167,0.0246493957089642,0.0429621626779484,4.82151117118992e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO3,R-spondin-3,40030,0.0191938676084936,0.00265589665634464,0.0139883101620581,0.0243994250549291,5.16252652714478e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA1,Carbonic anhydrase 1,39531,0.0421153160633337,0.00585254957683475,0.0306443188927376,0.0535863132339298,6.47845029623446e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A11,Protein S100-A11,39703,0.0321810022882722,0.00448055435332507,0.0233991157557551,0.0409628888207893,7.15598985539255e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPF,Centromere protein F,37169,0.03821256815218,0.0053215319324388,0.0277823655645999,0.04864277073976,7.30131855319229e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0394315242866505,0.0054934293761944,0.0286644027093095,0.0501986458639915,7.38420071044162e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCOR1,REST corepressor 1,39585,0.0317921121341827,0.00443185799297464,0.0231056704679524,0.040478553800413,7.63417524616262e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0254212770571834,0.00354980542900819,-0.0323788956980395,-0.0184636584163274,8.34082757004628e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.0198610337395922,0.00277820844439039,-0.0253063222905974,-0.014415745188587,9.12805979356375e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFIC,Nuclear factor 1 C-type,37411,0.0294348854825848,0.00413741839680192,0.0213255454248531,0.0375442255403166,1.1811983531978e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY75,Lymphocyte antigen 75,39866,0.0270890981724997,0.00381062125709604,0.0196202805085915,0.034557915836408,1.21964482658893e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0196167980361063,0.00276296486571317,0.0142013868993084,0.0250322091729041,1.31234446934449e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SBSN,Suprabasin,37420,-0.0237301849066708,0.00335049538595705,-0.0302971558631466,-0.017163213950195,1.48457942626748e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0122631852010144,0.00173315004972547,0.00886621110355247,0.0156601592984763,1.54900867087617e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPQ,Carboxypeptidase Q,37430,0.0263279383334891,0.00372523970406445,0.0190264685135228,0.0336294081534554,1.65513965885343e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.024814520993965,0.00353001330299244,0.0178956949200998,0.0317333470678301,2.17365054829814e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0160957506602752,0.00229633601977505,0.0115949320615161,0.0205965692590342,2.4895558801917e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0365574689934586,0.00522376830049936,0.0263188831244799,0.0467960548624374,2.71502118127049e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0247367744722443,0.00353574923822828,0.0178067059653169,0.0316668429791717,2.74032006558175e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0292871390864055,0.00418946001323934,0.0210757974604564,0.0374984807123547,2.86728594673978e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0182030680002528,0.00260859133620208,0.0130902289812968,0.0233159070192089,3.10886488003067e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.017163381060067,0.00246119876079745,0.012339431488904,0.02198733063123,3.2331241030503e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLU,Clusterin,37453,0.0218859161649224,0.00314146040665923,0.0157286537678703,0.0280431785619745,3.39159302398982e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0190129680369371,0.00272964755631616,0.0136628588265574,0.0243630772473168,3.4032393353962e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0336990699693328,0.00483919997003434,0.0242142380280655,0.0431839019106001,3.46524957462573e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.025981472577546,0.00373330028514739,0.0186642040186571,0.0332987411364349,3.5794726604244e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0181960222258344,0.00261885329320326,0.013063069771156,0.0233289746805128,3.84392333329872e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.057390939411295,0.00829530470746922,0.0411321421846554,0.0736497366379347,4.74222727771439e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST5,Cystatin-D,39559,0.0369815784500721,0.00534859266576812,0.0264983368251665,0.0474648200749776,4.88432348674085e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH15,Cadherin-15,39973,0.036508095313127,0.00528682167482652,0.0261459248304671,0.046870265795787,5.18993301935425e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0289891421217592,0.00420023193296505,-0.0372215967103707,-0.0207566875331477,5.36974426720027e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0376711847287169,0.00546539279817208,0.0269590148442996,0.0483833546131342,5.71791619072709e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCT,Secretin,37039,0.0299769306799248,0.00435693073364171,0.0214373464419871,0.0385165149178626,6.2430813148139e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHISA5,Protein shisa-5,37437,0.0155218992655837,0.00226140915376347,0.0110895373242073,0.0199542612069601,6.99545716410434e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B2M,Beta-2-microglobulin,37453,0.0208327651953572,0.00303643098225252,0.0148813604701422,0.0267841699205721,7.13707128630001e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0247748324697466,0.00361130387714254,0.0176966768705472,0.031852988068946,7.16799223457535e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0237464045860416,0.00346182656136304,0.0169612245257701,0.0305315846463132,7.21896178319135e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALY,RNA-binding protein Raly,37368,0.0328849957507681,0.00480430684430044,0.0234685543359392,0.042301437165597,7.98323544964858e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0223984859321244,0.00327809794531073,-0.0288235579049335,-0.0159734139593154,8.62905601222401e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0383321234599096,0.00561789022945696,0.0273210586101739,0.0493431883096452,9.22694979500716e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.01711762040296,0.00251939123241517,0.0121796135874263,0.0220556272184938,1.1263896154219e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0357559508543812,0.0052665362031937,0.0254335398961216,0.0460783618126409,1.17407630392634e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.0237225703881686,0.00350166403691353,-0.0305858319005191,-0.016859308875818,1.29005081220317e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0398896398140161,0.00589139576576613,0.0283425041131145,0.0514367755149177,1.33336202064665e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1A,Protein phosphatase 1A,39477,0.0203547901298384,0.00301289025705827,0.0144495252260042,0.0262600550336727,1.46966130444223e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0268727290695765,0.0040020140078127,0.0190287816142637,0.0347166765248894,1.94813007634344e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GM2A,Ganglioside GM2 activator,37178,0.0238895878128639,0.00356813257300947,0.0168960479697654,0.0308831276559625,2.23912375087476e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0319033351212894,0.00477720355464704,-0.0412666540883976,-0.0225400161541812,2.51248496242431e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR2,Folate receptor beta,40009,-0.018922797383439,0.00284217497442518,-0.0244934603333123,-0.0133521344335656,2.86801607127843e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSH,Pro-cathepsin H,39546,0.0474836578226117,0.00713209399409349,0.0335047535941884,0.0614625620510349,2.87291309667589e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.046115627842357,0.0069317082260117,0.0325294797193741,0.0597017759653399,2.98818601109679e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0266163713607149,0.00400153316364834,-0.0344593763614657,-0.0187733663599642,2.99478638029764e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0205044723566477,0.00309172123524775,0.0144446987355621,0.0265642459777333,3.43936582110306e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPE,Carboxypeptidase E,39906,-0.0252140705899846,0.00380346456745159,-0.0326688611421897,-0.0177592800377794,3.4818464121143e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.0121231059795555,0.00182935063337584,0.00853757873813886,0.0157086332209722,3.55489030065628e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0404508712928046,0.00610650903355346,0.0284821135870398,0.0524196289985694,3.62279718852332e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0297481108447057,0.00449940149393162,0.0209292839165998,0.0385669377728117,3.94896244828845e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBI3_IL27,Interleukin-27,40011,-0.0200509021162018,0.00303486961325693,-0.0259992465581853,-0.0141025576742182,4.04877111102627e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0227925425769263,0.00344978382559512,0.0160309662787598,0.0295541188750927,4.05001677540737e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0376328186079812,0.00570820861493402,-0.0488209074932518,-0.0264447297227105,4.45187433346514e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD209,CD209 antigen,39885,-0.0252072673088536,0.00383159865787014,-0.0327172006782791,-0.0176973339394281,4.88997158785588e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRLB,Fc receptor-like B,39477,0.0375226370172881,0.00571031436659081,0.0263304208587701,0.0487148531758061,5.15503891827031e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0262962221393333,0.00400456528026655,0.0184472741900108,0.0341451700886557,5.31157371989784e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D17,TBC1 domain family member 17,39489,0.0284720201008619,0.00433879563401029,0.0199679806582017,0.0369760595435221,5.4689437992602e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSR,Insulin receptor,37056,0.0107757172743184,0.00164278398927845,0.00755586065533265,0.0139955738933042,5.60299259123288e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRH,Corticoliberin,39455,0.0562114282183786,0.00857996447299054,0.0393946978513171,0.07302815858544,5.87556464157096e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0394377982559337,0.00602483222082162,0.0276291271031233,0.0512464694087441,6.1337569358401e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.038945918767573,0.00595489620565386,0.0272743222044914,0.0506175153306546,6.37249772978888e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZU1,Azurocidin,39344,0.0493037023719123,0.00755676191521333,0.0344924490180942,0.0641149557257304,7.03704731797381e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR15L,Protein GPR15L,37382,0.0393584896298917,0.00605847037438856,0.0274838876960901,0.0512330915636932,8.51216606781239e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL3,Follistatin-related protein 3,39803,0.0191367824133485,0.00295445886421952,0.0133460430394783,0.0249275217872188,9.6140904416305e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.15189580768819,0.0235860793424212,0.105667092177044,0.198124523199335,1.23461108276408e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0243615711323535,0.0037912179637039,0.0169307839234938,0.0317923583412131,1.35693304545753e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA12,Serpin A12,39405,0.0748273984385033,0.0116497346078903,0.0519939186070383,0.0976608782699682,1.37406686086331e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD93,Complement component C1q receptor,39238,-0.0194695598249613,0.00303575706429621,-0.0254196436709819,-0.0135194759789407,1.46452992423432e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0152832734958061,0.00239063186170112,0.0105976350468719,0.0199689119447403,1.68160325706745e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL3,Insulin-like 3,37388,0.0455731711784023,0.00715264824630764,0.0315539806156394,0.0595923617411653,1.93238809387359e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA7,Carbonic anhydrase 7,37169,-0.0211408670213889,0.00332223571485362,-0.027652449022502,-0.0146292850202758,2.03741219981726e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0738946171335718,0.0116284104976353,0.0511029325582066,0.0966863017089371,2.1460243049477e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH1,Protocadherin-1,40018,0.0129596203631724,0.00205042346402439,0.00894079037368455,0.0169784503526602,2.67620350716878e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB37,Ras-related protein Rab-37,39587,0.0519461266761171,0.00822158981904283,0.0358318106307932,0.0680604427214411,2.7164366223227e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LUZP2,Leucine zipper protein 2,37368,0.0272304128829577,0.00431462181282721,0.0187737541298163,0.035687071636099,2.85541898381479e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6,Interleukin-6,39788,0.0438971113828483,0.00697562592889326,0.0302248845622176,0.0575693382034791,3.19675812290255e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0188011703358309,0.00298933068799596,0.0129420821873588,0.024660258484303,3.27115810362847e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0256639601355612,0.00409693687560108,0.0176339638593831,0.0336939564117394,3.84364376593678e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0247306767820532,0.00395342322673573,0.0169819672576512,0.0324793863064553,4.06286689248843e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENSA,Alpha-endosulfine,37368,0.0324429298186387,0.00518701161531347,0.0222763870526243,0.0426094725846531,4.10425025941259e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0161528386977551,0.00259154207692822,0.0110734162269758,0.0212322611685344,4.69279555314452e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD1,Polycystin-1,37437,0.0160936458288966,0.00258556444303857,0.011025939520541,0.0211613521372522,4.97552814524603e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC1,Syndecan-1,39868,0.0243829015500349,0.00391857627104061,0.0167024920587953,0.0320633110412745,5.01823655149135e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0367963939822524,0.00591430950337175,0.0252043473556438,0.048388440608861,5.07040766570513e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK4,Kallikrein-4,40030,-0.0368853716249337,0.00593254223813386,-0.048513154411676,-0.0252575888381913,5.17653117440556e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDN1,Endothelin-1,37043,0.0172344267510609,0.00277424640580922,0.0117969037956749,0.022671949706447,5.37881583736339e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTL1,Cytokine-like protein 1,37437,0.0140165461565856,0.0022585150032242,0.00958985675026614,0.018443235562905,5.58988620053345e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0138816368333788,0.00223752313199948,0.00949609149465985,0.0182671821720978,5.63765822053654e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0220087673404281,0.00355672149814868,0.0150375932040567,0.0289799414767995,6.27733476554709e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0262226497729576,0.00424370874026625,-0.0345403189038795,-0.0179049806420358,6.59875092998859e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0172082833835397,0.00278705530874079,0.0117456549784077,0.0226709117886716,6.80786005485914e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0310898970349061,0.00503902568336956,0.0212134066955017,0.0409663873743104,7.00525431456806e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0436805733210015,0.00708119162076611,0.0298014377442999,0.0575597088977031,7.09226199370791e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS4,Galectin-4,39862,0.0320215051020159,0.00519999697322844,0.0218295110344882,0.0422134991695436,7.54356804760586e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0348955698067355,0.00567264791254216,0.0237771798981529,0.0460139597153181,7.8563419442001e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN1,Contactin-1,40052,-0.0161325647425723,0.00262719601431012,-0.0212818689306201,-0.0109832605545244,8.41279073944454e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0328638617859764,0.00536632603861943,0.0223458627502823,0.0433818608216705,9.37967969728149e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0311498143787122,0.00508754964820326,0.0211782170682338,0.0411214116891906,9.41724691440006e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0258740422192721,0.00422755399138294,-0.0341600480423826,-0.0175880363961615,9.55567557194768e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0251777494291503,0.00411445094364453,0.017113425579607,0.0332420732786936,9.6549608458751e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA12,Carbonic anhydrase 12,39788,-0.0191936185329982,0.00313865464260534,-0.0253453816325047,-0.0130418554334918,9.86638950067245e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCP1,Plastin-2,37437,0.0283077353321128,0.00463264721712462,0.0192277467865486,0.0373877238776771,1.02043442700219e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0153591680319527,0.00251657198731355,0.0104266869368181,0.0202916491270873,1.06347990559509e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0290759716908917,0.00476423001577114,0.0197380808599802,0.0384138625218031,1.07033013110212e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0226641597034936,0.00371868598925859,0.0153755351645467,0.0299527842424404,1.12178594599632e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0195276687220455,0.00320646350510051,0.0132430002520485,0.0258123371920425,1.15981220087371e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMBS,Porphobilinogen deaminase,40030,0.025699992440274,0.00423776711995747,0.0173939688851574,0.0340060159953907,1.3529900383353e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDM1,Nuclear protein MDM1,37039,0.0187248881558049,0.00308720961839214,0.0126739573037563,0.0247758190078535,1.35302821192092e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMPD3,AMP deaminase 3,37388,0.0423067973215377,0.00698890941553325,0.0286085348670926,0.0560050597759829,1.45554221693604e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0181880295935032,0.00300494607805785,-0.0240777239064966,-0.0122983352805098,1.4633001779565e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MET,Hepatocyte growth factor receptor,39879,-0.0116445257249396,0.00192496598825457,-0.0154174590619186,-0.00787159238796068,1.48793632683304e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0196977317078474,0.00326216604188834,0.0133038862657463,0.0260915771499486,1.59214791703546e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLVRB,Flavin reductase,39858,0.0383610084226791,0.00636003599383309,0.0258953378747662,0.0508266789705919,1.65947650970164e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0179934442551229,0.00298472469407057,0.0121433838547446,0.0238435046555012,1.69079975469684e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0271700908826597,0.00451200717705458,0.0183265568156327,0.0360136249496867,1.77159159532194e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANPEP,Aminopeptidase N,39891,0.0165515872003987,0.00275266574880057,0.0111563623327495,0.0219468120680478,1.86153295469227e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0327925780079995,0.00545680658451487,0.0220972371023503,0.0434879189136486,1.90153785062956e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE1,Ribonuclease pancreatic,37445,0.0132798872314715,0.00220969878071071,0.00894887762127847,0.0176108968416645,1.90486319654086e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.0193379971136176,0.00321916973785117,-0.0256475697998059,-0.0130284244274293,1.93769970736036e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.026183650396264,0.00438092737858562,0.0175970327342362,0.0347702680582918,2.33386354618599e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0423717712515193,0.00709974952674833,0.0284562621790926,0.0562872803239461,2.46078017233152e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0153146440946098,0.00256771276313551,-0.0203473611103554,-0.0102819270788642,2.51955748548392e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0179725286928382,0.00301892795082874,-0.0238896274764626,-0.0120554299092139,2.6840991728968e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0200309344465503,0.00336809972534088,-0.0266324099082184,-0.0134294589848821,2.79385355376577e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0210015563524605,0.0035363378483979,0.0140703341696006,0.0279327785353204,2.9318911200232e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRC1,Macrophage mannose receptor 1,37445,0.0161386184734411,0.00271740030831922,0.0108125138691354,0.0214647230777468,2.93786069958261e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.028589973766477,0.00481579226853093,0.0191510209201564,0.0380289266127976,2.97920878464722e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.0166044364614059,0.00279988513311634,0.0111166616004978,0.0220922113223139,3.09758598593873e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD276,CD276 antigen,39862,-0.0205684995190446,0.00346953299820581,-0.027368784195528,-0.0137682148425612,3.12343821536213e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.0148436163314937,0.00250548503121822,0.00993286567030601,0.0197543669926814,3.19722313626217e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL34,Interleukin-34,39456,0.0209096026807684,0.00353018556574265,0.0139904389719128,0.027828766389624,3.22594065299052e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0410852787834663,0.0069375771801239,0.0274876275104234,0.0546829300565091,3.24464117993543e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0209797889316204,0.00354506364032056,0.0140314641965921,0.0279281136666487,3.33906471890978e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0188941191140906,0.00319751230766905,0.0126269949910593,0.0251612432371219,3.52425658351164e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0200935579802735,0.00340571996307069,0.0134183468526549,0.026768769107892,3.72301947256698e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0156349510670124,0.00265124981511351,-0.0208314007046348,-0.0104385014293899,3.78584818012066e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.027729199871295,0.00470450762990855,0.0185083649166742,0.0369500348259157,3.85773376118392e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTB,Lymphotoxin-beta,37368,0.0198819353673209,0.00337322873747117,0.0132704070418774,0.0264934636927644,3.85859609110934e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0120004158614666,0.0020403458516052,0.00800133799232036,0.0159994937306127,4.14556926812857e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0197944878189661,0.00338591113620615,0.0131581019920021,0.0264308736459302,5.12804546862399e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0149069028801066,0.00255278787690675,-0.0199103671188439,-0.00990343864136942,5.35680609036631e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0444146901075649,0.00765398026134934,0.0294128887953202,0.0594164914198097,6.67070768890989e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0253737520768298,0.0043793995713607,-0.0339573752366968,-0.0167901289169628,7.03491735066223e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNC,Tenascin,39931,-0.0268760283084881,0.00463976198657444,-0.0359699618021739,-0.0177820948148022,7.06237830853536e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0193866618151494,0.0033474086101789,0.0128257409391988,0.0259475826911001,7.10571233806236e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYT1,Synaptotagmin-1,37388,0.0211166130485611,0.0036546712851158,0.0139534573297341,0.028279768767388,7.726813172803e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0208694317562275,0.0036135709267494,0.0137868327397987,0.0279520307726563,7.8269861550193e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP2,Neuropilin-2,39858,-0.0162465795329389,0.0028136609858561,-0.0217613550652169,-0.010731804000661,7.87637496942189e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG3,Desmoglein-3,39964,0.0189634309898495,0.00328817506109228,0.0125186078701086,0.0254082541095904,8.20967413041084e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN3,Matrilin-3,39720,-0.0178115224547191,0.00308931375390521,-0.0238665774123733,-0.0117564674970649,8.29169488197158e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.0357999491365899,0.00621168427557394,-0.0479748503167148,-0.023625047956465,8.40066791569879e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0193289633292336,0.00336455411947801,0.0127344372550568,0.0259234894034105,9.39587227108007e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP4,Guanylate-binding protein 4,39489,0.0276244539505833,0.00482404759894444,0.0181693206566522,0.0370795872445144,1.04465963511281e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0160258778035979,0.00279896941968924,-0.0215118578661888,-0.010539897741007,1.04900966184044e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0294158785188125,0.00514434414220349,0.0193329640000937,0.0394987930375314,1.09677360214183e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG4,Desmoglein-4,39725,0.0276450963269448,0.00483609145900042,0.018166357067304,0.0371238355865857,1.10752180317151e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0333354513361839,0.00583185622954677,-0.0447658895460956,-0.0219050131262722,1.10940950436969e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0138888115099562,0.00243312274710162,0.00911989092563699,0.0186577320942753,1.16184033073368e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR2,Complement receptor type 2,39931,0.0255083626054688,0.00446969740991682,0.0167477556820318,0.0342689695289058,1.1704306837837e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0282209851940313,0.00494543394518657,0.0185279346614657,0.037914035726597,1.17425755491849e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A14,Protein S100-A14,37411,0.028733667898151,0.00504176249101016,0.0188518134157711,0.0386155223805309,1.22927321928774e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR1,Cadherin-related family member 1,39489,0.0239661985177269,0.00421412912436777,0.0157065054339661,0.0322258916014877,1.31521789143685e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD7,T-cell antigen CD7,37037,0.0240149604130185,0.00422496727627833,0.015734024551513,0.032295896274524,1.34324307756017e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST7,Cystatin-F,39882,0.0517090296862638,0.00910148523797663,0.0338701186198296,0.069547940752698,1.35931268932845e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0228723805385594,0.0040300297052512,0.014973522316267,0.0307712387608517,1.40691964805138e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0214631771493431,0.00381662764629265,0.0139825869626095,0.0289437673360767,1.90725979550532e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0154887356999393,0.00276104711129026,0.0100770833618104,0.0209003880380682,2.06606462805696e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0237007370761766,0.00424990030588006,0.0153709324766517,0.0320305416757015,2.49052765217566e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.0143476766559747,0.0025733473201047,0.00930391590856946,0.0193914374033799,2.50804444196776e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0373408717148258,0.00669835980311951,0.0242120865007116,0.0504696569289401,2.52959491874934e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0231841063765788,0.00416244836220565,0.0150257075866558,0.0313425051665019,2.59174161514442e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0172280836458132,0.00309383489757354,0.0111641672465691,0.0232920000450573,2.61929766112284e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH1,Neurexophilin-1,39489,0.0205330347539977,0.0037055281785775,0.0132701995239858,0.0277958699840096,3.05277948854827e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST1,Cystatin-SN,35640,0.0550915167815955,0.00994241709796647,0.0356043792695812,0.0745786542936097,3.07107469957856e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN2,Prefoldin subunit 2,39489,0.0305125470633029,0.00550861688879667,0.0197156579612615,0.0413094361653444,3.09009921119256e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN10,Ataxin-10,39489,0.0399660020245259,0.00722060979540448,0.0258136068255332,0.0541183972235187,3.16253762041785e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGA4,Pepsin A-4,37445,0.0339496050070065,0.00613914914544973,0.0219168726819251,0.045982337332088,3.26109677819313e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CABP2,Calcium-binding protein 2,37039,0.035816657013414,0.00649326432878123,0.0230898589290028,0.0485434550978252,3.53397041727677e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0216412850394338,0.00394445376215339,0.0139101556656131,0.0293724144132544,4.17532435543166e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA1,Annexin A1,37072,0.0236711145552444,0.004316481400292,0.015210811010672,0.0321314180998167,4.23716243494187e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.0285558386167926,0.00520785842332053,0.0183484361070844,0.0387632411265008,4.2529145018839e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0177045806310064,0.00323668194118526,0.0113606840262833,0.0240484772357295,4.56840827517434e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.0340093398830683,0.00623014487597539,0.0217982559261566,0.0462204238399801,4.87787173444808e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLFM4,Olfactomedin-4,36654,0.0662477654992877,0.0121471692863496,0.0424393136980425,0.090056217300533,5.02314027421383e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0146502790922612,0.00269061590747011,0.00937667191361975,0.0199238862709026,5.26008029564734e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN2,Calsyntenin-2,40058,-0.0211232732379398,0.00388518241812011,-0.0287382307774552,-0.0135083156984244,5.50061504364302e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,0.0139434304550044,0.00258409634947664,0.00887860161003015,0.0190082592999786,6.91607374515314e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAD,Chondroadherin,37124,0.0267808703060094,0.00497598950990004,0.0170279308666053,0.0365338097454135,7.49078578964143e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB2A2,Mammaglobin-A,37021,-0.0166447331975955,0.00310021647432021,-0.0227211574872631,-0.0105683089079279,8.05663278721594e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC16,Mucin-16,39788,0.0984088071733709,0.0183336254267102,0.0624749013370189,0.134342713009723,8.08782063571043e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0150895292298379,0.00282375729497651,0.00955496493168395,0.0206240935279919,9.22982988759846e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRL,Prolactin,40009,-0.0399329479615114,0.00747966328669403,-0.0545930880034317,-0.0252728079195911,9.47925819022299e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0206159801714995,0.00386359806428335,0.0130433279655042,0.0281886323774949,9.65786412880541e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0211138806376567,0.00395914865378276,0.0133539492762425,0.028873811999071,9.79516840802098e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSHB,Thyrotropin subunit beta,39868,0.0393749664716783,0.00738816638919865,0.0248941603488489,0.0538557725945077,9.98377177749715e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0253960808475019,0.00476536299785572,0.0160559693717046,0.0347361923232991,9.99566275408309e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLGN,Calmegin,37039,0.0229310661676472,0.00430869629037102,0.01448602143852,0.0313761108967744,1.04289979357756e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.012988910079068,0.00244173323739516,-0.0177747072243626,-0.00820311293377353,1.05410343716869e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0195797347496055,0.0036817014917043,0.0123635998258651,0.0267958696733459,1.06253940763549e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SATB1,DNA-binding protein SATB1,37411,0.0157087161458516,0.0029610704030589,0.00990501815585617,0.0215124141358471,1.14395933974951e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0139671111714983,0.00263932416335872,0.00879403581131522,0.0191401865316814,1.22920645530684e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN8,Tetraspanin-8,37382,0.0510576039796919,0.00967509701431673,0.0320944138316311,0.0700207941277527,1.33185901423359e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0273994969488681,0.00520913085215443,0.0171896004786454,0.0376093934190908,1.46024461337243e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS53,Serine protease 53,37388,0.0193392110664506,0.00368201434936511,0.012122462941695,0.0265559591912063,1.52451670662121e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0260467423635714,0.00496933409380236,0.0163068475397187,0.035786637187424,1.6167727752403e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LXN,Latexin,39682,-0.0345353908417999,0.00659313108435014,-0.0474579277671262,-0.0216128539164736,1.64329582576743e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0270828076449281,0.00519526391963775,0.0169000903624381,0.0372655249274181,1.88571362791072e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0225306562849273,0.00435166816839504,0.014001386674873,0.0310599258949816,2.28223706108347e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0348788906532701,0.00676575722046299,0.0216180065011626,0.0481397748053775,2.57016197620603e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMB,Granzyme B,39866,0.0325715706966226,0.00632292581682163,0.0201786360956522,0.044964505297593,2.61695864559795e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0286651783961855,0.0056024021382937,0.0176844702051298,0.0396458865872411,3.14711175382172e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0152578171598809,0.00298250142980193,0.00941211435746914,0.0211035199622927,3.16095480988667e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.019328165372963,0.00379676728305902,0.0118865014981674,0.0267698292477587,3.6090626816107e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOB,Apolipoprotein B-100,37445,0.0113836297090614,0.00223672739146488,0.00699964402179028,0.0157676153963326,3.63971184862798e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0357204983554361,0.00702581677647726,0.0219498974735407,0.0494910992373315,3.74237665384425e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI1,Neuroserpin,37088,0.0153710090280855,0.00304183347665658,0.00940901541383858,0.0213330026423324,4.40254408921212e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0254003011506073,0.00503647875535885,0.015528802790104,0.0352717995111106,4.63587496283314e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0182314117238865,0.0036192530036731,0.0111376758366872,0.0253251476110858,4.77120417454387e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0125969236840075,0.0025042012835105,0.00768868916832687,0.017505158199688,4.94976340943522e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0303996758619458,0.00605681502761897,0.0185283184078126,0.042271033316079,5.24851349180425e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0105937537005945,0.00211876086146763,-0.0147465249890711,-0.00644098241211792,5.79546835606159e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0346141381636081,0.00694083835941738,0.02101009497915,0.0482181813480662,6.20748230826995e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0155244526808783,0.00311876759649099,0.00941166819175592,0.0216372371700006,6.499639814476e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRUNE2,Protein prune homolog 2,37169,0.0139743092790658,0.00281364167270437,0.00845957160056519,0.0194890469575663,6.89724089003066e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0250501551757326,0.00505417813191686,0.0151439660371755,0.0349563443142896,7.25923598745705e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPA,Apolipoprotein(a),37186,-0.0858799538914907,0.017362185555889,-0.119909837581033,-0.0518500702019482,7.65284996106812e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0125438707407924,0.00253672988805595,0.0075718801602027,0.017515861321382,7.70937982628864e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0127867007996326,0.00259173860195488,-0.0178665084594642,-0.00770689313980108,8.1702955925107e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY2,Protein canopy homolog 2,39585,0.0293069363866237,0.00594714015143165,0.0176505416898177,0.0409633310834297,8.39622673924448e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP1,Caspase-1,39489,0.0325139232987895,0.00660056000654849,0.0195768256859544,0.0454510209116245,8.48167002721892e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN3,Perilipin-3,39868,0.020854955272622,0.00423763464125233,0.0125491913757674,0.0291607191694766,8.67965061655397e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB1,Calbindin,39788,0.0203185525489661,0.00413034266505755,0.0122230809254533,0.0284140241724789,8.77038908667056e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C8B,Complement component C8 beta chain,37453,0.0147211721557939,0.00299260358829493,0.00885566912273587,0.020586675188852,8.79218955749376e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.012979092504379,0.00264123245190908,0.00780227689863717,0.0181559081101208,9.02645454354067e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0122067685979938,0.00248563279948622,0.0073349283110008,0.0170786088849868,9.15305830448763e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAN,Aggrecan core protein,39730,0.0136240538757575,0.00277978405682565,0.00817567712437926,0.0190724306271358,9.62329109319955e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLN,Mesothelin,39766,0.0253463372039879,0.00517487508217504,0.0152035820429248,0.0354890923650509,9.778771194447e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.0214124330666628,0.00438463474847036,0.0128185489596609,0.0300063171736647,1.05401948744859e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLMP,CXADR-like membrane protein,40030,0.00985085387642693,0.0020201798898099,0.00589130129239953,0.0138104064604543,1.09162005806087e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0144271711978123,0.0029622210519789,0.00862121793593368,0.020233124459691,1.12469015634336e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0183767588261004,0.0037740285765332,0.0109796628160953,0.0257738548361054,1.13086529967357e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,39788,-0.0115207225797012,0.0023667710843557,-0.0161595939050384,-0.00688185125436402,1.13988418020362e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLC,Galectin-10,39841,-0.0319722360590953,0.00657156182607212,-0.0448524972381967,-0.019091974879994,1.15406500735023e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCN,Decorin,39585,-0.0104235785091477,0.00214439528712055,-0.0146265932719039,-0.00622056374639139,1.18012415141398e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.0283080823115847,0.00583424577571755,0.0168729605911783,0.0397432040319911,1.23550791039129e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.0135605980545942,0.00279521698721879,0.00808197275964542,0.0190392233495431,1.23992378831523e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0188920785980413,0.00389725995973153,0.0112534490769675,0.0265307081191151,1.26391834144157e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0249538794478371,0.00515843308588153,0.0148433505995093,0.0350644082961649,1.32698288138712e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0189006622609777,0.00391092004118784,0.0112352589802496,0.0265660655417059,1.36148399065371e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0185290029123033,0.00383727784290876,0.0110079383402022,0.0260500674844045,1.38739081998503e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIF,Leukemia inhibitory factor,39489,0.0244744371042372,0.00506936021485848,0.0145384910831146,0.0344103831253598,1.39275534715022e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR1,Folate receptor alpha,39809,0.013016180332865,0.00270174791389016,0.00772075442164033,0.0183116062440897,1.46565927912054e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK8,Kallikrein-8,39315,0.0165322633447641,0.00343173167423474,0.00980606926326403,0.0232584574262642,1.4676946289382e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.028534016238591,0.00593521442974941,0.0169009959562821,0.0401670365208998,1.5416652859621e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX18,Sorting nexin-18,37382,0.0214617987257199,0.00446562411318464,0.012709175463878,0.0302144219875618,1.55633482949845e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOSB,Protein fosB,39489,0.0184955053318485,0.00385631840775505,0.0109371212526486,0.0260538894110484,1.63230702863958e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0167679222419726,0.00350366705155716,0.00990073482092058,0.0236351096630246,1.71813532399555e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0277411473578157,0.00581764173332133,0.0163385695605059,0.0391437251551255,1.87613740292172e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0173226126348379,0.00363643484088034,0.0101952003467124,0.0244500249229633,1.92122536612663e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMH,Granzyme H,39585,0.0353876613699127,0.00743262548385299,0.0208197154215608,0.0499556073182645,1.94231682820247e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM2,Myomesin-2,37021,-0.0242129930948605,0.0050858491737541,-0.0341812574754185,-0.0142447287143024,1.94827105254289e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0144339529458937,0.00303797678690168,-0.020388387448221,-0.0084795184435664,2.04353293790114e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0302752439808037,0.00637882956375855,0.0177727380358369,0.0427777499257705,2.09423825134952e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN1,Calsyntenin-1,39489,0.0235731283849744,0.0049706109373042,0.0138307309478582,0.0333155258220907,2.12959533949597e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.012918536048976,0.00272943233162466,-0.0182682234189603,-0.00756884867899165,2.23449599574745e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPO,Erythropoietin,39866,0.0360113859480488,0.00761716940743067,0.0210817339094847,0.050941037986613,2.29056818547177e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0195699342218699,0.00414187845948957,0.0114518524412704,0.0276880160024695,2.32181058150512e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.021560028289876,0.0045663278035249,0.0126100257949672,0.0305100307847848,2.3606741173818e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2,Ataxin-2,36991,0.0518160515650809,0.0109923331665196,0.0302710785587024,0.0733610245714594,2.45594269901262e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0285023541335542,0.00606327839435322,0.0166183284806219,0.0403863797864865,2.61764071191518e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.0194073050600679,0.00413615527185853,-0.0275141693929106,-0.0113004407272252,2.73047136764771e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROCR,Endothelial protein C receptor,37021,-0.0169253107278984,0.00360792918282874,-0.0239968519262427,-0.00985376952955404,2.74416789906332e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0222814357370981,0.00476469066523461,0.0129426420332383,0.0316202294409579,2.94822277594821e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0652215575765226,0.0139638242335159,0.0378524620788315,0.0925906530742136,3.0259801414134e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI3,Elafin,39594,0.0244135571334661,0.00522913180755918,0.0141644587906501,0.0346626554762821,3.05526360417751e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD1,Leiomodin-1,37411,-0.0162360794710116,0.00347739903858751,-0.0230517815866432,-0.0094203773553801,3.05529025248464e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15,Interleukin-15,39866,0.0149513632434553,0.00320329617869944,0.00867290273320442,0.0212298237537062,3.07368783775793e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0123299932653353,0.00264321529094397,0.00714929129508516,0.0175106952355855,3.11477874668184e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0136440006643894,0.00292637148059722,0.0079083125624188,0.0193796887663599,3.15582612995211e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA4,Carboxypeptidase A4,36868,0.0200585387425508,0.00430298389305947,0.0116246903121542,0.0284923871729474,3.16967449952017e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0155273284061676,0.00333449964007992,-0.0220629477007243,-0.008991709111611,3.24673361330387e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,0.0213571345574646,0.00458818386381913,0.0123642941843791,0.0303499749305501,3.26942763919264e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0201806700549747,0.00435439082600238,0.01164606403601,0.0287152760739394,3.60525434393802e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.012939181440724,0.00279662402452667,0.00745779835265173,0.0184205645287963,3.7445461026433e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0182892542962042,0.00395621763735575,0.0105350677269869,0.0260434408654215,3.81416905840246e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD6,Programmed cell death protein 6,39868,-0.0317516307231064,0.00687641396671485,-0.0452294020978675,-0.0182738593483453,3.91469136310307e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAL,Galanin peptides,39931,-0.0293179764615219,0.00634996469606018,-0.0417639072657998,-0.0168720456572439,3.92285818144458e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F3,Tissue factor,39931,-0.012363753579747,0.00267982593061583,-0.017616212403754,-0.00711129475573994,3.98731936745667e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.017254639187893,0.00374266125434858,-0.0245902552464162,-0.00991902312936976,4.05959593488004e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF4,Neurotrophin-4,39477,0.0180933774477139,0.00392639810440898,0.0103976371630723,0.0257891177323555,4.09508543311029e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTG,Protogenin,40030,0.0112881558211586,0.00245600042256366,0.00647439499293381,0.0161019166493834,4.33615972768594e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MBL2,Mannose-binding protein C,37257,-0.0487517037804745,0.0106091867259361,-0.0695457097633092,-0.0279576977976398,4.36207750590554e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0186812149501656,0.00407396423518124,0.0106962450492104,0.0266661848511209,4.57040469844164e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0318600944415703,0.00695305816140577,-0.0454880884379256,-0.018232100445215,4.64291519382381e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0436303965062249,0.00954900901403284,0.0249143388387206,0.0623464541737293,4.94263339723427e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC1,Glypican-1,40030,0.0130123416284339,0.00286046975353261,0.00740582091150999,0.0186188623453578,5.42874550407774e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRELP,Prolargin,39862,0.0099384019072391,0.00218788513657089,0.00565014703956015,0.014226656774918,5.60051832403382e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0109450368494637,0.00240984557568097,-0.0156683341777984,-0.00622173952112901,5.61783788713146e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMS1,PMS1 protein homolog 1,37039,0.0222865201386896,0.00491145655465274,0.0126600652915702,0.0319129749858089,5.73846886065858e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0209436082483068,0.00461756012762022,0.0118931903981712,0.0299940260984424,5.78450479712193e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSPN,Persephin,39866,0.0421465096603741,0.00929969608016918,0.0239191053432425,0.0603739139775057,5.88422453993765e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0168869551967265,0.00373612607692971,0.00956414808594429,0.0242097623075088,6.24038183982642e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,37437,0.015934349006312,0.00352778805589171,0.00901988441676419,0.0228488135958597,6.33073166976369e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF16,Fibroblast growth factor 16,37056,0.0215252973947024,0.00477119504053072,0.0121737551152622,0.0308768396741426,6.49233282992142e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.015500230904469,0.00343995260214014,0.00875792380427431,0.0222425380046636,6.65412864143174e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,39248,0.0130206573016927,0.00289441608194156,0.00734760178108719,0.0186937128222981,6.8921351629143e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0124817290665938,0.00277665474028616,-0.0179239723575546,-0.00703948577563289,6.99748360700253e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC1,Sialoadhesin,39931,0.0185158594689182,0.00412157379253391,0.0104375748355517,0.0265941441022847,7.09077593213016e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.0250963498658179,0.00558673563630502,0.01414634801866,0.0360463517129757,7.11128126453022e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFD,Complement factor D,37453,0.00808417428337646,0.00180240186384399,0.00455146663024223,0.0116168819365107,7.34346708834242e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNG,Interferon gamma,39587,0.0505587767352219,0.0112879481630009,0.0284343983357402,0.0726831551347036,7.55199303701328e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00925413894313648,0.00207001349890278,-0.0133113654009859,-0.00519691248528703,7.86627114617334e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0137375760413893,0.00307352202172263,-0.0197616792039656,-0.00771347287881291,7.88833855643674e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00978476271837454,0.00219525482864597,0.00548206325422844,0.0140874621825206,8.35889324772377e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICOSLG,ICOS ligand,39788,0.00828081594338912,0.00185840894512288,0.00463833441094828,0.01192329747583,8.41259359381882e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAP,Cartilage-associated protein,37039,0.0217220155769616,0.0048784316362808,0.0121602895698512,0.031283741584072,8.55087508326043e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH3,Cadherin-3,40009,0.015214130276192,0.00341832785477012,0.00851420768084254,0.0219140528715414,8.61428424872437e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0172076405545956,0.00386666374953289,0.00962897960551113,0.02478630150368,8.64719283009745e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNU13,NHP2-like protein 1,37021,0.027175847764848,0.00611192018708469,0.015196484198162,0.039155211331534,8.80492524544046e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0202046996014933,0.00454924671561509,0.0112881760388878,0.0291212231640989,9.01258480489986e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0370957159830017,0.00837596323076104,0.02067882805071,0.0535126039152933,9.53888386316778e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0261476015715929,0.00590673911998013,0.0145703928964319,0.037724810246754,9.64179586291185e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0391343271395096,0.00884458929014136,0.0217989321308325,0.0564697221481866,9.72291280577761e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD55,Complement decay-accelerating factor,39315,0.0110425035333859,0.00250563753988282,0.00613145395521556,0.0159535531115562,1.05487326796951e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK11,Kallikrein-11,39779,0.0126512047987645,0.00287136240771394,0.00702333447964514,0.0182790751178838,1.05987939297661e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLASP1,CLIP-associating protein 1,36962,0.031676571064096,0.00723109293537819,0.0175036289107547,0.0458495132174372,1.19268903758713e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARTN,Artemin,39587,0.0193356263569013,0.00442291377928326,0.0106667153495061,0.0280045373642965,1.24077410919125e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.0120822726416193,0.00277832435926928,0.00663675689745147,0.017527788385787,1.37750626459321e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.018629955754296,0.00428867228077788,0.0102241580839714,0.0270357534246206,1.40961960062664e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN4,Contactin-4,39858,-0.0102051698008509,0.00235505728890961,-0.0148210820871138,-0.00558925751458808,1.47786722395413e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN1,Tetraspanin-1,39585,0.0172654992966627,0.00398438161638882,0.00945611132854058,0.0250748872647848,1.47805958844148e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON1,Spondin-1,39885,0.0135862807858379,0.00314210344506681,0.00742775803350694,0.0197448035381688,1.54189524880864e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0142752698456543,0.00330322367197675,0.00780095144857993,0.0207495882427288,1.55832120367615e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF7,SLAM family member 7,39866,-0.0245305167224426,0.00569549439015051,-0.0356936857271376,-0.0133673477177476,1.66466372086993e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN2,Alpha-actinin-2,37021,-0.0251090964212464,0.00583189592697797,-0.0365396124381232,-0.0136785804043695,1.67831980787098e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0248680495369635,0.00579241886226831,0.0135149085669176,0.0362211905070094,1.77156911736739e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3D,Protein FAM3D,37382,0.0352457697040494,0.00824356116247341,0.0190883898256016,0.0514031495824973,1.91972525466404e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0129494248571302,0.00303242633321645,0.00700586924402591,0.0188929804702344,1.96325266802262e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC2,Mucin-2,37437,0.0380263920985623,0.00890926325928049,0.0205642361103726,0.0554885480867521,1.98406387213445e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0174461025334689,0.00408811641573861,0.00943339435862127,0.0254588107083166,1.99008957498506e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00962738949838868,0.0022657958288947,0.00518642967375508,0.0140683493230223,2.15940605796957e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0106192133449149,0.00250307591691941,0.00571318454775287,0.015525242142077,2.22324103637252e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0419750549690546,0.00990535371077214,0.0225605616959412,0.061389548242168,2.27445509860152e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.0140917117004347,0.00332910656515318,-0.020616760568135,-0.0075666628327345,2.32233485708036e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBB,Inhibin beta B chain,37124,0.0206596823278766,0.00488670860317258,0.0110817334656583,0.0302376311900949,2.37642604983461e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0241105540023212,0.00570922413625228,0.0129204746952668,0.0353006333093757,2.4234282283169e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECM1,Extracellular matrix protein 1,37106,0.0150130850322093,0.00357419462284304,0.00800766357143694,0.0220185064929817,2.68174863110466e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNLY,Granulysin,39858,0.0210764803515412,0.00502896594401786,0.0112197071012662,0.0309332536018162,2.79198489552676e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTPN,Myotrophin,39585,0.0134172378084209,0.00320230975331872,0.00714071069191624,0.0196937649249256,2.80646818084204e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0135183499254575,0.00322794365879733,0.00719158035421472,0.0198451194967003,2.83313810803413e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYAL1,Hyaluronidase-1,39747,0.00941775789264756,0.00224953468447238,0.0050086699110817,0.0138268458742134,2.84769500033295e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0254979458739624,0.00609421895565849,0.0135532767208718,0.0374426150270531,2.88342273123249e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0350758263632482,0.0083972016648014,-0.0515343416262589,-0.0186173111002375,2.96885473159456e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.0137763636451417,0.00329897343651776,0.00731037570956685,0.0202423515807165,2.98647070584848e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.0136208321602072,0.00326462616827517,-0.0200194994500266,-0.00722216487038791,3.03544423659308e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB44,Ras-related protein Rab-44,37368,0.0173908391818736,0.00417265296782771,0.00921243936493131,0.0255692389988159,3.09451094805792e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0223830032582476,0.00537597509128534,-0.0329199144371669,-0.0118460920793283,3.15017025792003e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.013025097192593,0.00312883162901839,0.00689258719971696,0.0191576071854691,3.15837578914337e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARCL1,SPARC-like protein 1,39871,-0.0111485273597363,0.00268633023178092,-0.0164137346140269,-0.00588332010544573,3.34054193217271e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,0.018119760339864,0.00436832801560751,0.00955783742927326,0.0266816832504547,3.37148206337822e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MILR1,Allergin-1,39587,-0.020260913303171,0.00488653436415247,-0.0298385206569098,-0.0106833059494321,3.39700605303046e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAN,Versican core protein,40009,-0.0120899535113732,0.00291770599462334,-0.0178086572608349,-0.00637124976191143,3.4356212728971e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0355013036328349,0.00860324059032021,0.0186389520758073,0.0523636551898625,3.70587423092071e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP9,Matrix metalloproteinase-9,39843,0.0246302480008385,0.00597873958707597,0.0129119184101696,0.0363485775915074,3.81377208143119e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST6,Cystatin-M,39524,0.0190525769946849,0.0046270516001072,0.00998355585847477,0.028121598130895,3.84718940250133e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSPN,Claspin,39453,0.0139981966186817,0.00340115807718714,0.00733192678739492,0.0206644664499685,3.87966181255697e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0116630087776722,0.00283479345466236,0.006106813606534,0.0172192039488104,3.90764182947687e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFLAM,Pikachurin,37382,0.0124543725457216,0.00302723189022538,0.00652099804087988,0.0183877470505634,3.90973888613069e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAM,Basal cell adhesion molecule,39858,-0.00950006453987281,0.00232372878042655,-0.0140545729495089,-0.00494555613023677,4.36698199707358e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0138140336046721,0.00338568727444709,0.00717808654675581,0.0204499806625884,4.52331599657822e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0128256743507802,0.00314535936667842,-0.0189905787094699,-0.00666076999209053,4.57587511121405e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0138237612129738,0.0033976768789704,0.00716431453019179,0.0204832078957557,4.75235027148669e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0173471513916213,0.00426987816065488,0.00897819019673772,0.0257161125865048,4.87906783959245e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDK2,Protein sidekick-2,37124,0.0148756664138981,0.00366953237780156,0.00768338295340708,0.0220679498743892,5.06731236901396e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF15,Growth/differentiation factor 15,40052,0.0169290645615159,0.00418447852769525,0.00872748664723319,0.0251306424757986,5.24133026391572e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEFL,Neurofilament light polypeptide,39438,0.0173597338619785,0.00429178799022223,0.00894782940114291,0.0257716383228141,5.26039400337147e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEO1,Neogenin,37411,0.00853818126198535,0.0021334617301774,0.00435659627083764,0.0127197662531331,6.31350934673017e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP8,Neutrophil collagenase,39985,0.0282918212357866,0.0070709838783669,0.0144326928341875,0.0421509496373857,6.33262476273771e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0165770291654169,0.00414688083076595,0.00844914273711563,0.0247049155937182,6.43716301746127e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP2,Guanylate-binding protein 2,39587,0.0233713166700917,0.00585270236261532,0.0119000200393657,0.0348426133008178,6.54694487989418e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK14,Kallikrein-14,40030,-0.0177634538293962,0.00445350888622374,-0.0264923312463947,-0.00903457641239763,6.67450535736867e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPS10,40S ribosomal protein S10,37021,-0.0168598270059243,0.00423872516045635,-0.0251677283204188,-0.00855192569142986,6.99957833682454e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0264714322526044,0.0066735904269615,0.0133911950157598,0.0395516694894489,7.32829317764775e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0257127260018418,0.00650240952160196,-0.0384574486641816,-0.012968003339502,7.7137719362569e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAFB2,Scaffold attachment factor B2,37411,0.0106986669313741,0.00270610829105357,0.0053946946809091,0.0160026391818391,7.73994698757487e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.0114455758171289,0.00289542106084513,0.00577055053787245,0.0171206010963854,7.75728603261385e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0171338047396258,0.00434919860647189,0.00860937547094091,0.0256582340083107,8.19874796621014e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0125265796125083,0.0031916051960396,-0.0187821257967459,-0.00627103342827071,8.7155017280198e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERC2,ERC protein 2,37039,0.0290250250145952,0.0074036685425292,0.014513834671238,0.0435362153579524,8.88652738292874e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSB,Lupus La protein,39489,0.0233837314564186,0.00599384615291097,0.0116357929967131,0.0351316699161241,9.60822107038054e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0150800334488978,0.00387284949382953,-0.0226708184568037,-0.00748924844099194,9.91656220817459e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH6,Cadherin-6,39868,-0.0145882955111044,0.00375443906714542,-0.0219469960827095,-0.00722959493949942,0.000102483245426917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIM,Vimentin,39585,0.0449630123175366,0.0115721723770703,0.0222815544584788,0.0676444701765943,0.000102562279511726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0188171905661371,0.00484392176940984,-0.0283112772341804,-0.00932310389809378,0.000102866752364029
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX3,Syntaxin-3,37388,0.0145555573628083,0.00375423536315722,0.00719725605102016,0.0219138586745965,0.000106207295463491
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA4,Apolipoprotein A-IV,37453,0.0135152774272905,0.00349484771198305,0.00666537591180371,0.0203651789427773,0.000110604782142417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL,Podocalyxin,39788,0.00572751954335526,0.00148247523608221,0.00282186808063414,0.00863317100607638,0.000112223914441083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFAP,Glial fibrillary acidic protein,39453,0.016635435360098,0.00431692695997192,0.00817425851855303,0.025096612201643,0.00011689042559934
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0207785475797221,0.00540006956036766,0.0101944112414015,0.0313626839180427,0.000119642987414999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0167529738246991,0.00436800646886757,0.0081916811457187,0.0253142665036796,0.000125852309353078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO4,Roundabout homolog 4,37043,-0.0067627486913545,0.00176334311248877,-0.0102189011918325,-0.00330659619087652,0.00012605351921735
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0165321758373863,0.00432262382069326,0.00805983314882755,0.0250045185259451,0.000131598570003457
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK2,Protein AHNAK2,37043,0.0110847372713955,0.00290090909080424,0.00539895545341921,0.0167705190893718,0.000133454099713836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0124643856839307,0.00326654267442573,0.00606196204205625,0.0188668093258051,0.000136267180207117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0138050232598847,0.00363198315614599,-0.0209237102459309,-0.00668633627383857,0.000144767601992383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00718486382739109,0.00189171312160114,-0.0108926215457293,-0.00347710610905285,0.000146460318462492
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0115195695064882,0.00303686334332901,-0.0174718216594131,-0.00556731735356337,0.000149356031499417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.017936111999967,0.00473455815657435,0.0086563780130813,0.0272158459868527,0.000152222662351742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0137366741812854,0.00362605400592323,-0.020843740032895,-0.00662960832967588,0.000152340181628383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB1A1,Uteroglobin,39903,0.0203669080604278,0.00539739755168123,0.0097880088591326,0.030945807261723,0.000161572973654444
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0172257169135685,0.00458119821289798,0.00824656841628841,0.0262048654108485,0.000170587554101253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0135183102162297,0.00359656884623616,0.00646903527760683,0.0205675851548526,0.000171539303997611
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0220313908281317,0.00586193465233338,0.0105419989095583,0.0335207827467052,0.000171731831803125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDI2,Protein DDI1 homolog 2,37124,0.0278915303412753,0.00742224336055533,0.0133439333545868,0.0424391273279637,0.00017212755904132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RETN,Resistin,39790,0.0151077038983097,0.00402445234406773,0.00721977730393697,0.0229956304926825,0.00017466890556457
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0216417846953892,0.00576759045732202,0.0103373073990381,0.0329462619917404,0.000175842531201493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0288180952299451,0.00770001349289685,0.0137260687838673,0.043910121676023,0.000182776336644088
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0228601888946887,0.0061415993840962,-0.0348977236875173,-0.0108226541018602,0.000198331593361354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0159791495775701,0.00430136390135743,0.00754847633090952,0.0244098228242307,0.000203989518866834
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200,OX-2 membrane glycoprotein,39866,-0.00941520429378022,0.00253931805764248,-0.0143922676867595,-0.00443814090080095,0.00020979920680037
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.0385856157910198,0.0104092741152897,0.018183438525052,0.0589877930569876,0.000210564474981061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0227688048357627,0.00618977695146208,-0.0349007676606284,-0.0106368420108971,0.000235590075311218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO6,Unconventional myosin-VI,37411,0.0138465714168303,0.00376842639492493,0.00646045568277748,0.0212326871508832,0.000239361395703557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0166573222772701,0.00453465536509663,-0.0255452467928595,-0.00776939776168073,0.000240189846102424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP1,Dipeptidase 1,39713,-0.0171220960450223,0.00467424508146738,-0.0262836164046984,-0.00796057568534623,0.000250020000743758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYMP,Thymidine phosphorylase,39764,0.0244722511610696,0.00668901568082206,0.0113617804266583,0.0375827218954808,0.000254443085974432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0395939885868439,0.0108290324892402,0.0183690849079331,0.0608188922657547,0.000256894910693169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0290480399266293,0.00794797599763871,0.0134700069712574,0.0446260728820011,0.000258230626750686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRAXIN,Draxin,39749,0.0151230304528691,0.00414851099253502,0.00699194890750043,0.0232541119982377,0.00026781583836952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB1,Lamin-B1,37348,0.0208614455022669,0.00572825699933056,0.00963406178357902,0.0320888292209548,0.000271700950853962
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0669154533650124,0.01843906389975,0.0307748881215024,0.103056018608522,0.000285405442642931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0141799270258092,0.00391027846815088,0.00651578122823347,0.0218440728233849,0.000288401668542352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0173287883201403,0.00479875119137853,-0.0267343406552422,-0.00792323598503836,0.000305829865151643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NINJ1,Ninjurin-1,39477,0.0201007218393172,0.00557355948091285,0.00917654525672802,0.0310248984219064,0.000311391474399886
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0186030614343982,0.00518541349063211,0.00843965099275928,0.0287664718760372,0.000334787756791289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.0103147439255475,0.00288719354644247,-0.0159736432765748,-0.00465584457452031,0.000354734161227947
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAVL4,ELAV-like protein 4,36991,0.0298153586063334,0.00834689468712283,0.0134554450195726,0.0461752721930941,0.0003554922134242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0178081047311275,0.00499340580814139,0.00802102934717039,0.0275951801150847,0.000363307951059486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL28,C-C motif chemokine 28,39815,0.020930876533688,0.00588091451929715,0.00940428407586564,0.0324574689915105,0.00037318123767907
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0246739111655587,0.00693812677505978,0.0110751826864415,0.0382726396446759,0.000377451398687533
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0120675601631916,0.00339809930410188,0.00540728552715189,0.0187278347992313,0.00038448616427091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHB,Lutropin subunit beta,39477,0.0309625558761796,0.00873877528601895,0.0138345563155824,0.0480905554367767,0.000396571995298851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0146238794274456,0.00412993953139369,0.00652919794591399,0.0227185609089772,0.000399819111323424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDS,Iduronate 2-sulfatase,40058,0.00314527147107109,0.000888567826380752,0.00140367853136482,0.00488686441077737,0.000401691366366095
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPS,Colipase,39836,0.0241835431260474,0.00683420169549362,0.0107885078028799,0.0375785784492149,0.000403388499145871
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSC2,Desmocollin-2,39673,-0.0116267463463876,0.00328659435357461,-0.0180684712793938,-0.00518502141338136,0.00040489603518035
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0226791117310948,0.00641491012925067,0.0101058878777634,0.0352523355844261,0.000408592054030234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWF,von Willebrand factor,40052,-0.025412838600956,0.00721111585450587,-0.0395466256757875,-0.0112790515261245,0.000426063490635799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCC1,Regulator of chromosome condensation,37368,0.0176194962194502,0.00500418921617326,0.00781128535575063,0.0274277070831498,0.00043142209816725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.00814782810012525,0.00231830269309248,-0.0126917013785865,-0.00360395482166399,0.000441675658386468
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0245670297618568,0.00700116250737824,0.0108447512473955,0.0382893082763182,0.000451030992145646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA7A,Semaphorin-7A,40002,0.00932243151279491,0.00265823330880263,0.00411229422754175,0.0145325687980481,0.000454415724508276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00643397829086994,0.00183939980956043,0.0028287546641315,0.0100392019176084,0.000470491381226417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0310215884452756,0.008881661116252,0.0136135326574217,0.0484296442331295,0.000479605376249563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPS,Calcyphosin,37388,0.0300127156485814,0.00859350137029662,0.0131694529628,0.0468559783343628,0.0004800677057389
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00942997021221795,0.00270283663667883,0.00413241040432744,0.0147275300201085,0.000486271840948792
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL3,Myosin light chain 3,37043,-0.0250774639172676,0.00720040025114961,-0.0391902484095209,-0.0109646794250144,0.000497831047828822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0190103130400386,0.0054621391614979,0.00830452028350269,0.0297161057965745,0.000502283372799035
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0142070754321969,0.0041003119702623,-0.022243686893911,-0.00617046397048278,0.00053216468670451
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAG,S-arrestin,36991,-0.0181686841450661,0.00524978747017296,-0.0284582675866051,-0.00787910070352707,0.000540201141613253
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0127990964689145,0.00370163070272148,-0.0200542926462485,-0.00554390029158036,0.000546545225886944
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY6D,Lymphocyte antigen 6D,39761,0.0123321613654934,0.00356972096110661,0.00533550828172449,0.0193288144492624,0.000552430179526183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG1,Arginase-1,39754,0.01761926014819,0.00510441925902906,0.00761459840049303,0.027623921895887,0.000558379165155581
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD48,CD48 antigen,39908,0.00985857932955831,0.00285617662666753,0.00426047314128995,0.0154566855178267,0.000558563394259198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00916503237299489,0.0026558947422373,0.00395947867820979,0.01437058606778,0.000560572382163328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0204960824966817,0.00594316860776067,0.00884747202547081,0.0321446929678926,0.000564795974491784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD160,CD160 antigen,40058,0.01524500621966,0.00442512551624733,0.00657176020781526,0.0239182522315048,0.000572291391140945
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0100663720942505,0.00292818236722288,0.00432713465449363,0.0158056095340073,0.000588051592774187
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOC,Brother of CDO,39585,-0.00794807124829784,0.00231262826252709,-0.0124808226428509,-0.00341531985374474,0.000590123875923146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXTL1,Exostosin-like 1,37021,0.0162053478780648,0.00471519173654181,0.00696357207444289,0.0254471236816868,0.000590367703330607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.0115281372348571,0.00335661760264627,0.00494916673367038,0.0181071077360438,0.000595261052500919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0175908533578932,0.00512457448054033,0.00754668737603414,0.0276350193397522,0.000599539218653893
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0250426052232072,0.00730945446387138,0.0107160744740193,0.0393691359723951,0.000614291924812463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.00951155724313944,0.00277667353616284,-0.0149538373740186,-0.00406927711226027,0.00061517003670935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL4,Delta-like protein 4,37043,0.0290965594969538,0.00851194910076146,0.0124131392594613,0.0457799797344462,0.00063199710366672
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00914648350743046,0.00267828449494651,0.0038970458973353,0.0143959211175256,0.000639569523319025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF3,Neurotrophin-3,39866,0.0113426173083738,0.00332317176740066,0.00482920064426849,0.0178560339724791,0.000643661295872358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.010806186913985,0.0031663109758846,-0.0170121564267188,-0.00460021740125122,0.0006447747107818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0174885324688524,0.00516254293171851,0.00736994832268407,0.0276071166150206,0.000706859270905669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00674676164277012,0.00199232192792388,0.0028418106640393,0.0106517126215009,0.000709905543931911
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0119008695741389,0.00351771829296934,0.00500614171991904,0.0187955974283588,0.000718693293608049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.00750407836608716,0.00221824316923533,-0.0118518349777884,-0.00315632175438592,0.000718989572559803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00940294555038289,0.00277991261834959,0.00395431681841769,0.0148515742823481,0.000720115342861075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0118509563595661,0.00350582695398368,-0.0187223771893741,-0.00497953552975809,0.00072562207222417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0340690426438938,0.0100910403847192,0.0142906034898441,0.0538474817979434,0.000736792471018522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0192073109035805,0.00569105775854439,-0.0303617841103275,-0.00805283769683345,0.000740293726694069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00936249004489939,0.00278082399706623,0.00391207501064957,0.0148129050791492,0.000762606739134309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0197671180537346,0.00588598090995441,0.00823059547022393,0.0313036406372452,0.000786358531541903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.024288369678839,0.00724732733081358,0.0100836081104444,0.0384931312472336,0.00080636418332904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99,CD99 antigen,39858,-0.00631655030062543,0.00188971031388513,-0.0100203825158403,-0.00261271808541058,0.000831870046538125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKCQ,Protein kinase C theta type,39587,0.0142997347781389,0.00428198615117036,0.00590704192184499,0.0226924276344328,0.000841214530093491
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.0200430255967124,0.00601517828035673,-0.0318327750262115,-0.00825327616721317,0.000864310607431732
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00718157452029235,0.00215735007804389,-0.0114099806732584,-0.00295316836732632,0.000874325162264549
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN1,Nectin-1,37056,0.0105393130428722,0.00317067772893238,0.00432478469416475,0.0167538413915797,0.000889798094137976
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.0104729199301934,0.00315595271954052,0.00428725259989395,0.0166585872604928,0.000907584842994104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0160122339578497,0.00483834523449676,0.00652907729823604,0.0254953906174633,0.000936928009536236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0227620229803753,0.00691625699666218,0.00920615926691742,0.0363178866938332,0.00100017541370509
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX2,Peroxiredoxin-2,37249,0.0197141908125361,0.00601019696476354,0.0079342047615996,0.0314941768634727,0.00104026593145315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00773606736384193,0.00237220319410428,0.00308654910339754,0.0123855856242863,0.0011119937415641
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0150081975298208,0.00462363506665054,-0.0240705222604559,-0.00594587279918576,0.00117288271538631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0127261003669204,0.00392053142362591,0.00504185877661359,0.0204103419572271,0.00117325680302586
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00665318752879694,0.00205249939410724,0.00263028871634675,0.0106760863412471,0.0011914462722362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0137033588771455,0.00423055785049752,-0.0219952522641207,-0.00541146549017037,0.0012018986529677
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF8,SLAM family member 8,39477,0.0165846152519467,0.00513875613579613,0.00651265322578632,0.0266565772781072,0.00125195933574459
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.010998110700332,0.00341254288259911,-0.0176866947502263,-0.00430952665043777,0.00127232201879434
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMOD4,Tropomodulin-4,36962,-0.0129648386337648,0.0040288261258976,-0.0208613378405241,-0.00506833942700553,0.00129393325131973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00903979642315042,0.00280949860643531,0.00353317915453721,0.0145464136917636,0.00129580262233081
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0190404888812195,0.00591858076681685,0.00744007057825845,0.0306409071841805,0.00129819446602362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH4,Myosin-4,37021,-0.0151380286245708,0.0047192922704793,-0.0243878414747102,-0.00588821577443135,0.00134125676101943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.0180726474471402,0.00564893781022173,0.00700072933910561,0.0291445655551748,0.00138026946949845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.0114371732480016,0.00357521300322343,0.00442975576168371,0.0184445907343196,0.00138224438845349
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0220227107744442,0.00691742480019207,0.00846455816606778,0.0355808633828207,0.00145712052621212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.00795161319979135,0.0025015497253382,0.00304857573812847,0.0128546506614542,0.00148228134558438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G1B,Phospholipase A2,40031,-0.0127770590127367,0.00403268829601608,-0.0206811280729282,-0.00487298995254516,0.00153580210736798
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH3,Neurexophilin-3,37056,0.00929581506055789,0.00293678284074216,0.00353972069270326,0.0150519094284125,0.00155272252556365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00667592636995421,0.00211190522959849,0.00253659211994117,0.0108152606199673,0.00157525834035377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0170147436933397,0.00540254895407062,0.00642574774336132,0.0276037396433181,0.00163918801254138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100G,Protein S100-G,37411,-0.0139742249163686,0.00443756465949532,-0.0226718516489794,-0.00527659818375776,0.00164143718817912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0193673289745126,0.0061531094078764,0.00730723453507491,0.0314274234139504,0.00165002408462916
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00807459037437998,0.0025676437772226,0.00304200857102368,0.0131071721777363,0.00166535993897231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0112408136647338,0.00359199672142788,0.00420050009073519,0.0182811272387325,0.00175485212570977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.0133884015736645,0.00427989749194373,-0.0217770006578742,-0.00499980248945475,0.00176260031026713
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0126081845126396,0.00403239729161128,-0.0205116832041977,-0.00470468582108154,0.00177153883984329
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBN,Ameloblastin,39587,-0.00878413900688617,0.00281745171227394,-0.0143063443629431,-0.00326193365082924,0.00182559623894425
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH12,Protocadherin-12,37411,0.00779041113815504,0.00249953337045994,0.00289132573205356,0.0126894965442565,0.0018324124311714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0162065033025784,0.00520299807223825,0.00600862708099146,0.0264043795241654,0.00184439878350038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.0111313957143453,0.00358210722938201,0.00411046554475659,0.0181523258839341,0.00189078139882655
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0111619038770526,0.00360086771510813,0.00410420315544066,0.0182196045986645,0.00194071400888684
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.0128499087348127,0.00414842717147737,0.00471899147871706,0.0209808259909083,0.00195541275869802
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EP300,Histone acetyltransferase p300,37056,0.00904747390866342,0.00292453050959357,0.00331539410986002,0.0147795537074668,0.0019812362145214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD9,Enhancer of filamentation 1,37056,0.0102070096591722,0.00330073175564736,0.00373757541810339,0.016676443900241,0.00198994464200447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00928686352071729,0.00301021979372233,0.00338683272502153,0.015186894316413,0.00203831178246138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDHB15,Protocadherin beta-15,37368,-0.012113069842579,0.00392684691173779,-0.0198096897895851,-0.00441644989557294,0.00204182098006634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0107943850280358,0.00352352205998534,0.00388828179046454,0.0177004882656071,0.00219177954005814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171B,Protein FAM171B,37368,0.00832576582921984,0.002738752486278,0.00295781095611496,0.0136937207023247,0.00237042995640904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00899960228587185,0.00296049526854989,-0.0148021730122296,-0.00319703155951407,0.0023712564971568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0136003433588574,0.00447788911862416,0.00482368068635405,0.0223770060313607,0.00239225064356574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00949900227555684,0.00313631850441073,-0.0156461865442019,-0.00335181800691181,0.00246074885024848
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00676580999914727,0.002234142890258,0.00238688993424159,0.0111447300640529,0.00246264462396533
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.0105862499061912,0.00351663976650909,0.00369363596383335,0.017478863848549,0.00261379911922715
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.00796715854769272,0.00264878621009382,-0.0131587795194766,-0.00277553757590883,0.00263509442029472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00869112802534074,0.00289384290488818,0.0030191959317599,0.0143630601189216,0.00267461889057318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.0107489543631237,0.00358516017997323,0.0037220404103762,0.0177758683158713,0.00272103923799465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPJ,Centromere protein J,37169,0.0215045127907224,0.00717297176225385,0.00744548813670488,0.03556353744474,0.0027226652000429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCLRE1C,Protein artemis,36962,-0.00915972444103316,0.00306514477731177,-0.0151674082045642,-0.00315204067750209,0.00281008391026652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00718541045867294,0.00240832718474832,-0.0119057317407796,-0.00246508917656623,0.00285337511330409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0204260481589641,0.00685566173558768,-0.033863145160716,-0.00698895115721223,0.00289220281198299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0154402251913655,0.00520707640200013,0.00523435544344524,0.0256460949392858,0.00302984553118024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00870967968551734,0.00293798089923863,0.00295123712300963,0.0144681222480251,0.00303705327679604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RYR1,Ryanodine receptor 1,37021,-0.00986219882811258,0.0033432358599666,-0.0164149411136471,-0.00330945654257804,0.00318440265079825
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0190233180575212,0.00645474081407674,0.0063720260619308,0.0316746100531116,0.00321144121030413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.01154820565048,0.0039224383480571,-0.019236184812672,-0.00386022648828811,0.00324402699569888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGA,Chromogranin-A,37437,-0.0227513811666173,0.00774325364411337,-0.0379281583090795,-0.00757460402415508,0.0033065810757209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0120804395796825,0.00412240556168414,0.00400052467878161,0.0201603544805834,0.00339072610261146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD109,CD109 antigen,39858,-0.00971574068521226,0.00333056813725341,-0.0162436542342289,-0.00318782713619557,0.003537459136904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0348372619704213,0.0119641818999158,0.0113874654465864,0.0582870584942562,0.00359861657890828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.0105099188038651,0.00360971501042782,-0.0175849602243036,-0.00343487738342657,0.00360227063559772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUK1,Guanylate kinase,37021,-0.0119142849523993,0.00409233490460449,-0.019935261365424,-0.00389330853937446,0.00360456030656722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0108266532625688,0.00372971182862351,0.00351641807846669,0.0181368884466709,0.00370354542367599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALB,Ras-related protein Ral-B,37056,0.00838818447227004,0.00289062947360758,0.00272255070399919,0.0140538182405409,0.0037157501046973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNR,Tenascin-R,39749,-0.0119994401425862,0.00414019187329565,-0.0201142162142457,-0.00388466407092673,0.00375727096544496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.00723444702896139,0.00249943053851894,-0.0121333308844585,-0.00233556317346427,0.003803449687758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0149388341560961,0.0052054689855083,-0.0251415533676924,-0.00473611494449988,0.00411342434262372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0174138420012632,0.00606966496386306,0.00551729867209159,0.0293103853304348,0.0041233793191388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.0161266845836162,0.00562745034868307,0.0050968819001974,0.027156487267035,0.00416616656074383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.0049145457300343,0.00171829596657765,-0.00828240582452648,-0.00154668563554211,0.00424019465378219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0164640021599225,0.00576567800516987,0.00516327326978958,0.0277647310500555,0.00430330368168328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0170693414799573,0.00597906642827314,0.00535037128054197,0.0287883116793727,0.00431133878367396
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNN,Tenascin-N,37437,0.0120995816500649,0.00424617545281685,0.00377707776254389,0.0204220855375859,0.00438504995095988
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH23,Cadherin-23,37388,-0.00755908531673296,0.00265292066050263,-0.0127588098113181,-0.00235936082214781,0.00438755420001065
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNXB,Tenascin-X,39858,-0.00721275635828999,0.0025388243356114,-0.0121888520560883,-0.00223666066049164,0.00450315458730101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0181488101305182,0.00640381921880428,0.0055973244616618,0.0307002957993746,0.00460285951953469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF3,Trefoil factor 3,39839,0.0135203154654542,0.00478531409240556,0.00414109984433929,0.0228995310865691,0.00472835917048889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH7B,Myosin-7B,36962,-0.0122746127807233,0.00434554828286264,-0.0207918874151341,-0.00375733814631253,0.00474051594215536
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0118609437775007,0.00421298818796318,0.00360348692909287,0.0201184006259085,0.00488002051396291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0190260701456487,0.00678940266370621,0.00571884092478447,0.0323332993665128,0.00508100449952083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.01129465621634,0.00403204054823144,-0.0191974556908736,-0.00339185674180634,0.00509831702578685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,40009,0.00746334916935744,0.00266595938933658,0.00223806876625774,0.0126886295724571,0.00512427962099504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.0161960591087001,0.00578587210440297,0.00485574978407033,0.02753636843333,0.0051283335138048
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0811513960248262,0.0290163465153611,0.0242793568547184,0.138023435194934,0.0051681446384281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.00783241527350185,0.0028021695862443,0.00234016288446303,0.0133246676625407,0.00519541274957346
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.0079483268768549,0.00284715037415735,-0.0135287416102033,-0.0023679121435065,0.00525110004735192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD9,COMM domain-containing protein 9,37368,0.0108050876119532,0.0038790316527009,0.0032021855726594,0.0184079896512469,0.00535177918926429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPN,Asporin,37437,0.00742191056085673,0.0026651887823827,0.00219814054738663,0.0126456805743268,0.0053641573075225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00727114775968318,0.00261267484163069,-0.0123919904492793,-0.00215030507008703,0.0053917551672958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN2,Contactin-2,40030,0.0121603655395783,0.00437325715100007,0.00358878152361812,0.0207319495555384,0.00543179789158212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00222103424042871,0.000798772749555202,-0.00378662882955691,-0.000655439651300517,0.00543413092384745
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BEX3,Protein BEX3,36962,-0.0128236857158402,0.0046228339991471,-0.0218844403541685,-0.00376293107751186,0.00554520957613308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDRG1,Protein NDRG1,39489,0.018956329401098,0.00684115429826099,0.00554766697650647,0.0323649918256895,0.0055963248632987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.0152885456586563,0.0055173597585012,0.00447452053199398,0.0261025707853187,0.0055965019062673
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0190673049060898,0.00688623428295965,0.00557028571148888,0.0325643241006907,0.00563096035932145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0178201002332013,0.00643763751338237,0.0052023307069719,0.0304378697594308,0.00564611220491104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00807672917092425,0.00293544241822519,0.00232326203120287,0.0138301963106456,0.00594126511609331
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPP1,Osteopontin,40012,-0.0122211306814914,0.00444247756954774,-0.020928386717805,-0.00351387464517782,0.00594849406132549
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0193897055141833,0.00705422336402761,-0.0332159833076775,-0.00556342772068923,0.00599200349121294
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF1,Trefoil factor 1,39789,0.0202437543695099,0.00742621946858166,0.00568836421108989,0.03479914452793,0.00641802125351913
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KEL,Kell blood group glycoprotein,39489,0.00954169644358575,0.00350455013738734,0.00267277817430657,0.0164106147128649,0.00648306113359028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM1,Myomesin-1,36991,0.0127460218881323,0.00468260569984393,0.00356811471643816,0.0219239290598264,0.00649750322230416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0142658850862532,0.00524275922553707,0.00399007700420052,0.0245416931683058,0.00651575187064179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.012689258002941,0.00469603230484653,-0.0218934813204402,-0.00348503468544183,0.00689865452703972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0118075065420011,0.00437251722324906,-0.0203776402995693,-0.00323737278443297,0.00693456057059314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACHE,Acetylcholinesterase,37124,0.00870868114013616,0.00323006311101826,0.00237775744254036,0.015039604837732,0.00702380835029142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00740076645724144,0.00275136868805383,-0.0127934490858269,-0.00200808382865593,0.00715745018795483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF2,Trefoil factor 2,39908,0.0150549443828538,0.00563048179332896,0.00401920006792908,0.0260906886977786,0.0075066641987808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00777798001179845,0.00290905938117455,0.00207622362469634,0.0134797363989006,0.00751098482393748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.0257008195141893,0.00966599834237003,0.00675546276314404,0.0446461762652346,0.00784939444006579
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.0235921719012796,0.00887384760887694,-0.0409849132146784,-0.00619943058788076,0.00785569671149145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00866723037646487,0.00326285652437176,-0.0150624291642335,-0.00227203158869623,0.00790744935558511
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK15,Kallikrein-15,37351,0.0131691080399806,0.0049795464689447,0.00340919696084898,0.0229290191191122,0.0081872551656485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP7,Retinoid-binding protein 7,37382,0.0157505365866777,0.00595635963933655,0.00407607169357804,0.0274250014797773,0.00819491200744646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,37056,0.0144530434337423,0.005479098582116,0.00371401021279492,0.0251920766546896,0.00835312023771921
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL1,Follistatin-related protein 1,37043,-0.00596672963626626,0.00226715893135072,-0.0104103611417137,-0.00152309813081886,0.00850304685685866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.0119465706309721,0.00455702706043709,0.00301479759251541,0.0208783436694288,0.00876250670810981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0332285430504024,0.0127367603316138,-0.0581925933003654,-0.00826449280043937,0.00909256379439484
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0383888702902031,0.01473846054264,0.00950148762662865,0.0672762529537776,0.00920469882404525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0144475857818268,0.00556669152537002,0.00353687039210162,0.0253583011715521,0.00945959224639705
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00807564840114646,0.00311952175980467,-0.0141899110503636,-0.0019613857519293,0.00964123317469932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.012958435025621,0.00501488250976908,-0.0227876047447684,-0.00312926530647359,0.00977697285805581
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.019942943003125,0.00774462909945397,0.0047634699681952,0.0351224160380548,0.0100309204091427
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00713143080143183,0.00278111905159958,-0.012582424142567,-0.00168043746029665,0.0103515005488638
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00673650637695962,0.00262720093612154,-0.0118858202117578,-0.0015871925421614,0.0103542132519347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0128357808606696,0.00501340561229181,0.00300950586057765,0.0226620558607615,0.0104695441006955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.00993493681909857,0.00388829099427514,0.00231388647031929,0.0175559871678779,0.0106268523797433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX5,Syntaxin-5,37056,0.0102641772375022,0.00402450423374113,0.00237614893936957,0.0181522055356348,0.0107705070788824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC1,Hamartin,37056,0.0192532843403829,0.00755271897903644,0.00444995514147146,0.0340566135392943,0.0108086891757073
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00869283781927281,0.00342065465245126,0.00198835470046834,0.0153973209380773,0.0110541285967141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0157349674941726,0.00619728107968618,-0.0278816384103575,-0.00358829657798765,0.0111280177120088
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.0102763698177775,0.0040664074623218,-0.0182465284439282,-0.00230621119162677,0.0115112679005041
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GL3,Endophilin-A3,37083,0.0206072099408496,0.0081550096183736,0.00462339108883732,0.0365910287928618,0.0115177181364768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL19,Interleukin-19,39419,0.017104571193088,0.00677406173042196,0.00382741020146099,0.0303817321847151,0.0115793646128086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.0035978036071453,0.00142901373344456,0.000796936689593962,0.00639867052469664,0.0118243947767356
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA10,Annexin A10,39489,0.0194426236639582,0.0077393913446326,0.0042734166284783,0.0346118306994381,0.0120093078814482
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.015208343677676,0.00608611991289095,-0.0271371387069422,-0.00327954864840971,0.0124715748278962
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.01441637256382,0.00576999770485596,0.00310717706230226,0.0257255680653376,0.0124839362772018
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0168612851805276,0.00675974985404052,0.00361217546660817,0.030110394894447,0.0126303981713359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00761981608769311,0.00305668210791293,-0.0136109130192025,-0.00162871915618377,0.0126825701927855
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESPL1,Separin,36962,-0.0132199322395991,0.00531456109432413,-0.0236364719844744,-0.00280339249472383,0.0128770480401247
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00654145607026412,0.00265588692637522,0.00133591769456869,0.0117469944459596,0.0137885309674902
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0110718151398037,0.00450072117602829,0.00225040163478829,0.0198932286448192,0.0139040249143323
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00695213939919223,0.0028452990800337,-0.0125289255960583,-0.00137535320232618,0.0145635899455712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00484514039440448,0.00199100065442463,0.000942779111732205,0.00874750167707675,0.0149659826135005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00720061669498461,0.0029834677388662,-0.0130482134631624,-0.00135301992680686,0.0158110381819867
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00891773153482863,0.00370435605315835,0.00165719367063827,0.016178269399019,0.0160818075438771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXDNL,Peroxidasin-like protein,37368,0.0141490758591437,0.00588159565340001,0.00262114837847965,0.0256770033398077,0.0161569620642705
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0132358955957686,0.0055168032076622,-0.0240488298827865,-0.00242296130875065,0.0164424577146062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.00870849300185991,0.00363419279058789,0.00158547513230763,0.0158315108714122,0.016576777308781
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO1,Alpha-enolase,39830,0.0186892363339547,0.00780323285260379,0.00339489994285125,0.0339835727250581,0.0166289460924175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0138327611509534,0.00578060784523772,0.00250276977428744,0.0251627525276193,0.0167245720603749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSMB,Beta-microseminoprotein,39780,0.0158340836104035,0.0066230433439285,0.00285291865630365,0.0288152485645034,0.0168252489569359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00889828906434682,0.0037244207819969,0.00159842433163289,0.0161981537970608,0.0168999416934339
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPN1,Epsin-1,37169,0.0100837107057433,0.00425452936464727,0.00174483315103462,0.0184225882604519,0.0177968743175652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0144987280809936,0.0061293705224601,0.00248516185697182,0.0265122943050154,0.0180199583792378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN1,Prorelaxin H1,37411,-0.0187659899005234,0.00796762731647797,-0.0343825394408203,-0.00314944036022663,0.0185229478837597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0203951301737291,0.00876434929706204,0.00321700555148752,0.0375732547959707,0.0199773863565198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.0119601780538305,0.00514411409568125,0.0018777144262952,0.0220426416813657,0.020085748265071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00696887016769877,0.0030095790769777,-0.0128676451585751,-0.00107009517682247,0.0205950272785274
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL11,Interleukin-11,39587,0.0142132989567333,0.00614463394268419,0.00216981642907225,0.0262567814843943,0.0207286700556633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00578830838306975,0.00250438982681332,-0.0106969124436239,-0.000879704322515634,0.0208331804614433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.0107628193463492,0.00466262952349147,-0.0199015732123924,-0.00162406548030587,0.020997005565574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00853252836102464,0.003707551744742,0.00126572694133031,0.015799329780719,0.0213849329417808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEG1,Protein LEG1 homolog,36703,-0.0159067273224694,0.00691217018472126,-0.0294545808845231,-0.00235887376041576,0.0213926556120953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.0144113166810686,0.00627230391063206,0.00211760101622976,0.0267050323459074,0.0215995317295145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3G,Semaphorin-3G,37124,0.00994150061112658,0.00432879787558751,0.00145705677497506,0.0184259444472781,0.0216573268736883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR4,Proline-rich protein 4,37031,-0.0158494371397887,0.00690385971052634,-0.0293810021724203,-0.00231787210715705,0.0217066325340156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00729258042516223,0.00320281642672811,-0.0135701006215493,-0.00101506022877513,0.0228065762194824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0139248524331122,0.00612587139951655,0.00191814449005973,0.0259315603761646,0.0230322630446415
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17C,Interleukin-17C,39587,-0.0148601672688308,0.00655991223579687,-0.0277175952509927,-0.00200273928666896,0.0235078352642803
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MELTF,Melanotransferrin,37437,0.00649959164397559,0.00287034886771387,0.000873707863256407,0.0121254754246948,0.0235657889916077
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.019300427126184,0.00854048913087081,0.00256106842967726,0.0360397858226908,0.0238454382050458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36A,Interleukin-36 alpha,37056,-0.0130152875123456,0.00581617975887644,-0.0244149998397434,-0.00161557518494779,0.0252525091664638
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRTN,Neurturin,39587,0.010912562358141,0.00490226946504915,0.00130411420664471,0.0205210105096374,0.0260267864570255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGM2,Phosphoglucomutase-2,37039,0.0133038026353677,0.0059807273421862,0.00158157704468276,0.0250260282260526,0.0261353503610638
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00723784622024928,0.00326579141598746,-0.0136387973955847,-0.000836895044913856,0.0266901454255012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.0043961143549767,0.0019923917989868,-0.00830120228099084,-0.000491026428962564,0.0273696617480486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.00731687521489863,0.00332093164487396,0.000807849190945665,0.0138259012388516,0.0275906418116694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00779534558624491,0.00354046173925465,0.000856040577305799,0.014734650595184,0.0276973927171034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0140201594100038,0.00636798860390252,-0.0265014170736528,-0.00153890174635489,0.0277063176944473
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGN,Secretagogin,39587,-0.00936154547175703,0.00425596738706823,-0.0177032415504108,-0.0010198493931033,0.0278477881974599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00716453805580876,0.00325722199025533,-0.0135486931567092,-0.000780382954908315,0.0278505082218208
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.0112460276767858,0.00511667099644308,0.00121735252375733,0.0212747028298142,0.0279730572525537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN15,Tetraspanin-15,37021,-0.0107167844494629,0.00487757036862173,-0.0202768223719615,-0.00115674652696434,0.0280266512653568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPE,Coatomer subunit epsilon,39489,0.010241301817755,0.00467314655086587,0.0010819345780579,0.0194006690574521,0.0284287696513919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0149207921738019,0.00681287907543032,0.00156754918595843,0.0282740351616453,0.0285327139471531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0154800998238422,0.00707819101512636,-0.0293533542134899,-0.00160684543419455,0.0287590723610196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH17,Cadherin-17,39868,-0.0143358218031402,0.00655878813901076,-0.0271910465556013,-0.00148059705067912,0.0288488891948596
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX33,Testis-expressed protein 33,37169,-0.00855459120132876,0.00392272776488164,-0.0162431376204968,-0.000866044782160756,0.0292174257977704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00860549789450127,0.00396909118987251,0.00082607916235115,0.0163849166266514,0.0301635184437083
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0139936977532156,0.00647282898615112,-0.0266804425660718,-0.00130695294035943,0.0306396519414965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGB,Secretogranin-1,39952,0.00840540967446354,0.0038942366694744,0.000772705802293714,0.0160381135466334,0.0309097059749572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MN1,Transcriptional activator MN1,37039,-0.0125996295880747,0.00584574435430094,-0.0240572885225046,-0.00114197065364489,0.0311524461026259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP10,Bone morphogenetic protein 10,37124,-0.00600727570025917,0.00279355200671533,-0.0114826376334212,-0.000531913767097119,0.0315409978520241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.0104195567834809,0.00484655012481577,-0.0199187950281198,-0.000920318538841952,0.0315818678818926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.0170522285026745,0.00794317657507388,-0.0326208545898193,-0.00148360241552969,0.0318293424359141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00705492985640727,0.00330495919380552,-0.0135326498762661,-0.000577209836548445,0.0328080615880863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00760461158713499,0.00357022691660163,0.000606966830595799,0.0146022563436742,0.0331894255007391
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00666802598188545,0.00314858204007393,0.000496805183340551,0.0128392467804303,0.0342112730264134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPTC,Opticin,39788,-0.00920796498283917,0.004350087936162,-0.0177341373377167,-0.000681792627961642,0.0342981668106049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GKN1,Gastrokine-1,39123,0.00587428162315085,0.00277518196321214,0.00043492497525505,0.0113136382710467,0.0342998024055521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0183248576562196,0.00869174473615444,0.00128903797335691,0.0353606773390823,0.0350204147917614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM25,Transmembrane protein 25,37411,-0.00931480452421951,0.00442094906203878,-0.0179798646858155,-0.000649744362623503,0.0351385589958607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00634179899788177,0.00302814623675595,0.000406632373840117,0.0122769656219234,0.0362506298143857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTNNA1,Catenin alpha-1,36991,-0.00726749682149462,0.00347066512211049,-0.0140700004608312,-0.000464993182158065,0.0362810548420504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36G,Interleukin-36 gamma,37021,0.0139147145073373,0.00666535366707001,0.000850621319880087,0.0269788076947945,0.0368514601315486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX1B,Syntaxin-1B,37039,0.00872530185858438,0.00419818723465602,0.000496854878658585,0.0169537488385102,0.0376964506105004
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG3,Secretogranin-3,39885,-0.00664287767463521,0.00319893966422466,-0.0129127994165155,-0.000372955932754881,0.0378555583693236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00654438610368328,0.00315307910071606,0.000364351066279798,0.0127244211410868,0.0379546330224309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0102536392435416,0.00494678209951187,0.000557946328498288,0.0199493321585848,0.0382107494746438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00750620581343463,0.00366911568835618,-0.0146976725626127,-0.000314739064256519,0.040797882510963
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,37382,0.016033483564734,0.00783762544137296,0.000671737699643028,0.031395229429825,0.0408045338797852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REST,RE1-silencing transcription factor,36962,-0.00721201884002409,0.00352568100351444,-0.0141223536069124,-0.000301684073135782,0.0408188589972861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGN,Mimecan,39858,0.00796891061116179,0.0038984308428996,0.000327986159078579,0.015609835063245,0.0409567610271395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1,Integrin beta-1,39862,0.00437026475171218,0.00214365281464659,0.000168705235004866,0.0085718242684195,0.0414963905362728
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_DRA,,39799,-0.00713922033941452,0.00350261980381747,-0.0140043551548968,-0.000274085523932266,0.0415412517354125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROK1,Prokineticin-1,39866,0.0129906183291179,0.00639402518963259,0.000458328957438071,0.0255229077007978,0.0422024632401123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT2,Angiopoietin-2,40030,-0.0076373434717982,0.00376021973648769,-0.0150073741553141,-0.000267312788282329,0.0422622231607561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00604153377713454,0.00297605263717314,0.000208470608275184,0.0118745969459939,0.0423683183973036
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERVV_1,,37021,-0.00947205673074791,0.00475254593197929,-0.0187870467574273,-0.000157066704068509,0.0462766978098564
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0126209395248031,0.00633600641961264,0.000202366942362349,0.0250395121072439,0.0463950999432395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA11,Serpin A11,40052,-0.00803768306449765,0.0040379966009364,-0.015952156402333,-0.000123209726662301,0.0465512812678726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00640754869508409,0.00322491705566129,8.6711265987964e-05,0.0127283861241802,0.0469522503778996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.00977834962128474,0.00493367267548249,0.000108351177339049,0.0194483480652304,0.0475042820817795
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00707076278385224,0.00356795449208352,7.75719793685405e-05,0.0140639535883359,0.0475284095325965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,-0.010939019405121,0.00553338835148172,-0.0217844605740252,-9.35782362168364e-05,0.0480685882594149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00789442687117022,0.00399620687513028,-0.0157269923464256,-6.18613959148754e-05,0.0482345569812181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00905178713247583,0.00458947540943859,5.64153299761911e-05,0.0180471589349755,0.0485932796781613
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.0128578929898841,0.00656458055443986,-0.0257244708765862,8.68489681799672e-06,0.0501716834828114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31,Interleukin-31,37056,-0.0110938670411909,0.00567873328300043,-0.0222241842758717,3.64501934899623e-05,0.0507718557168137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0116603608162841,0.00597883736649213,-0.0233788820546086,5.81604220404892e-05,0.0511614147542968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_A,,37411,0.00616278878217634,0.0031896771477667,-8.89784274463838e-05,0.0124145559917991,0.0533674591302429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0144719870236273,0.00753928804128263,-0.0292489915845413,0.000305017537286621,0.0549366332934973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00745443999670546,0.00388391827430426,-0.000158039820930899,0.0150669198143418,0.0549667582007815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00483455925955038,0.00252194971525349,-0.00977758070144721,0.000108462182346456,0.0552598204679496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.0064031739348704,0.00334761613673243,-0.012964501562866,0.000158153693125153,0.055800864185582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00919484438126291,0.00482144999177838,-0.0186448863651485,0.000255197602622723,0.0565293434255698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WNT9A,Protein Wnt-9a,39587,0.00529360490238784,0.00277753023951923,-0.00015035436706984,0.0107375641718455,0.056685598198061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.00655001295083399,0.00343764160479391,-0.000187764594562084,0.0132877904962301,0.0567486255554882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00747663098282382,0.00392503601634211,-0.000216439609206718,0.0151697015748543,0.0568204831737178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00746621418761355,0.00392324782664622,-0.0151557799278401,0.000223351552613032,0.0570532449653396
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,39667,-0.00712850950565264,0.00375532134214425,-0.0144889393362554,0.000231920324950087,0.0576823794178098
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00480782889290831,0.00253337742598881,-0.00977324864784638,0.000157590862029761,0.0577443814181631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00730318089929738,0.00384846317562979,-0.000239806924937015,0.0148461687235318,0.0577591061954363
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0140481332983665,0.0074085715317683,-0.0285689335006324,0.000472666903899332,0.0579555342588419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0056603574102996,0.00299340281368155,-0.00020671210451623,0.0115274269251154,0.0586531529578954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL2,Chordin-like protein 2,39868,0.0104967905299944,0.00556117269021428,-0.00040310794282559,0.0213966890028144,0.0591093169332148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00639165263289517,0.00340025824616184,-0.0130561587953724,0.000272853529582039,0.060163481891075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00978199449126852,0.00520576525957648,-0.0199852944000384,0.00042130541750139,0.0602572422560002
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00911632639137131,0.00488800867349025,-0.00046417060866958,0.0186968233914122,0.0621946757056013
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCG22,Protein PBMUCL2,37021,-0.00998344535872915,0.00535296610880304,-0.0204752589319831,0.000508368214524813,0.0621993589499964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0112707601936809,0.00605106651732914,-0.023130850567646,0.000589330180284219,0.0625398627275754
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00674469763292898,0.003623290704244,-0.0138463474132472,0.000356952147389251,0.0626981361941399
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.0091328457794879,0.0049072111535452,-0.0187509796404365,0.000485288081460688,0.0627513269665997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA3,Carbonic anhydrase 3,40017,0.0110670120518717,0.00594829154575523,-0.000591639377808586,0.0227256634815519,0.0628278487789797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00919736250628966,0.00495462519263372,-0.000513702871272429,0.0189084278838518,0.0634305034131389
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUCL3,Mucin-like protein 3,36962,-0.00822491281153404,0.0044430136007066,-0.016933219468919,0.000483393845850902,0.0641630786427185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0109154734776317,0.00591960684559967,-0.022517902895007,0.000686955939743704,0.0652083553139238
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEF,Thyrotroph embryonic factor,37021,0.00771788032192754,0.00419012720174659,-0.000494768993495768,0.0159305296373509,0.0655092945250724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0119964956525659,0.00652150012863435,-0.0247786359046892,0.000785644599557447,0.0658598185893775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00887587920530892,0.00482811336318531,-0.000587222986534287,0.0183389813971521,0.0660292218351261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00486278750594813,0.00264880113586504,-0.000328862720347347,0.0100544377322436,0.0664025648054359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0467259618332256,0.0255367296957197,-0.0967779520368362,0.00332602837038506,0.0673091356304317
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00974794825289278,0.00533156398095568,-0.000701917149780344,0.0201978136555659,0.0675165615243729
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0152879118592124,0.00836352742743991,-0.00110460189856986,0.0316804256169946,0.0675832069280486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00598252796864739,0.00328424294285072,-0.0124196441366348,0.000454588199340018,0.0685366306410653
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.005400396929669,0.00296691825835872,-0.0112155567160521,0.00041476285671409,0.0687506753483596
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00858077502859962,0.00471928714293931,-0.0178305778287607,0.000669027771561423,0.0690508801790403
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOP56,Nucleolar protein 56,37021,0.0198104967692216,0.0109018939985864,-0.00155721546800777,0.0411782090064509,0.0692151939260712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00779717124513413,0.0042939071645433,-0.016213229287639,0.000618886797370748,0.069413325051695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.0103438786465254,0.00570110580047461,-0.000830288722404836,0.0215180460154556,0.069644581515427
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.0083124199999138,0.00458561169216335,-0.000675378916726362,0.017300218916554,0.069898129498862
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.0100842663978159,0.00557410186947419,-0.0210095060619853,0.000840973266353507,0.0704539064425024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN2,Neuroligin-2,36991,-0.00842449428512135,0.00465772861975365,-0.0175536423798385,0.00070465380959581,0.07051846658458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELENOP,Selenoprotein P,37453,0.00396535132862642,0.00219497135711434,-0.000336792531317694,0.00826749518857053,0.0708527415320811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.01494215261075,0.00827522377975176,-0.0311615912190635,0.00127728599756346,0.0709953788850113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA5,Annexin A5,39415,0.00537903604331157,0.00298857056763463,-0.000478562269252311,0.0112366343558754,0.0719006673069025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPE4,NXPE family member 4,37021,-0.00620839749261097,0.00345237470787808,-0.012975051920052,0.000558256934830065,0.0721527511478972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00684042925135338,0.00380470095927417,-0.000616784628823985,0.0142976431315307,0.0722169200038395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.00310873482503408,0.00173856758996667,-0.000298857651300592,0.00651632730136875,0.0737819452438927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00649281576616041,0.00363924242742349,-0.0136257309239105,0.000640099391589638,0.0744285132548493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00693854988224373,0.00389789939044865,-0.000701332923035618,0.0145784326875231,0.0750862306439704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPT,Microtubule-associated protein tau,39489,0.0092561354315351,0.00520087178136219,-0.000937573259934788,0.019449844123005,0.0751399649406165
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00595519241169616,0.00335461759220932,-0.000619858069034111,0.0125302428924264,0.0758800264690761
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00993719479956392,0.00562882788199519,-0.00109530784914665,0.0209696974482745,0.0775142356694112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0121195852298948,0.00688511283860816,-0.00137523593377718,0.0256144063935668,0.0783864142348572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0101931286329272,0.00579286137948412,-0.0215471369367161,0.00116087967086168,0.0784942478455212
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD8,Frizzled-8,36991,0.00739672638494256,0.0042063338132153,-0.000847687888959428,0.0156411406588446,0.0786902752540466
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00809361494846444,0.00460945447295123,-0.000940915818519969,0.0171281457154489,0.0791334182489432
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.00598686086205777,0.00341142913592922,-0.000699540244363494,0.012673261968479,0.079288273992075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0147550519879276,0.00842084133905352,-0.0312599010124725,0.00174979703661733,0.0797615732583754
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00821570501328049,0.0047025501048079,-0.001001293192143,0.017432703218704,0.0806470823679812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00472334331410685,0.00271148923688503,-0.000591175590187805,0.0100378622184015,0.0815321746352499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00788865524404497,0.00456231137143353,-0.0168307855320547,0.00105347504396476,0.0838161137984797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1B,Lithostathine-1-beta,40052,0.00927290546329871,0.00536324845143832,-0.00123906150152039,0.0197848724281178,0.0838331985990211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL1,Interferon lambda-1,39489,0.0076269147015301,0.00443443581810538,-0.00106457950195645,0.0163184089050166,0.0854651476779962
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JUN,Transcription factor AP-1,39587,0.00880242210061729,0.00512612133997319,-0.00124477572573015,0.0188496199269647,0.0859677918648557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB2,Integrin beta-2,39731,-0.00486607048387111,0.00283673070864415,-0.0104260626728136,0.000693921705071437,0.086295139668087
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG3,Proteoglycan 3,37437,-0.00845127242855221,0.00493697864722056,-0.0181277505771045,0.00122520572000009,0.086950679765305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POF1B,Protein POF1B,37056,0.00764611605563254,0.00447194850252912,-0.00111890300932453,0.0164111351205896,0.0873272611913796
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00430193820377553,0.00253182557332751,-0.00926431632749744,0.000660439919946386,0.0893156475579369
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNG,Uracil-DNA glycosylase,37368,0.00582436497560293,0.00342814989696299,-0.000894808822444529,0.0125435387736504,0.0893456016896626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00547824370718735,0.00322555384215362,-0.000843841823433747,0.0118003292378084,0.0894543567808879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.0104795258540809,0.00617254955057614,-0.0225777229732102,0.00161867126504829,0.089575891625487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00724741995004223,0.00427039444975998,-0.0156173930715718,0.00112255317148733,0.0896954273457986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00775252749423688,0.00457546297816169,-0.00121537994296003,0.0167204349314338,0.0902186439196091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00560117449612845,0.00331377278422689,-0.000893820160956243,0.0120961691532132,0.090999775308001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOC,Myocilin,39858,-0.00766515214536633,0.00453643261232982,-0.0165565600655328,0.00122625577480011,0.0911072964887386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAGLN3,Transgelin-3,36962,-0.00996976413464535,0.00590783256207992,-0.021549115956322,0.00160958768703129,0.0915214041903764
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00776325371870985,0.00461330656670052,-0.00127882715202318,0.0168053345894429,0.0924383141422574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00953526066360945,0.00567766637338402,-0.00159296542822323,0.0206634867554421,0.0930907650260314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00896980597772478,0.00535670255141102,-0.0194689429784904,0.00152933102304082,0.0940558570217697
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0129203229462418,0.00774333481059801,-0.00225661328253032,0.0280972591750139,0.0952218507241712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX9,Transcription factor SOX-9,37039,0.00445380545579309,0.00266931024132855,-0.000778042617210873,0.00968565352879706,0.0952357100727279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0052536439498294,0.00315066853906016,-0.000921666386728512,0.0114289542863873,0.0954409803805218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSP90B1,Endoplasmin,39405,0.0111084435140614,0.00666269759623787,-0.00195044377456482,0.0241673308026876,0.0954830297949933
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK12,Kallikrein-12,39477,-0.02265965802739,0.0136068586019534,-0.0493291008872187,0.0040097848324387,0.0958706845212138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00804611147243766,0.00483186322728649,-0.0175165633979192,0.00142434045304387,0.0958928852873116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0110941634261242,0.0066730765686525,-0.0241733935006831,0.00198506664843467,0.0964311636390269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.0111656219355672,0.0067208743045451,-0.0243385355724756,0.0020072917013412,0.0966699921995659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5A,Cytochrome b5,36962,0.0117048808198247,0.00707981791008837,-0.00217156228394854,0.0255813239235979,0.0982990139375135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0159072140013549,0.00962188689912703,-0.0347661123236438,0.00295168432093409,0.098307450140497
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPLX2,Complexin-2,36962,-0.00488278508036989,0.00296342061926459,-0.0106910894941285,0.000925519333388714,0.0994412112756105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAN,Neurocan core protein,40009,0.00595420455539139,0.0036244343023203,-0.00114968667715639,0.0130580957879392,0.100444709437464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00976083658907841,0.00594597632032623,-0.0214149501769178,0.001893276998761,0.100699482716692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00764217051012631,0.00467381063356236,-0.0168028393519085,0.00151849833165592,0.102050980891448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0104655608734606,0.00640229069129834,-0.0230140506284053,0.00208292888148417,0.102140353456111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAPPA,Pappalysin-1,39587,0.00763566790635974,0.00468638626194029,-0.00154964916704323,0.0168209849797627,0.1032632884781
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM132A,Transmembrane protein 132A,37043,0.0101027409944403,0.00620165733054039,-0.00205250737341889,0.0222579893622994,0.10332867902619
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTN,Neuroplastin,39477,0.0134822989147645,0.00829419577552398,-0.0027743248052625,0.0297389226347915,0.104074093838192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00370776949134256,0.002281167418157,-0.000763318648245165,0.00817885763093028,0.10410091801891
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF12,Fibroblast growth factor 12,37056,0.0075212062228421,0.00463187513778659,-0.00155726904721962,0.0165996814929038,0.104443888569682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHIT1,Chitotriosidase-1,39906,0.0240581924167895,0.0148863834582667,-0.00511911916141324,0.0532355039949923,0.106087878960893
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLNL,Mesothelin-like protein,37039,-0.00576638601624025,0.00358429943099556,-0.0127916129009915,0.00125884086851103,0.107686163562852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTKN2,Rhotekin-2,37021,-0.0082529323966337,0.00513412225810101,-0.0183158120225117,0.00180994722924428,0.107975938303154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00392607517321754,0.00244982550802695,-0.00087558282251528,0.00872773316895036,0.10904761203977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00408618044345508,0.002565900969519,-0.000942985456802166,0.00911534634371233,0.111293713448642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.0092264160393172,0.00579831028477235,-0.0021382721188366,0.020591104197471,0.111582935106758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0137763372553017,0.0086782986591456,-0.00323312811662364,0.0307858026272271,0.112435679555706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L,Seizure 6-like protein,39913,0.00420992308960716,0.0026574810150273,-0.000998739699846352,0.00941858587906068,0.113172905311287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL33,Interleukin-33,39587,0.00611355012473425,0.00386551314119244,-0.00146285563200294,0.0136899558814714,0.113769619211348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6,Seizure protein 6 homolog,37039,-0.00483652805607392,0.00307142563604812,-0.0108565223027282,0.0011834661905804,0.115353161925373
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRC,Chymotrypsin-C,39856,0.00955112835549752,0.00609439770218528,-0.00239389114078562,0.0214961478517807,0.117088180513596
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.0128610586292426,0.00821668151603527,-0.00324363714218652,0.0289657544006717,0.117551291879315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.0120735665888571,0.00771850155677865,-0.00305469646242902,0.0272018296401433,0.117785904553445
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTN3,Myeloblastin,39421,0.00713821898666968,0.00456480471817594,-0.00180879826095517,0.0160852362342945,0.117896336770005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTTG1,Securin,37169,0.00642012286711486,0.00412305075895454,-0.00166105662043604,0.0145013023546657,0.119463583040731
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00366120202448814,0.00235188737800713,-0.000948497236405828,0.00827090128538211,0.119559563032677
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,37124,0.00605757373592767,0.00390904326676814,-0.00160415106693789,0.0137192985387932,0.121254020609954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBLN2,Fibulin-2,37437,-0.0046286993498048,0.00299122811151524,-0.0104915064483747,0.00123410774876507,0.121784250034774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0105964353807505,0.00685114368542034,-0.0240246770041744,0.00283180624267335,0.12196775035315
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1B,Protein phosphatase 1B,37056,0.0097441675344087,0.00630167736896733,-0.00260712010876727,0.0220954551775847,0.122060562648847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00737161466943245,0.00476981553707665,-0.0167204531221027,0.00197722378323778,0.122256232831112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00841747070092356,0.00544988323583492,-0.01909924184316,0.00226430044131289,0.122485632350516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRXN3,Neurexin-3,37039,0.00534256426356803,0.00346592911763636,-0.00145065680699923,0.0121357853341353,0.123230763009613
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00619847351815154,0.00402327113405862,-0.0140840849409064,0.00168713790460337,0.123424826686426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN4,Alpha-actinin-4,39587,0.00477695202312568,0.00310074788081854,-0.00130051382327865,0.01085441786953,0.123439012032196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0182513248856377,0.0118888574164335,-0.00505083565057188,0.0415534854218473,0.124764240746686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.0103682693733213,0.00675790845662019,-0.00287723120165424,0.0236137699482969,0.124994015320013
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.006557501347924,0.00429649192793681,-0.00186362283083214,0.0149786255266801,0.126972505592133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00689358189984482,0.00453639838841499,-0.0157849227411382,0.00199775894144856,0.128631564947714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR1B,Cornifin-B,37169,0.013152485998882,0.00866039347545097,-0.00382188521300192,0.0301268572107659,0.128863337650189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00735460080565407,0.00485702203435615,-0.0168743639929921,0.00216516238168398,0.129989730662501
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD1,Glutamate decarboxylase 1,36962,-0.00387929788380978,0.00256206783770421,-0.00890095084571003,0.00114235507809047,0.130017575935711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKLR,Pyruvate kinase PKLR,39881,0.00952360764893081,0.00631064417427314,-0.00284525493264455,0.0218924702305062,0.13128426370698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB5,Integrin beta-5,39913,0.00564835806727591,0.00374497697886353,-0.0016917968112966,0.0129885129458484,0.131510470488563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0145455230686975,0.00964597753785652,-0.00436059290550133,0.0334516390428962,0.13159412738047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00434342807365348,0.00288274658783216,-0.00130675523849756,0.00999361138580452,0.131911389275309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4C,Semaphorin-4C,39788,0.00419996219018944,0.00279405397841654,-0.00127638360750698,0.00967630798788585,0.132812816114685
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL1,Delta-like protein 1,39913,0.00420520908446286,0.00280431930080733,-0.00129125674511952,0.00970167491404523,0.133751405075134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0100179602538347,0.00669829956748416,-0.0231466274061036,0.00311070689843428,0.134782513047262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL9,Interleukin-9,37169,-0.00844638367340649,0.00565782618403427,-0.0195357229941137,0.00264295564730069,0.135495631655543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00779068615722132,0.00522606561895428,-0.00245240245592907,0.0180337747703717,0.136054793302241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKAP12,A-kinase anchor protein 12,37124,-0.00308605593663373,0.00208347394673559,-0.00716966487223549,0.000997552998968031,0.138575208044739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00622791265201004,0.00421071759885531,-0.00202509384174637,0.0144809191457664,0.139143328324997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00434473422500065,0.00294387546175016,-0.010114730130031,0.00142526168002966,0.140006599469329
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1A,Interleukin-1 alpha,39587,0.00778194825524598,0.00527303776021448,-0.00255320575477441,0.0181171022652664,0.140017655137167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0134924711777172,0.0091582687386283,-0.00445773554999429,0.0314426779054286,0.1407061369209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00607565229347109,0.00413851185035282,-0.00203583093322045,0.0141871355201626,0.142107322313449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN2,Prorelaxin H2,37095,0.0205916854394676,0.0140265596213966,-0.00690037141846974,0.048083742297405,0.142114510777972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00693844691163597,0.00473509714947764,-0.0162192373246121,0.00234234350134021,0.142856630531032
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN1,Transcobalamin-1,37235,0.00493161961609351,0.00338026051494469,-0.00169369099319808,0.0115569302253851,0.144603286353826
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAV,Integrin alpha-V,40030,-0.00237844979951972,0.00163247523499869,-0.00557810126011715,0.000821201661077707,0.145147062936838
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH2,Growth hormone variant,39477,0.0236375835107556,0.0162364690571993,-0.00818589584135505,0.0554610628628662,0.145458959724578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.0066087025945935,0.00454220487528653,-0.0022940189609681,0.0155114241501551,0.145701397225375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00470445591586186,0.0032466302896681,-0.00165893945188762,0.0110678512836113,0.147353744861781
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00737221825273032,0.00509988220884659,-0.0173679873820696,0.002623550876609,0.14832264065757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBH,Dopamine beta-hydroxylase,37430,-0.0155447352510103,0.0107630427589083,-0.0366402990584707,0.00555082855644998,0.148686246418491
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAND5,DAN domain family member 5,37056,-0.00764969123214925,0.00530766147383364,-0.0180527077208632,0.00275332525656469,0.149536511614707
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP13,Collagenase 3,39489,-0.00456347448280574,0.00316966678144021,-0.0107760213744286,0.00164907240881708,0.149962926722283
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0168560293973398,0.0117132405521862,-0.00610192208494512,0.0398139808796248,0.150153730266269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00684839413285669,0.0047742209682671,-0.0162058672306602,0.00250907896494682,0.151466846815919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSN,Gelsolin,37383,-0.00263942780835767,0.00184215160422859,-0.00625004495264569,0.000971189335930361,0.151939205285936
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00455540013661971,0.00318348166354677,-0.0107950241971714,0.00168422392393197,0.152468608322541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00307497835780319,0.00215009631513631,-0.00728916713547035,0.00113921041986397,0.152694566711378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00794990013185576,0.00560849904570932,-0.00304275799773452,0.018942558261446,0.156368245664738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP350,Centrosome-associated protein 350,36962,-0.00505960061596555,0.00357612883890407,-0.0120688131402175,0.00194961190828642,0.157143238456394
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA6C,Semaphorin-6C,37056,0.00365864205692592,0.00258763359260087,-0.00141311978457179,0.00873040389842363,0.157416340902223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00653121487185471,0.00462974744221846,-0.00254309011489348,0.0156055198586029,0.158351072742807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCA2A,Guanylin,39796,-0.00448829089233793,0.00318549933212895,-0.0107318695833107,0.00175528779863481,0.158861889103178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00365185093737949,0.00259261449564613,-0.00142967347408692,0.00873337534884591,0.158989286777695
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.0060495007886219,0.00429887580626627,-0.0144752973689038,0.00237629579165999,0.159383348440141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.011847296827602,0.00846083913469461,-0.0284305415316035,0.0047359478763994,0.161461537499877
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB116,Beta-defensin 116,36991,-0.0107008754596314,0.00764798858217533,-0.0256909330806951,0.00428918216143222,0.161784091562789
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCP11,T-complex protein 11 homolog,37169,-0.00820100571666081,0.00588334110971502,-0.0197323542917023,0.00333034285838064,0.163359960719243
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0116688701452205,0.00840019904770715,-0.0281332602787265,0.00479551998828551,0.164820285440903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS2,Podocin,37056,-0.0139871848032065,0.0100867220910155,-0.0337571601015968,0.00578279049518382,0.165558884427565
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD7,FERM domain-containing protein 7,37039,0.0045981560083692,0.00332092192529548,-0.00191085096520994,0.0111071629819483,0.166197560293448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLON5,IgLON family member 5,36962,0.0125584630849113,0.00911081752124579,-0.00529873925673042,0.0304156654265531,0.168099558716248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF5,Fibroblast growth factor 5,39587,-0.00450519441937818,0.00327041551600461,-0.0109152088307472,0.00190481999199085,0.168358702974648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTN,Titin,37021,-0.00925337518223356,0.00675755519871052,-0.0224981833717062,0.00399143300723906,0.1709170999856
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00512175781641182,0.00374214706069762,-0.0124563660553791,0.00221285042255551,0.171126364200585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.014210467148491,0.0103918933024374,-0.00615764372428626,0.0345785780212683,0.17150551425462
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00889914430988245,0.00650957146458278,-0.0216579043804647,0.00385961576069981,0.171621790783774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00373588741317079,0.00274601841547344,-0.00164630868115715,0.00911808350749874,0.173703125382992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00719295470451028,0.00532779805838563,-0.0176354388989461,0.00324952948992556,0.17701352694326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0226703829518212,0.0168274463602612,-0.0556521778179331,0.0103114119142907,0.177929845939951
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00743944619139228,0.00554950184207642,-0.0183164698018621,0.0034375774190775,0.180086243260968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00634532830598842,0.0047454110484708,-0.00295567734901434,0.0156463339609912,0.181196063059575
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00390643389059018,0.00292606713697404,-0.0096415254790593,0.00182865769787894,0.181883713433166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00847080170361754,0.00638249896081408,-0.00403889625957806,0.0209804996668131,0.18446455806783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD82,CD82 antigen,37169,-0.00550944965958887,0.00416351870157596,-0.0136699463146777,0.00265104699550001,0.185769113630513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00957516047428595,0.00724396812997129,-0.0237733380090297,0.00462301706045777,0.186253950462094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN1,Cerebellin-1,36991,-0.0125580750403298,0.00950187887610316,-0.031181757637492,0.0060656075568324,0.186310667062403
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELB,Transcription factor RelB,37056,0.00640284448366498,0.00486197759564269,-0.00312663160379469,0.0159323205711247,0.187887693282607
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00352140408059148,0.00268956412071964,-0.00175014159601902,0.00879294975720199,0.190456783823236
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0107782966878605,0.00824722560159296,-0.0269428588669827,0.00538626549126169,0.191269714126826
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00830719705095187,0.00636720944505209,-0.020786927563254,0.00417253346135022,0.192023212618228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00672288168594384,0.0051772385869743,-0.0168702693164135,0.00342450594452579,0.194122367797036
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCC,Netrin receptor DCC,37039,0.00288858614028214,0.00223415487735456,-0.00149035741933279,0.00726752969989707,0.196060988948965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD27,CD27 antigen,39913,0.0049627477276207,0.00383976482545056,-0.00256319133026241,0.0124886867855038,0.196216016746017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00375638598796004,0.0029146039031232,-0.00946900963808152,0.00195623766216143,0.197484368119676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAP1,Antigen peptide transporter 1,37169,-0.00748492995725615,0.00581198507959179,-0.0188764207132561,0.00390656079874376,0.197822673266133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00763477184307741,0.00592978794217429,-0.00398761252358419,0.019257156209739,0.19792904015852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00622748775407034,0.00483833291039655,-0.00325564475030689,0.0157106202584476,0.198077067767701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.0050568663749888,0.0039371373369823,-0.00265992280549651,0.0127736555554741,0.199020314221262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO6,Coronin-6,36991,-0.00480682228478632,0.00374571689818469,-0.0121484274052283,0.00253478283565566,0.199414895643022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,0.0153180469789857,0.0119564575804204,-0.00811660987863825,0.0387527038366096,0.20016257705376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00549404611310558,0.00429018791369515,-0.0139028144239481,0.00291472219773692,0.20035418962642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH17,Protocadherin-17,39868,0.00439865974335146,0.00345300283548534,-0.0023692258141998,0.0111665453009027,0.202729729326642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20,Interleukin-20,39587,0.00611904385035917,0.00482200438485493,-0.00333208474395648,0.0155701724446748,0.204465740368688
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0182412872550259,0.0144000443118428,-0.009982799596186,0.0464653741062378,0.205265740988551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDNRB,Endothelin receptor type B,37056,0.00583266484132218,0.00461041025672175,-0.00320373926185246,0.0148690689444968,0.205855114762889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171A2,Protein FAM171A2,37411,0.0193363711929486,0.0155230747501388,-0.0110888553173235,0.0497615977032207,0.212913197140927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLHL41,Kelch-like protein 41,37411,0.00626697867806479,0.00504956234944711,-0.00363016352685155,0.0161641208829811,0.21459271884286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM2,Isthmin-2,37437,-0.00545351198978038,0.00439696104756061,-0.0140715556429992,0.00316453166343842,0.214889148514747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00328073472384889,0.00264612339361404,-0.00190566712763464,0.00846713657533241,0.215057475368593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC8,Histone deacetylase 8,37056,0.00772961119009126,0.00624621510370798,-0.00451297041317638,0.0199721927933589,0.215928285104946
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHPK,Sedoheptulokinase,37169,-0.0051099988559959,0.00413762944919092,-0.0132197525764101,0.0029997548644183,0.21684992375841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTH3,Cytohesin-3,36962,0.00879331590792059,0.00714456558530417,-0.00521003263927559,0.0227966644551168,0.218431049520586
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00403833797046452,0.00330788692733428,-0.00244512040711067,0.0105217963480397,0.222172089271373
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00588890233005635,0.00482820684688923,-0.00357438308984653,0.0153521877499592,0.222605903526666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00898260270172523,0.00738522418614989,-0.00549243670312856,0.023457642106579,0.223894869499996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.00874065922066247,0.00718643605797997,-0.00534475545297827,0.0228260738943032,0.223899386796198
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00303806898958143,0.00250028649214604,-0.00186249253502482,0.00793863051418767,0.2243543256614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSND,Barttin,36962,-0.00403078616216152,0.0033312590531382,-0.0105600539063124,0.00249848158198936,0.226305018280594
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM3,Paralemmin-3,37021,0.00902524207226242,0.00747510463335465,-0.0056259630091127,0.0236764471536375,0.227310094426115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1,DNA topoisomerase 1,37382,0.013577869439195,0.0112486401570808,-0.00846946526868332,0.0356252041470733,0.227427213569001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLINT1,Clathrin interactor 1,36962,-0.00580858045072027,0.00483306953869882,-0.01528139674657,0.00366423584512942,0.229446913486336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00352485668459337,0.00294050586189089,-0.00928824817389951,0.00223853480471278,0.230656015303189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AREG,Amphiregulin,39788,-0.00550308715563056,0.00461204838506304,-0.0145427019903541,0.00353652767909299,0.232809589368718
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00835972510791795,0.00701615883517188,-0.00539194620901893,0.0221113964248548,0.233480387023153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00406270123044763,0.00341411867258163,-0.0107543738287076,0.00262897136781236,0.234079443744878
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.00461545723762476,0.00387918167380221,-0.00298773884302758,0.0122186533182771,0.234142109100226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00848742804328777,0.00714844644878919,-0.0224983830829146,0.00552352699633903,0.235126219630777
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00543233347636511,0.00458129827000604,-0.0144116780855769,0.00354701113284673,0.235737406959899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENG,Endoglin,40052,-0.00196589778943094,0.00167250183209743,-0.0052440013803419,0.00131220580148002,0.239842649614185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00634680455503522,0.00540544748610879,-0.00424787251773801,0.0169414816278084,0.240356362559109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAYN,Layilin,39713,0.0037360705631233,0.00318406800833976,-0.00250470273322264,0.00997684385946924,0.240667522566648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMI,N-myc-interactor,37311,0.00834844165444853,0.00713131709263392,-0.00562893984711396,0.022325823156011,0.241750909125775
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTO1,Protein LTO1 homolog,39587,0.00463380732633284,0.00398493327723859,-0.00317666189705479,0.0124442765497205,0.244915376687309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00463004882925065,0.0039849585222139,-0.0124405675327899,0.00318046987428859,0.245304515521657
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP73,Tumor protein p73,37039,-0.00395894227577399,0.00341984648776257,-0.0106618413917886,0.00274395684024066,0.247033010131139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB5,Serpin B5,39585,0.00554169507643146,0.00480375942716999,-0.00387367340082173,0.0149570635536846,0.248675054708195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00723778314914724,0.00628974479220406,-0.0195656829418672,0.00509011664357271,0.249865210373207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00317149261702211,0.00276488202375788,-0.00224767614954332,0.00859066138358755,0.251376057845428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.00951634846118135,0.00830877717589406,-0.00676885480357102,0.0258015517259337,0.252087088101903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B4,Protein ATP1B4,36962,-0.00473798554759081,0.0041375834919646,-0.0128476491918414,0.00337167809665981,0.252184779010414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH22,Cadherin-22,37169,-0.00327693003683587,0.00286365479122338,-0.0088896934276337,0.00233583335396195,0.252512604808495
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00668290216619146,0.00584862816904429,-0.00478040904513535,0.0181462133775183,0.253206822041562
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00303347627445803,0.00266075681961039,-0.00824855964089439,0.00218160709197833,0.254269736871936
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00227107400733142,0.0019939228541068,-0.00617916280138076,0.00163701478671791,0.254720974921237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00694176190698695,0.00611217182997962,-0.018921618693747,0.0050380948797731,0.2560912900114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB118,Beta-defensin 118,36991,0.00647580174216556,0.00574119248556123,-0.00477693552953445,0.0177285390138656,0.259359902950161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRNN,Cornulin,39397,0.00718588203196581,0.00638545865261842,-0.00532961692716628,0.0197013809910979,0.260457726085591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.0070645421855628,0.00629317897565974,-0.0193991729778559,0.00527008860673028,0.261640175207943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.00781742442373804,0.00697793370121417,-0.00585932563064174,0.0214941744781178,0.262599863035433
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00518541699393946,0.00464574680782848,-0.00392024674940435,0.0142910807372833,0.264368948790741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00550365736501289,0.00495220132801586,-0.015209971967924,0.00420265723789819,0.266435649273147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00557663651727002,0.00501926462945119,-0.0154143951909944,0.00426112215645431,0.266568621163496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00532022745868117,0.00479641330852683,-0.0147211975433938,0.00408074262603141,0.267360151584343
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF9,Fibroblast growth factor 9,36931,0.00443846193359207,0.00400306536511716,-0.00340754618203756,0.0122844700492217,0.267551631889556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00538259448860589,0.00485561103284249,-0.00413440313576539,0.0148995921129772,0.267652938659134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00691732690913962,0.00624720035833522,-0.0053271857931974,0.0191618396114766,0.268197957921041
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13,Interleukin-13,39587,0.00532633378235344,0.0048140704183941,-0.00410924423769899,0.0147619118024059,0.26856619048752
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.00931048155019372,0.00842749732044357,-0.0258283762982631,0.00720741319787568,0.269277688354188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0104432790508398,0.00945631498460563,-0.00809109831898721,0.0289776564206669,0.269452417024817
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBN2,Fibrillin-2,37039,0.00651533081874251,0.00593768115114674,-0.0051225242375051,0.0181531858749901,0.272536700622772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00620376731580371,0.00569003558644077,-0.0049487024336202,0.0173562370652276,0.275607140269073
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00672090376889363,0.00616839450785673,-0.00536914946650557,0.0188109570042928,0.275922113058361
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC3,Membrane primary amine oxidase,39931,-0.00322673660512238,0.00296484601990785,-0.00903783480414177,0.00258436159389702,0.276464917902894
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00653222864413922,0.00601275284472967,-0.00525276693153094,0.0183172242198094,0.277323847132457
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAN,Brevican core protein,39749,-0.0035611258247017,0.00328600607148435,-0.010001697724811,0.00287944607540763,0.278503341061249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17F,Interleukin-17F,39587,-0.00827138339891791,0.00765371671777734,-0.0232726681657615,0.00672990136792567,0.279846472086985
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00556642130633556,0.0051827049830586,-0.00459168046045929,0.0157245230731304,0.282822300273357
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN5,Contactin-5,39897,-0.00380696474464935,0.00355361538679666,-0.0107720509027708,0.00315812141347211,0.284053643882563
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00304102281976003,0.0028648291268035,-0.00257404226877483,0.00865608790829488,0.288478531285614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00380461347959541,0.0035851121549035,-0.0108314333032063,0.00322220634401544,0.288603597756917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB2,Beta-crystallin B2,37388,0.00594856425299338,0.00561057417153654,-0.00504816112321825,0.016945289629205,0.289053619414725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00542381598359221,0.00512091526165182,-0.0154608098964298,0.00461317792924536,0.289551035678067
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00436523613432402,0.00412655739787045,-0.00372281636550207,0.0124532886341501,0.29014745825763
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00522575460782564,0.00494934659441365,-0.0149264739328764,0.00447496471722511,0.291057418548866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.0056952498244869,0.00540177804663659,-0.00489223514692081,0.0162827347958946,0.291748633397364
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00422379027520157,0.00403122129402462,-0.0121249840114898,0.00367740346108668,0.294760643493062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD10,Frizzled-10,37039,0.00618180218064435,0.0059167716896237,-0.0054150703310181,0.0177786746923068,0.296137771763745
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00349128515464328,0.00338568334134483,-0.00314465419439258,0.0101272245036791,0.302470142239811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00440496970327016,0.00428688542821778,-0.012807265142577,0.0039973257360367,0.304182520172047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK1,Kallikrein-1,39720,-0.0127359946597957,0.0123991476812277,-0.037038324115002,0.0115663347954106,0.304357524534314
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00475901380397038,0.0046364559390118,-0.0138464674444335,0.00432843983649276,0.30470611624302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00730406158280315,0.00713380000443429,-0.00667818642588806,0.0212863095914944,0.305917015138585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00796836097375253,0.00787941996400216,-0.00747530215569171,0.0234120241031968,0.311897397260443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR4,Toll-like receptor 4,37056,0.00275251893345588,0.00272541827893144,-0.00258930089324974,0.0080943387601615,0.312540797329752
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVPL,Envoplakin,37169,-0.00327186922232963,0.00325218181105943,-0.00964614557200611,0.00310240712734685,0.314408076982471
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0125896776462513,0.0125411125204652,-0.0119909028938605,0.0371702581863631,0.315455639719707
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRV1,Acrosomal protein SP-10,37056,0.0072307856378088,0.00721276145792156,-0.00690622681971746,0.0213677980953351,0.316121065575126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.0038107201168141,0.00384402825240514,-0.00372357525789998,0.0113450154915282,0.321540064685986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0088828279748919,0.00902881258283044,-0.0265793006372396,0.00881364468745576,0.325216658054935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00246589976040518,0.00251945096804821,-0.00740402365777967,0.00247222413696932,0.327723484893022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00442091426697888,0.00456303128252702,-0.0133644555807318,0.00452262704677408,0.332635578283299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.0036034969974696,0.00372553693686716,-0.00369855539879003,0.0109055493937292,0.333437783284693
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0163172960297441,0.0169420265037257,-0.0168890759175583,0.0495236679770464,0.335499356522237
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.00688714327370523,0.00717236539050884,-0.00717069289169209,0.0209449794391026,0.336955548459355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A3,Protein S100-A3,37368,0.00427522879551908,0.00446124145141143,-0.00446880444924732,0.0130192620402855,0.337926269388941
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTOA,Otoancorin,36991,-0.00499919349423879,0.00523583705913836,-0.01526143413015,0.0052630471416724,0.33969485222776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMCN2,Hemicentin-2,37100,0.0053399710161433,0.00561244025963567,-0.00566041189274262,0.0163403539250292,0.341392025041399
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00321121338244052,0.00339957905174259,-0.00345196155897497,0.009874388323856,0.344882095554493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.0051057674304423,0.00540683058126256,-0.0157031553697169,0.00549162050883232,0.345024584438316
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5L,CD5 antigen-like,37380,0.00434639446884189,0.00461580616866811,-0.0047005856217476,0.0133933745594314,0.346397497030038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00705402671895335,0.00750698567847822,-0.0217677186487707,0.00765966521086397,0.347408415211398
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00772937246264275,0.0082471139136406,-0.00843497080809284,0.0238937157333783,0.348658774209614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPA33,Cell surface A33 antigen,39788,0.0120927622926193,0.0129497163311042,-0.0132886817163448,0.0374742063015834,0.350408588470694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00567352603057234,0.00610224189485864,-0.00628686808335059,0.0176339201444953,0.352517642097907
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00915748287741035,0.00989469916418636,-0.0102361274843949,0.0285510932392156,0.354726068852141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00393730413565437,0.00428073171425447,-0.0123275382955931,0.00445293002428439,0.357707439996241
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00370393648747863,0.00403482866055345,-0.0116122006621634,0.00420432768720613,0.358640360212593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESR1,Estrogen receptor,37056,0.00539023978817415,0.00587625615617009,-0.00612722227791923,0.0169077018542675,0.359006677508243
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.00370060305204569,0.00404580514309951,-0.00422917502842935,0.0116303811325207,0.360375242212107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRN1,Neuritin,37411,-0.00317433795955306,0.00347830456677392,-0.00999181491042995,0.00364313899132383,0.36146356108092
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NENF,Neudesin,37368,0.00990039001262558,0.0108527939752824,-0.011371086178928,0.0311718662041791,0.361656865779953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN2,Transcobalamin-2,40012,0.00263052190296895,0.00288781953504756,-0.00302960438572427,0.00829064819166216,0.362360365793272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00388588914013905,0.00427368043145391,-0.00449052450551061,0.0122623027857887,0.3632288002312
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00714707214226043,0.00786276390483515,-0.0225580893957373,0.00826394511121647,0.363378946337561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.00571763196810722,0.00631601547383908,-0.00666175836061738,0.0180970222968318,0.365344660123475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00360291753398596,0.00398134368238712,-0.00420051608349279,0.0114063511514647,0.365508366019477
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00305912179671682,0.00341449486054245,-0.00975153172338003,0.00363328812994639,0.370310694797507
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,39709,-0.00243771321683139,0.00272842008780554,-0.00778541658893025,0.00290999015526747,0.371628568972688
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00643654407555039,0.0072163974160923,-0.00770759485999052,0.0205806830110913,0.372444890446949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASN,Vasorin,39642,0.00240305034198541,0.00269990150937072,-0.00288875661638121,0.00769485730035203,0.373452008767807
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00476896617693503,0.00536479983545474,-0.0152839738544263,0.00574604150055627,0.374053319236274
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00311275788778409,0.00350590947764785,-0.0037588246884057,0.00998434046397388,0.374629242800061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00469712438121651,0.00530530636015196,-0.00570127608468134,0.0150955248471144,0.375976378285171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEBP1,Heme-binding protein 1,39585,-0.00469545385350744,0.00530524680441359,-0.0150937375901581,0.00570282988314319,0.376138605868393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHH,Sonic hedgehog protein,37056,-0.00381289222567522,0.00431421216313529,-0.0122687480654204,0.00464296361406995,0.376821349355022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",39585,0.00376922315899139,0.00426546521897853,-0.00459108867020653,0.0121295349881893,0.376893014770452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00488032920206445,0.00557109636434437,-0.00603901967205052,0.0157996780761794,0.381041332882078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP2,Dipeptidase 2,39788,-0.00250298947831699,0.00286807693588385,-0.00812442027264933,0.00311844131601536,0.382836211607973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDAN1,Codanin-1,37388,0.00189758462268075,0.00222707323715408,-0.00246747892214125,0.00626264816750275,0.394199712491669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00468944397844137,0.00556119170225211,-0.0155893797148555,0.00621049175797277,0.399107074295295
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00436652388990625,0.00518336350947733,-0.0145259163684818,0.00579286858866931,0.399572648516674
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.0039329954897453,0.0046736993124885,-0.0130934461422228,0.00522745516273217,0.400071203950598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASQ2,Calsequestrin-2,37021,0.00401370523407391,0.00481788653733194,-0.0054293523790967,0.0134567628472445,0.404812351904376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00764238314375324,0.00920413513055681,-0.0256824879996446,0.0103977217121381,0.406372556843387
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKIV2L,Helicase SKI2W,37021,0.00328899511796336,0.00397767543923668,-0.00450724874294054,0.0110852389788673,0.408329355358259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00646866091981109,0.00785344123467712,-0.00892408390015607,0.0218614057397782,0.410138429654255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00332303869606575,0.00405475434275483,-0.00462427981573371,0.0112703572078652,0.412489704211179
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.00483309976186093,0.00591512693910885,-0.00676054903879241,0.0164267485625143,0.413900207072687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00933028589779287,0.0114270495643655,-0.0130667312483636,0.0317273030439493,0.414223577176188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.00774717836591001,0.0094907392252761,-0.0108546705156311,0.0263490272474512,0.414350133789049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00371492886754715,0.00455853353583034,-0.0126496545977746,0.00521979686268032,0.415121689451676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD70,CD70 antigen,39866,-0.00338047431366629,0.00417181146559583,-0.0115572247862341,0.00479627615890153,0.417772180645991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00500585552743318,0.00618484167699814,-0.0171281452143495,0.00711643415948316,0.418314208771196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00267265998710177,0.00331887044315572,-0.00917764605568698,0.00383232608148344,0.420665781228205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR2,Toll-like receptor 2,37169,-0.00179726795072444,0.00224253384862637,-0.00619263429403212,0.00259809839258325,0.422888274749951
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4,Interleukin-4,39587,0.00712824240345659,0.00891527053749571,-0.010345687850035,0.0246021726569482,0.423981181824945
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00442973980666732,0.00554772105700353,-0.0153032730783942,0.0064437934650596,0.424606906479177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TG,Thyroglobulin,37368,0.00856635024759593,0.0107409098206759,-0.0124858330009289,0.0296185334961208,0.425149066882266
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEB,Nebulin,37021,-0.00295492481380543,0.00370931435771449,-0.0102251809549258,0.00431533132731498,0.425684434970389
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00460174050204993,0.00580984267636844,-0.0159890321477321,0.00678555114363221,0.428340350336086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00272182498007114,0.00343892523066499,-0.00401846847203223,0.00946211843217451,0.428680400601766
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00386924273302007,0.00489456710943995,-0.00572410880148223,0.0134625942675224,0.429239201580767
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00500264487647377,0.00635359161869216,-0.0174556844491104,0.00745039469616287,0.431075327618428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00501775510903767,0.00638346201813523,-0.0175293406645827,0.00749383044650737,0.431849154255406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00285242242629923,0.003637921981384,-0.00427790465721342,0.00998274950981187,0.433007171673392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00578680913637277,0.0074228618905031,-0.0087620001690133,0.0203356184417588,0.435644689269583
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANK2,Ankyrin-2,37021,-0.00545858960577465,0.00701804911882055,-0.0192139658786629,0.00829678666711364,0.436705025882621
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBQLN3,Ubiquilin-3,37021,-0.00359979018781178,0.00464286617277091,-0.0126998078864428,0.00550022751081921,0.43815394017487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00586903275422819,0.00758546369070816,-0.0207365415880162,0.00899847607955979,0.439109711848544
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP4,Caspase-4,37169,-0.0125821649893526,0.0162881213204295,-0.0445068827773943,0.0193425527986891,0.43984692092405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A16,Protein S100-A16,39456,-0.00474054817360567,0.00613744353942795,-0.0167699375108845,0.00728884116367311,0.439890533248888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00302909056511693,0.00392316229106426,-0.00466030752536902,0.0107184886556029,0.440066568179238
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00659913702308298,0.00854902095428887,-0.0233552180934892,0.0101569440473232,0.440177126398508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00363063118615079,0.00479692895317567,-0.00577134956207353,0.0130326119343751,0.449143881707259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00194980528757716,0.00257845867008741,-0.00310397370579417,0.00700358428094848,0.449548640826097
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00436282553309566,0.00581612890136197,-0.00703678711357381,0.0157624381797651,0.45319264255799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00453485828733829,0.00605118025245342,-0.00732545500747041,0.016395171582147,0.45361886506375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RUVBL1,RuvB-like 1,39477,0.00750035357582417,0.0100337253198924,-0.012165748051165,0.0271664552028134,0.454764404064736
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.00855547044546681,0.0115134825109001,-0.0140109552758973,0.031121896166831,0.457444865971174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPO,Lactoperoxidase,39344,-0.00436470788512931,0.00589996723002886,-0.0159286436559859,0.00719922788572726,0.459441613197495
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00548478954795696,0.00742675726247653,-0.0200412337824109,0.00907165468649703,0.46021328984706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRP15,RRP15-like protein,36991,0.00658793312969755,0.00893505138231036,-0.0109247675796307,0.0241006338390258,0.460944958295069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00338086743487716,0.00459833809609387,-0.0123936101032211,0.00563187523346682,0.462208035778436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.0018550223660331,0.00253599254238721,-0.00682556774911202,0.00311552301704583,0.46449997924993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10,Interleukin-10,39587,0.0056765278425788,0.00781778948954388,-0.00964633955692721,0.0209993952420848,0.467785852137919
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00298190338981489,0.00411785851866076,-0.01105290608639,0.0050890993067602,0.468993026315252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF6,Fibroblast growth factor 6,37056,0.00291594808533726,0.00405134166932732,-0.00502468158654429,0.0108565777572188,0.471692454286067
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTR,Methionine synthase,37021,0.00457729365934829,0.00636320262140888,-0.00789458347861311,0.0170491707973097,0.471945439523453
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.00213653915691216,0.00297164611479399,-0.00368788722808406,0.00796096554190838,0.472166721320419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PITHD1,PITH domain-containing protein 1,36931,-0.00560282912791117,0.0078143660253035,-0.020918986537506,0.00971332828168369,0.473392538952815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00198336829481008,0.00276941307504589,-0.00741141792190001,0.00344468133227986,0.473897296234349
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRING1,SREBP regulating gene protein,36962,0.00419206167164491,0.00591600883795021,-0.00740331565073751,0.0157874389940273,0.47858767149937
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00434114853172866,0.0061391452328773,-0.00769157612471085,0.0163738731881682,0.479498464114483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC2,Stanniocalcin-2,39831,0.00184625395332045,0.00261329331863761,-0.00327580095120926,0.00696830885785017,0.479896545362238
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00285837882217169,0.00405361521033364,-0.00508670699008224,0.0108034646344256,0.480733359280514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC5D,Netrin receptor UNC5D,37056,0.0018497958044004,0.00263056594855513,-0.00330611345476766,0.00700570506356845,0.481947829065428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDSN,Corneodesmosin,39992,0.00291846470524871,0.00417538748870691,-0.00526529477261684,0.0111022241831143,0.484581737400538
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YY1,Transcriptional repressor protein YY1,37056,-0.00191176021671237,0.00274463676648666,-0.00729124827902622,0.00346772784560147,0.486100493527983
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPGN,Epigen,37368,-0.00343229930657944,0.00493298995426595,-0.0131009596169407,0.00623636100378183,0.48657559539277
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1A,Lithostathine-1-alpha,39804,-0.00312187125635306,0.00458653113319611,-0.0121114722774174,0.00586772976471132,0.496096125611252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00355693860556923,0.00528406071411201,-0.0139136976052288,0.00679982039409031,0.500866617053379
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS2,Thrombospondin-2,39858,-0.00238428046996252,0.00355808558479642,-0.00935812821616351,0.00458956727623846,0.502802405735499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00357271644794692,0.0053373566029948,-0.0140339353898167,0.00688850249392289,0.503265114042667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00554381619341983,0.00829292086186494,-0.0107103086958354,0.0217979410826751,0.503826297973133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00188572426687414,0.0028242380587163,-0.00364978232820981,0.00742123086195809,0.504339030895525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00395820186181023,0.00594259599650442,-0.00768928629133844,0.0156056900149589,0.505376179557515
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSD1,Tryptase delta,37411,0.0024015983843614,0.00361399071573827,-0.00468182341848561,0.00948502018720842,0.506363677659797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.0025568359809183,0.00385326944661697,-0.00499557213445096,0.0101092440962876,0.506990149983443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00333279947143864,0.00511283979048373,-0.0133539654607868,0.00668836651790948,0.514509974976612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00300820074373918,0.00461947977482525,-0.0060459796149183,0.0120623811023967,0.514929031811658
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.0049320718525051,0.00758041203119433,-0.019789679433646,0.00992553572863579,0.515294009306508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN4,Nectin-4,39913,0.00188717087552907,0.00290242949137657,-0.00380159092756901,0.00757593267862714,0.51556984893281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRAS,GTPase Hras,37161,0.00626606087575185,0.00965611780125129,-0.0126599300147007,0.0251920517662044,0.516400426143664
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00419052985449596,0.00647292031939489,-0.0168774536805099,0.00849639397151801,0.517388136633848
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00329525852865699,0.00509452274085387,-0.0132805231007306,0.00669000604341658,0.517757270985121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL21R,Interleukin-21 receptor,37056,-0.00347027006619541,0.00537379354788956,-0.014002905420059,0.00706236528766813,0.518435280555662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17A,Interleukin-17A,39558,0.00268875367746971,0.00418142424840831,-0.00550683784941058,0.01088434520435,0.520218302127289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKKL1,Dickkopf-like protein 1,39788,-0.005324829206826,0.00830045333354858,-0.0215937177405812,0.0109440593269292,0.521200195193203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00250088156773325,0.00390949247310109,-0.00516172367954488,0.0101634868150114,0.522382244217465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00323402473899075,0.00508926731804355,-0.00674093920437461,0.0132089886823561,0.525139348463822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,37437,0.00145611956621705,0.0022981639944421,-0.00304828186288947,0.00596052099532358,0.526351761754118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.00643997289522198,0.0102174836964737,-0.0135862951498666,0.0264662409403105,0.528516106518354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.00268793238494507,0.00429134330796189,-0.00572310049866023,0.0110989652685504,0.531088720727912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00194638030398378,0.00314246803699953,-0.0042128570485353,0.00810561765650286,0.535675351495771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0023252429094699,0.00376129672301614,-0.00969738448658154,0.00504689866764174,0.536450700267867
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGF,Beta-nerve growth factor,39749,0.000748212001214849,0.00121329907794041,-0.00162985419154836,0.00312627819397805,0.537457518767619
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00343578931947683,0.0056448888453028,-0.00762819281731667,0.0144997714562703,0.542761830708004
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00402692889040245,0.00671300814438355,-0.0091305670725893,0.0171844248533942,0.548603418016374
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF20,Fibroblast growth factor 20,37056,-0.00253844769618346,0.00424803635825877,-0.0108645989583706,0.00578770356600374,0.550145214393565
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXOSC10,Exosome component 10,37021,-0.00356350567301936,0.00602314939625262,-0.0153688784896745,0.00824186714363578,0.554105228851437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00447690219613878,0.00759632690811442,-0.0104118985437655,0.019365702936043,0.55563600036674
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2,T-cell surface antigen CD2,37021,0.00222447970662655,0.00379216878094064,-0.0052081711040171,0.0096571305172702,0.557483595095348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00303888371743199,0.0052474252814801,-0.013323837269133,0.00724606983426902,0.562518831936351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00219110609763824,0.00379073711637287,-0.00962095084572907,0.0052387386504526,0.563263300988934
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WIF1,Wnt inhibitory factor 1,40030,-0.00189741057560971,0.00330869978868633,-0.00838246216143491,0.00458764101021549,0.566340514807668
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.00260901199435817,0.00456147919360915,-0.0115495112138321,0.00633148722511577,0.56735438032013
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI16,Peptidase inhibitor 16,37445,-0.00134753195026948,0.00235873445568887,-0.00597065148341966,0.0032755875828807,0.567809500634849
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL6,Fc receptor-like protein 6,39866,0.0037194296026274,0.00651314914871471,-0.00904634272885344,0.0164852019341082,0.567963799642797
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR3,Folate receptor gamma,39858,-0.0106295963047265,0.0186634388536079,-0.0472099364577979,0.0259507438483449,0.568996954301577
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNB2,Ephrin-B2,37039,-0.00338668729436761,0.00595114284066906,-0.015050927262079,0.00827755267334376,0.569310302446652
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCIN,Adseverin,36991,0.00411429844365464,0.00730592694457719,-0.0102053183677166,0.0184339152550259,0.573345560063914
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOS,Proto-oncogene c-Fos,36931,-0.0019661426045964,0.00349165616271965,-0.00880978868352692,0.00487750347433412,0.57337820127784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.00143851273467395,0.00256083908091366,-0.00645775733326472,0.00358073186391681,0.574306204465567
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.0016493404287717,0.002938693354541,-0.00411049854612866,0.00740917940367205,0.57463521440146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,37039,0.00354911165916373,0.00634489112218838,-0.0088868749403255,0.015985098258653,0.575921972290975
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN4,Prefoldin subunit 4,36962,0.00300419635171533,0.00537570871021299,-0.00753219272030212,0.0135405854237328,0.576275990383974
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00218736537016389,0.00393475235947095,-0.00989947999472696,0.00552474925439918,0.578282342303857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00264254861190133,0.00476219558147582,-0.0119764519515939,0.00669135472779128,0.578971611000264
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00370665430478982,0.00671686190740849,-0.0168717036433105,0.00945839503373083,0.581065079159436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.00118433243782035,0.00215261047799584,-0.00303478409905149,0.0054034489746922,0.582202299442526
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00145047818319526,0.00264277948919225,-0.00372936961562156,0.00663032598201208,0.583119032769396
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00121912567609358,0.00222710261761382,-0.00314599545442951,0.00558424680661667,0.584110220308582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00263697205483365,0.00482013608375645,-0.0120844387789963,0.00681049466932899,0.584337079261805
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00416087372508628,0.00773979720614762,-0.0193308762491356,0.0110091287989631,0.590865899144896
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO1,R-spondin-1,39749,0.00186678903245968,0.00348236018934433,-0.0049586369386552,0.00869221500357457,0.591917636172341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX2,Transcription factor SOX-2,37391,0.00125758251133286,0.00234746347278838,-0.00334344589533236,0.00585861091799807,0.592161066902034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.00437149927566038,0.00817427111478785,-0.0116500721093238,0.0203930706606446,0.592805756041637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.00243253843753854,0.00461016203961979,-0.0114684560351933,0.00660337916011625,0.597752947354852
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00264801853903933,0.00504420539454109,-0.0125346611123399,0.0072386240342612,0.599618109145331
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00340050097400954,0.00648291058282822,-0.0161070057163529,0.00930600376833377,0.59991656261667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00187078983301551,0.0035900441917903,-0.00516569678289347,0.00890727644892449,0.602302411842392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD177,CD177 antigen,39844,-0.00641956899876349,0.0123240709740715,-0.0305747481079436,0.0177356101104166,0.60244588809748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.0017344329575433,0.00334564594708384,-0.00829189901382762,0.00482303309874103,0.604177504431756
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00260257305596446,0.00502863934445557,-0.0124587061710974,0.00725356005916847,0.604780770758822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00256976648530505,0.00501941362135239,-0.0124078171831557,0.00726828421254564,0.60868376210994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX101,Testis-expressed protein 101,37039,0.00245260347045259,0.00480412524341315,-0.00696348200663719,0.0118686889475424,0.609695545621357
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2BP,LRP2-binding protein,37039,-0.0039949299924737,0.00787785027389026,-0.0194355165292986,0.0114456565443512,0.612086716826055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00246263657118811,0.00489163255815083,-0.0120502363851637,0.00712496324278751,0.614663050239732
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.00275312363441241,0.0055158449629145,-0.00805793249290002,0.0135641797617248,0.617695940657077
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00316408777270974,0.00644374727734353,-0.00946565689088358,0.0157938324363031,0.623410484316576
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP1,Retinol-binding protein 1,37039,0.00337544353538461,0.00693916435603282,-0.0102253186024397,0.0169762056732089,0.626667775826527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00402319063220517,0.00827682781946868,-0.0121993918939534,0.0202457731583638,0.626919291693288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD2,Glutamate decarboxylase 2,37056,-0.00222277072453592,0.00460504741778589,-0.0112486636633963,0.00680312221432442,0.629329980299788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN7,Tetraspanin-7,36991,0.00449055468371054,0.00931194048021986,-0.0137608486575204,0.0227419580249415,0.629646209925192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.00162498917949716,0.00344636028626823,-0.00837985534058289,0.00512987698158857,0.637284028647462
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNW1,Interferon omega-1,37021,-0.00163217635632238,0.00349883140964237,-0.00848988591922142,0.00522553320657666,0.640871197207123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00223654482272109,0.00485166306368726,-0.00727271478210594,0.0117458044275481,0.644816847554393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00369356782996814,0.00804442365007307,-0.0120735025241751,0.0194606381841114,0.646136684689008
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00409114922303768,0.00905977003573359,-0.0136660000470002,0.0218482984930755,0.651583948245089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2B,Alpha-amylase 2B,38832,0.00213229705063109,0.00474980124844027,-0.00717731339631184,0.011441907497574,0.653493393620362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00294797553112141,0.00673031862577697,-0.0102434489754015,0.0161394000376443,0.661383125111953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.00293888267535973,0.00674768683408106,-0.0161643488701586,0.0102865835194392,0.663177956527889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.0023014523341075,0.00536309336759481,-0.00821021066637833,0.0128131153345933,0.667836042830209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,40052,0.00130446988030297,0.00309143975801414,-0.00475475204540474,0.00736369180601068,0.673058408979605
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GJA8,Gap junction alpha-8 protein,36962,0.00248561799875813,0.00590184427963274,-0.00908199678932204,0.0140532327868383,0.673645498112813
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMP,Olfactory marker protein,36991,0.00202169921450935,0.00480440886887,-0.00739494216847585,0.0114383405974946,0.673907415975774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00319221368121317,0.00763497167781372,-0.0181567581697281,0.0117723308073017,0.675877563724979
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL4,Myosin light chain 4,37043,0.00213668063310736,0.00513413477992933,-0.00792622353555412,0.0121995848017689,0.677291279098787
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.00432765215085554,0.0104236831338785,-0.0247580710932575,0.0161027667915464,0.678020393914402
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBR1,T-box brain protein 1,37039,-0.00197499623578467,0.00476237407577729,-0.0113092494243082,0.00735925695273882,0.678362178209285
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELL,L-selectin,37453,0.000918952766877687,0.00223551082233948,-0.0034626484449077,0.00530055397866307,0.681027250039839
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.00256701902283644,0.00628614777740005,-0.00975383062086767,0.0148878686665405,0.68301516781015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,36962,-0.00159157659595933,0.00390038472492669,-0.00923633065681565,0.00605317746489699,0.683239002989268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00174173606956745,0.0043890689841753,-0.00686083913941614,0.010344311278551,0.691495428591488
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,-0.00125547557407656,0.00316374009776113,-0.00745640616568837,0.00494545501753525,0.691496209170578
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00175539003405226,0.00451644735398979,-0.00709684677976773,0.0106076268478722,0.697529424279539
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00158483194227373,0.0040846390744105,-0.00959072452811831,0.00642106064357086,0.698023751112014
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL25,Interleukin-25,36903,-0.00130639408626143,0.00339199447502812,-0.00795470325731655,0.00534191508479369,0.700139682627827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00178713177932998,0.00464463456927967,-0.00731635197645818,0.0108906155351181,0.700410635516395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNPO1,Transportin-1,37169,-0.00133274197021414,0.00349886061340058,-0.00819050877247928,0.005525024832051,0.703278025955788
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.00220047043521473,0.00583151121367088,-0.00922929154358021,0.0136302324140097,0.705924994789118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.00162802027883073,0.00442537662466101,-0.00704571790550486,0.0103017584631663,0.712966419684727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,39477,0.00165082146454875,0.0045914181936064,-0.0073483581949198,0.0106500011240173,0.719192279800753
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,39477,0.00110621065881015,0.00309929370510437,-0.00496840500319442,0.00718082632081472,0.721153922492296
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3,Interleukin-3,36962,-0.00210225398327143,0.00589089816133371,-0.0136484143794855,0.00944390641294265,0.721198796281666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00201276621638606,0.00566549931695976,-0.00909161244485507,0.0131171448776272,0.722394954177687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.00268886837528339,0.00758019764425323,-0.0121683190074529,0.0175460557580197,0.722802943888718
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00260676682234616,0.00737358275867576,-0.0118454553846583,0.0170589890293506,0.723697529556163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMCH,Pro-MCH,37021,-0.00286840792689029,0.00818855313943867,-0.0189179720801901,0.0131811562264095,0.726123041805774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.00149942586315833,0.00431708023557098,-0.00696205139856078,0.00996090312487745,0.728352438990431
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-0.00143036839365701,0.00422694608173234,-0.0097151827138524,0.00685444592653839,0.735072540986188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABO,Histo-blood group ABO system transferase,37445,0.00476246442227795,0.0141734767274767,-0.0230175499635763,0.0325424788081322,0.73686667897076
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.00136481925943458,0.00413440688231546,-0.00946825674877288,0.00673861822990372,0.741320229783994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.00317451964901365,0.00976998980489852,-0.0223236996666148,0.0159746603685875,0.74524250309765
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.000914122903291501,0.00282137424517574,-0.00461577061725294,0.00644401642383594,0.745942886464403
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGN,Cingulin,37039,0.00123713825692094,0.00383989965963514,-0.00628906507596393,0.00876334158980581,0.747321566708531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00162931762866695,0.00507151069387513,-0.0115694785886622,0.0083108433313283,0.748011871375857
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00190250772560188,0.00595269086722953,-0.0135697818253718,0.009764766374168,0.749273127797917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00111110346443129,0.00347675045528241,-0.00570332742792224,0.00792553435678481,0.749291028179327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00127714393526827,0.00400511502494515,-0.00657288151362421,0.00912716938416076,0.749823917075352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53BP1,TP53-binding protein 1,37056,0.0027711367022805,0.00869558083891825,-0.0142722017419993,0.0198144751465603,0.749971696627305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.000965204424544082,0.00303498619657157,-0.0049833685207362,0.00691377736982436,0.750469387135604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00111052143737139,0.00350110026265109,-0.00575163507742475,0.00797267795216753,0.751102841987109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,0.00143587471016227,0.0045601964987779,-0.00750211042744242,0.010373859847767,0.752863546061128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.000981270185478872,0.00312907153052301,-0.00515171001434622,0.00711425038530396,0.753831442860354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00227406981988657,0.007331225206695,-0.0166432712250088,0.0120951315852356,0.756421635107587
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.00145523621065328,0.00469245921087417,-0.0106524562639667,0.0077419838426601,0.756472900054808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.0012215517120052,0.00403692566335197,-0.00913392601217505,0.00669082258816465,0.762203642442289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00397988266296635,0.0132918591882949,-0.0300319266720243,0.0220721613460916,0.764622225148572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSTN,Osteocrin,37039,-0.00122098392339684,0.0041318525182544,-0.00931941485917546,0.00687744701238178,0.767612632527407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,0.00103574463132732,0.00353058515754019,-0.00588420227745145,0.00795569154010608,0.769248165428184
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MB,Myoglobin,40052,0.00147505743145104,0.00511863931227807,-0.00855747562061398,0.0115075904835161,0.773217437863517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF830,Zinc finger protein 830,37368,-0.00227260559940889,0.00796597419843238,-0.0178859150283364,0.0133407038295186,0.775427037954874
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB7,Integrin beta-7,40030,0.00125859186762322,0.00449134435378742,-0.00754444306580011,0.0100616268010466,0.779307635909096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,36962,-0.00115118065482519,0.00411730381339246,-0.00922109612907442,0.00691873481942404,0.77979208028003
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.00239252213513129,0.00857008719604068,-0.0144048487691084,0.019189893039371,0.780117796247416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00245814532202294,0.00899343527433526,-0.0151689878156742,0.02008527845972,0.784606426936791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.000869658781027989,0.00325991912756743,-0.00725910027106015,0.00551978270900417,0.789647323560037
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,0.00102912738044864,0.00388660601046444,-0.00658862040006166,0.00864687516095895,0.791176733831214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH4,Cadherin-4,36991,-0.00119898620100431,0.00462553568343593,-0.0102650361405387,0.00786706373853012,0.795477096277221
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM25,RNA-binding protein 25,36962,-0.00116026698185512,0.00451233813642536,-0.0100044497292488,0.00768391576553859,0.797080835822102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00126171509135037,0.00497756096301218,-0.00849430439615351,0.0110177345788543,0.799900807025537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN1,Neuroligin-1,37039,-0.00163626894708499,0.00664676833544935,-0.0146639348845657,0.0113913969903957,0.805550513478822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00156337785682296,0.00636479060047023,-0.0140383674337446,0.0109116117200987,0.805973182253682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22,Interleukin-22,37368,-0.00158073973442027,0.00647081166850217,-0.0142635306046845,0.011102051135844,0.807011715003694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0011483846621148,0.00488140170229478,-0.00841916267438297,0.0107159319986126,0.814012181419304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHC1,SHC-transforming protein 1,36962,-0.00261526481022279,0.011419565635818,-0.0249976134564261,0.0197670838359805,0.818859948262847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2,Interleukin-2,39587,0.000703952792587535,0.00307747969056064,-0.00532790740091133,0.0067358129860864,0.819071429572735
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF3,Fibroblast growth factor 3,37056,0.00069067709126132,0.00304282850563587,-0.00527326677978498,0.00665462096230762,0.820438752735985
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,-0.00155756701439559,0.00707625685253575,-0.0154270304453657,0.0123118964165745,0.825787567131153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HK2,Hexokinase-2,39585,-0.000592551227121894,0.00269973611610351,-0.00588403401468478,0.00469893156044099,0.826275214310335
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00104549838386312,0.0048435514345036,-0.00844786242776394,0.0105388591954902,0.829104606380099
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000674403794542805,0.00318045659996938,-0.00690809873048279,0.00555929114139719,0.832074275495046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.0011232202812129,0.00537061278069534,-0.0116496213313758,0.00940318076894996,0.834340700378791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,39587,0.00133806199574953,0.00649663080537616,-0.0113953343827877,0.0140714583742868,0.836822909116816
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN15,Lipocalin-15,37411,0.00125636855788038,0.00612534116243839,-0.0107493001204989,0.0132620372362596,0.837489285808428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.00110168073673349,0.00547324240273543,-0.00962587437262796,0.0118292358460949,0.84047896008686
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD2,Leiomodin-2,36991,-0.00126191864577485,0.00633854951147301,-0.013685475688262,0.0111616383967122,0.8421982860903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.000973975278121787,0.00500741118042707,-0.0107885011917588,0.00884055063551527,0.845782086754599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5,Interleukin-5,39587,0.00277028703023594,0.014249820030589,-0.0251593602297186,0.0306999342901905,0.845858496820389
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,0.00109244752446957,0.00578455679422598,-0.0102452837922134,0.0124301788411525,0.850208216102553
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY96,Lymphocyte antigen 96,39749,-0.000649723067736332,0.00348656730740822,-0.00748339499025643,0.00618394885478377,0.852172397634328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3A,Uroplakin-3a,36991,-0.000824942540512649,0.00471721689364399,-0.0100706876520549,0.00842080257102958,0.861177346593683
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,0.00102174062343211,0.00586000427300694,-0.0104638677516615,0.0125073489985257,0.861586539805238
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI2B,Protein EVI2B,36962,-0.000704873057651917,0.00407406159408002,-0.00869003378204876,0.00728028766674493,0.86264244651692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000608041030747235,0.00353739029759206,-0.00754132601402768,0.00632524395253321,0.863526867097407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR1,Toll-like receptor 1,37056,0.000433513433223846,0.00257962386838422,-0.00462254934880923,0.00548957621525692,0.866544188843749
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,39931,0.000493026462839984,0.00295658009499653,-0.00530187052335322,0.00628792344903318,0.867564406785596
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",39489,0.000887653833437174,0.0053322124221634,-0.0095634825140031,0.0113387901808774,0.867789180039782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.000799424065712727,0.00485314514515906,-0.00871274041879903,0.0103115885502245,0.869164178695353
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REN,Renin,39868,0.00107004287580068,0.00650954509465287,-0.0116886655097189,0.0138287512613203,0.8694336165469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.000507184161639244,0.00324957857378038,-0.0058619898429703,0.00687635816624879,0.87597480811888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLLT1,Protein ENL,36962,-0.00109854002232297,0.00705185096083777,-0.014920167905565,0.0127230878609191,0.876208536212625
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.000851720526252101,0.0055421585320658,-0.0117143512491011,0.0100109101965969,0.877864188636649
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000542815405421385,0.00356177194918465,-0.00752388842582331,0.00643825761498054,0.878873424773954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00040281881377763,0.00267870290863113,-0.00565307651469465,0.00484743888713939,0.880468042878887
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.000870395921708651,0.00580409173588306,-0.0105056238806222,0.0122464157240395,0.880796529693845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.000594919450872049,0.00409613687969672,-0.00862334773507762,0.00743350883333352,0.884524272261145
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL2,Interferon lambda-2,36991,0.00084157432875876,0.00612357058206587,-0.0111606240120903,0.0128437726696079,0.890691474644194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00105081503983592,0.00769890742105085,-0.0161406735850956,0.0140390435054237,0.891436921240006
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHDC3L,KH domain-containing protein 3,36962,0.000814034119013024,0.00656849520479825,-0.0120602164823915,0.0136882847204176,0.901372539286189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.000367582027598896,0.00315758394161205,-0.00582128249796072,0.00655644655315851,0.907327454122028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA2,Adenosine deaminase 2,39782,0.000473279031035004,0.00407120805376743,-0.00750628875434916,0.00845284681641917,0.907455664070409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC9,Histone deacetylase 9,36991,-0.000710498773072498,0.00634770988177117,-0.013152010141344,0.011731012595199,0.910880669562192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.0012657257527278,0.0114457823905903,-0.0236994592382847,0.0211680077328291,0.911947551119528
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,37021,0.000819098246541291,0.00748944213528872,-0.0138602083386246,0.0154984048317072,0.912913028912729
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00025917807128532,0.00241037519690514,-0.00498351345721938,0.00446515731464874,0.914373268092032
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLNS1A,Methylosome subunit pICln,37039,0.000357092969818869,0.00332744209598592,-0.00616469353831354,0.00687887947795128,0.914538686969119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL24,Interleukin-24,39587,-0.000497736035026638,0.00466325149462082,-0.00963770896448344,0.00864223689443016,0.9149999153717
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,39858,0.000301474223025389,0.0028247376307799,-0.00523501153330322,0.005837959979354,0.915007335620063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTF,Ciliary neurotrophic factor,36991,-0.000355790001053419,0.00335364774984216,-0.00692893959074406,0.00621735958863722,0.915512208257791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF174,Zinc finger protein 174,37056,0.000378206922356315,0.00377480443770077,-0.00702040977553718,0.00777682362024981,0.920193058249275
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.000419501764108491,0.00439642924674046,-0.00819749955950281,0.00903650308771979,0.923983411051913
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL6B,Myosin light chain 6B,37039,0.000862406051292819,0.00913462123843836,-0.0170414515760464,0.018766263678632,0.924784345935653
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPN3,Calpain-3,37368,-0.000350987712363444,0.00372128217783997,-0.00764470078092979,0.0069427253562029,0.924857135263593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.000587091141453842,0.00627086333475449,-0.011703800994665,0.0128779832775726,0.92541081701678
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKZF2,Zinc finger protein Helios,39477,0.000863008540772927,0.00929042012200716,-0.0173462148983611,0.019072231979907,0.925990310492467
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALLD,Palladin,37056,0.000348698372718041,0.00402666055883485,-0.00754355632259826,0.00824095306803434,0.930992839084207
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGR,Progesterone receptor,37056,0.000853084530602536,0.0103832436010015,-0.0194980729273603,0.0212042419885654,0.934520938981046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFRC,Transferrin receptor protein 1,39918,0.000303928802639064,0.00385523026365094,-0.00725232251411678,0.0078601801193949,0.937164491143603
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCLN,Nicalin,39587,-0.000408403550479859,0.00520593287751974,-0.0106120319904185,0.00979522488945883,0.937471387671417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSV,Cathepsin L2,39967,0.000311473766687256,0.00404336130188705,-0.00761351438501136,0.00823646191838587,0.938597951379498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAGE2A,G antigen 2A,36962,0.000453698888974131,0.00602663824872931,-0.0113585120785353,0.0122659098564836,0.939991292985355
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00027586441491382,0.00368686268342138,-0.00695038644459209,0.00750211527441973,0.94035618510643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRND,Prion-like protein doppel,37388,-0.000362204564824238,0.00501900765160066,-0.0101994595619615,0.00947505043231305,0.942470416255669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000166672481625492,0.0023598154197139,-0.00445856574101374,0.00479191070426473,0.943693707926506
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.000263266665389994,0.00410055871609098,-0.00830036174892831,0.00777382841814832,0.948809845293966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",37368,0.000258598018006814,0.00433548445498623,-0.00823895151376619,0.00875614754977982,0.95243778124837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSCA,Prostate stem cell antigen,37382,0.0014726571805008,0.0250794399868157,-0.047683045193658,0.0506283595546595,0.953176236142197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,0.000165178766507287,0.00294876754567203,-0.0056144056230099,0.00594476315602447,0.955329722192846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR5,Proline-rich protein 5,37056,-0.000262926135479254,0.00470624443527991,-0.00948716522862788,0.00896131295766937,0.955448203275812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.000268476414074743,0.00491543869524615,-0.0093657834286077,0.00990273625675719,0.956442797433032
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSG1,Tryptase gamma,37056,0.000143822084931255,0.00265926708243047,-0.00506834139663246,0.00535598556649497,0.956869572551611
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,36991,-0.000227605942526482,0.00439589658797492,-0.00884356325495733,0.00838835136990437,0.958707241503965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK3,Prostate-specific antigen,37437,-0.000395658922673321,0.00777800723524339,-0.0156405531037504,0.0148492352584037,0.959430710277885
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00015478985098409,0.00330816138346986,-0.00632920646061684,0.00663878616258502,0.96268105258185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN6,Prefoldin subunit 6,37039,0.000303806406274265,0.00652005253467315,-0.0124754965616851,0.0130831093742336,0.962836165907379
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.000660514341431115,0.0142253752383099,-0.0285422498085185,0.0272212211256562,0.962966543079337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAX,Integrin alpha-X,37169,0.000234952325991998,0.00522382829342153,-0.0100037511291142,0.0104736557810982,0.964126285870056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUOX2,Dual oxidase 2,39585,0.000311745393172199,0.00704018194967492,-0.0134870112281906,0.014110502014535,0.96468108119113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.000162899386740441,0.00448019764729366,-0.00861828800195514,0.00894408677543602,0.970995867278381
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.000205432772843025,0.00759569563102144,-0.0150929962096451,0.014682130663959,0.978423496891784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRX,Cone-rod homeobox protein,39585,0.00027901040801322,0.0106833587923699,-0.0206603728250318,0.0212183936410582,0.979164862219771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,3.84369432132043e-05,0.0032345576200285,-0.00630129599204265,0.00637816987846905,0.9905189695791
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN7,Septin-7,37169,-5.86712636654067e-05,0.00507039214087767,-0.00999663985978564,0.00987929733245483,0.990767780856476
